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ABSTRACT 
Intermittent social defeat stress produces vulnerability to drugs of abuse, a phenomena 
known as cross-sensitization, which is proceeded by a corresponding upregulation of ventral 
tegmental area (VTA) mu-opioid receptors (MORs). Since VTA MORs are implicated in the 
expression of psychostimulant sensitization, they may also mediate social stress-induced 
vulnerability to drugs of abuse. Social stress and drugs of abuse increase mesolimbic brain-
derived neurotrophic factor (BDNF) signaling with its receptor, tropomyosin-related kinase B 
(TrkB). These studies examined whether VTA MOR signaling is important for the behavioral and 
cellular consequences of social stress. First, the function of VTA MORs in the behavioral 
consequences of intermittent social defeat stress was investigated. Lentivirus-mediated 
knockdown of VTA MORs prevented social stress-induced cross-sensitization, as well as stress-
induced social avoidance and weight gain deficits. Next it was examined whether VTA MOR 
expression is critical for stress-induced alterations in the mesocorticolimbic circuit. At the time 
cross-sensitization was known to occur, lentivirus-mediated knockdown of VTA MORs prevented 
stress-induced increases in VTA BDNF and its receptor, TrkB in the nucleus accumbens (NAc), 
and attenuated NAc expression of delta FosB. There was no effect of either stress or virus on 
BDNF expression in the prefrontal cortex. Since social stress-induced upregulation of VTA MORs 
is necessary for consequences of social stress, next activity dependent changes in AKT, a 
downstream target of MOR stimulation associated with sensitization to psychostimulant drugs, 
were investigated. Using fluorescent immunohistochemical double labeling for the active form of 
AKT (pAKT) and markers of either GABA or dopamine neurons in the VTA, it was determined that 
social stress significantly increased the expression of pAKT in GABA, but not dopamine neurons, 
and that this effect was dependent on VTA MOR expression. Moreover, intra-VTA inhibition of 
pAKT during stress prevented stress-induced weight gain deficits, while acute inhibition of VTA 
pAKT blocked the expression of cross-sensitization in subjects that had previously exhibited 
sensitized locomotor activity. Together these results suggest that social stress upregulates MORs 
on VTA GABA neurons, resulting in AKT phosphorylation, and that increased VTA MOR-pAKT 
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signaling may represent a novel therapeutic target for the intervention of substance abuse 
disorders. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
1. INTRODUCTION 
Substance abuse represents a broad reaching societal and economic problem, with 24.6 
million Americans admitting to being ‘current drug users’ in 2013 (SAMHSA, 2014). In the 2012 
fiscal year, the United States nationally spent over $24 billion dealing with the prevention, 
treatment, and criminal consequences of substance abuse (USDOJ, 2011), and when comorbid 
disorders are taken into account, addiction has some of the highest costs of any medical disorder 
(Kreek et al., 2005). While treatment has been the focus of much research, a majority of 
recovering addicts are likely to relapse, thus there is a need for research that focuses on reducing 
the occurrence of substance abuse (Sinha, 2011, NIDA, 2012). Vulnerability to substance abuse 
and addiction are influenced by a variety of genetic and environmental factors (Kreek et al., 
2005). One environmental variable that can influence the transition from recreational drug use to 
abuse is stress, and it has been correlated with both increased substance abuse and relapse 
(Sinha, 2001, 2008, 2011, NIDA, 2012).  
The neurobiological mechanisms of stress and addiction have been widely studied in 
humans and animals. In rodents, mild or intermittent experiences of stress induce changes in the 
mesocorticolimbic circuit that are similar to those seen after exposure to drugs of abuse (Nikulina 
et al., 2014). Much research has focused on increases in dopamine (DA) transmission from the 
ventral tegmental area (VTA) to the nucleus accumbens (NAc) and the changes observed in 
those regions. While the literature generally agrees that increases in VTA DA transmission are 
necessary for many of the behaviors observed after stress or sensitization to drugs of abuse, less 
attention has been paid to the involvement of VTA gamma amino-butyric acid (GABA) 
transmission. Drugs that activate mu-opioid receptors (MORs) have been shown to induce cross-
sensitization to psychomotor stimulants, and in the VTA these receptors have been traditionally 
viewed as being localized to GABA neurons (see review of Nikulina et al., 2014). When inhibitory 
mu-opioid receptors (MORs) are activated on VTA GABA neurons, they reduce GABA 
transmission, thereby increasing VTA DA activity (Johnson and North, 1992, Margolis et al., 
2014). In the case of social stress-induced cross-sensitization to amphetamine, there is a 
2 
corresponding increase in VTA mu-opioid receptor (MOR) expression (Nikulina et al., 2005, 
Nikulina et al., 2008). Taken together, it is possible that stress-induced increases in VTA MOR 
signaling in VTA GABA neurons may indirectly mediate the changes that occur in VTA DA 
neurons, and the behaviors associated with increased DA transmission to the NAc.  
The goal of the experiments described herein is to determine whether VTA MORs play a 
functional role in the effects of social stress. The first experiment asks whether VTA MORs serve 
a functional role in social stress-induced behaviors, specifically stress-induced cross-sensitization 
to amphetamine. The second asks if VTA MORs are necessary for social stress-induced changes 
throughout the mesocorticolimbic circuit. Since MOR activation has been linked to 
phosphorylation of intracellular signaling kinase AKT (Polakiewicz et al., 1998, Iglesias et al., 
2003, Russo et al., 2007, Mazei-Robison et al., 2011), the third experiment asks whether VTA 
MORs mediate stress-induced cross-sensitization through activation of intracellular AKT signaling 
in GABA neurons. The combined results of these experiments will not only improve our 
understanding of stress-induced cross-sensitization to psychomotor stimulants, but may also aid 
in the identification of potential new therapeutic targets.  
 
1.1  Substance Abuse: A Role for Stress 
In 2012, illegal drug use by United States citizens over age 12 reached its highest point in 
ten years, and worldwide, an estimated 183,000 drug-related deaths occurred (UNODC, 2014). 
Estimates from 2012 revealed that 3.5% – 7.0% of the world population had used an illegal drug 
in the last year (UNODC, 2014), while in the United States, an estimated 22.7 million people age 
12 or older have a diagnosable substance abuse disorder (SAMHSA, 2014). Given that the 
majority of recovering addicts are likely to relapse (Sinha, 2011, NIDA, 2012), there is a need for 
research aimed at reducing the occurrence of substance abuse. Similar to the craving induced by 
drug cues, images depicting a stressor induce increases in cocaine craving and anxiety in 
recovering addicts (Sinha et al., 1999, Sinha et al., 2000), suggesting that stressful experiences 
are as potent as drug cues in potentiating relapse. While much research has targeted relapse and 
addiction treatments, the reality is that treatment can be costly and is not always readily available. 
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In fact, treatment for substance abuse was unavailable to 20.2 million of the 22.7 million people 
who were classified as having a substance abuse disorder in 2013 (SAMHSA, 2014), a problem 
which further emphasizes the importance of studying variables which confer vulnerability to drugs 
of abuse. While vulnerability to addiction likely has some genetic component, twin studies have 
shown that only 30-60% of the variance can be explained by heritability (Kreek et al., 2005), 
suggesting that environmental experiences also play a key role in determining susceptibility to 
drugs of abuse. 
Stress is one variable that influences the transition from recreational drug use to abuse. 
In humans, stress has been associated with vulnerability to substance abuse and increased risk 
of relapse (Brewer et al., 1998, Sinha, 2001, 2008, 2011, NIDA, 2012). In rodents, the intermittent 
social defeat stress paradigm (Fig. 1.1) serves as a naturalistic model of social stress-induced 
changes in the behavior and pathology of humans, in particular, this paradigm has been shown to 
augment the effect of psychomotor stimulants, a phenomena termed ‘cross-sensitization’ (see 
reviews of Miczek et al., 2008, Nikulina et al., 2014). While many laboratory stress paradigms 
exist, a basic requirement of such models of vulnerability to addiction, is that the behavioral or 
biological feature being used to classify animals as vulnerable, must be manipulated and 
characterized prior to drug exposure (Piazza and Le Moal, 1996). In addition to satisfying this 
requirement, this model of social defeat stress has high face validity when compared to stress 
responses in humans (Covington and Miczek, 2005, Sinha, 2008).  
Similar to the persistent sensitization induced by intermittent drug exposure (Paulson et 
al., 1991), this social defeat model induces persistent cross-sensitization to amphetamine lasting 
at least 2 months (Nikulina et al., 2004). The effects of stress and psychostimulant drugs are 
related, with both stimuli involving changes in stress-related hormones and trophic factors, 
specifically glucocorticoid hormones (cortisol in humans, corticosterone in rodents) and/or 
corticotropin releasing factor (Piazza and Le Moal, 1996, Sinha, 2001, Marinelli and Piazza, 
2002). The literature strongly suggests that stress and drugs of abuse both act on the 
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Figure 1.1. Schematic of Intermittent Social Defeat Stress. While models of intermittent social 
defeat stress can be daily or episodic, they all consist of a brief losing social interaction in the 
home cage of an aggressive resident. In the above schematic, the defeated intruder rat is a white 
Sprague Dawley, while the aggressive resident is a black and white Long Evans rat. To provoke 
attack by residents, for the first 5 min of stress procedures, the intruder is placed inside a 
protective cage that permits sensory contact (Top). During the physical aggressive encounter, the 
protective cage is removed, allowing the resident to attack (Bottom) until the intruder indicates 
that it has been defeated by display of the submissive supine position (Bottom far right). After 
having been defeated, the intruder is placed back inside the protective cage and exposed to 
threat of attack for an additional 20 min. In contrast to continuous social defeat models, at the 
conclusion of intermittent stress procedures, subjects are returned to home cages that are not in 
proximity to aggressive residents. 
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mesocorticolimbic brain circuit (Cleck and Blendy, 2008, Nikulina et al., 2014), thus the regions 
comprising this circuit serve as potential points of convergence for the effects of stress and drugs 
of abuse. In support of this, augmented dopamine transmission along the mesolimbic pathway 
(VTA-NAc) has been found to be associated with many of the effects of stress and drugs of 
abuse (Piazza and Le Moal, 1996, Sinha, 2001, Marinelli and Piazza, 2002, Cleck and Blendy, 
2008, Nikulina et al., 2014). 
 
1.2  Basic Anatomy of the Mesocorticolimbic Dopamine Circuit 
The mesocorticolimbic circuit (Fig. 1.2), consisting of interconnected midbrain, limbic, and 
cortical areas, has been strongly implicated in the effects of both stress and drugs of abuse 
(Sinha, 2008, Morales and Pickel, 2012, Nikulina et al., 2014). Although neuroplasticity in the 
VTA, NAc, and prefrontal cortex (PFC), as well as other structures, is important for reward, 
stress, and reinforcing behaviors, it is well accepted that increased mesolimbic (VTA-NAc) DA 
transmission is crucial for many of the effects stress and drugs of abuse (see reviews of Fields et 
al., 2007, Nikulina et al., 2014). In fact, VTA DA transmission and release in the NAc is necessary 
for the induction of sensitization to both psychomotor stimulants and opiates (Joyce and Iversen, 
1979, Vezina et al., 1987, Vezina and Stewart, 1989, Pierce and Kumaresan, 2006). The neurons 
found in the VTA are highly heterogeneous, with neuronal types differentially distributed across 
the rostocaudal and mediolateral axes of the VTA (Nair-Roberts et al., 2008, Morales and Pickel, 
2012). The entire VTA region largely consists of dopamine neurons (50-65%), followed by GABA 
neurons (30-35%; Swanson, 1982, Oades and Halliday, 1987, Yamaguchi et al., 2007, Nair-
Roberts et al., 2008), and glutamate neurons (2-3% Nair-Roberts et al., 2008). Study of this 
region has been complicated by the recent finding that a significant portion of glutamate neurons 
also express tyrosine hydroxylase (TH), the rate limiting enzyme in the synthesis of dopamine  
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Figure 1.2. Schematic of Mesocorticolimbic Projections. The VTA (green), NAc (yellow), and 
PFC (blue) represent major nodes in the mesocorticolimbic circuit that are highly interconnected 
by afferent and efferent projections (Fields et al., 2007, Sesack and Grace, 2010, Morales and 
Pickel, 2012, Walsh and Han, 2014, Fields and Margolis, 2015). 
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(Fields et al., 2007, Morales and Pickel, 2012, Morales and Root, 2014). Based on this, VTA 
neurons can release GABA, DA, glutamate, or co-release glutamate and DA. 
In addition to sending/receiving VTA excitatory/inhibitory projections to/from other areas of the 
mesocorticolimbic circuit (Fig. 1.2), the VTA also contains a population of GABA interneurons 
(Fields et al., 2007, Ting and van der Kooy, 2012). Excitatory glutamate projections from the PFC 
innervate the VTA and NAc, while the NAc sends inhibitory GABA projections to the PFC and 
VTA (Morales and Pickel, 2012, Fields and Margolis, 2015). Despite receiving GABA projections 
from the NAc, the rostromedial tegmental nucleus (tail of the VTA) is one of the primary sources 
of GABA release in the VTA and its neurons preferentially synapse with VTA DA neurons (see 
reviews of Ting and van der Kooy, 2012, Nikulina et al., 2014). Projections from VTA DA, GABA, 
and glutamate neurons synapse in both the NAc and PFC (see reviews of Fields et al., 2007, 
Morales and Pickel, 2012). Although VTA DA neurons project both to the NAc (mesolimbic 
pathway) and to the PFC (mesocortical pathway), far more DA transmission is associated with 
the mesolimbic than the mesocortical DA pathway (see review of Fields et al., 2007). While 
increased DA transmission along the mesolimbic pathway is associated with many of the effects 
of stress and drugs of abuse, this increase in activity of VTA DA neurons can be mediated by 
local inputs from GABA neurons (see reviews of Ting and van der Kooy, 2012, Nikulina et al., 
2014), as well as extrinsic projections from the PFC and NAc (see reviews of Morales and Pickel, 
2012, Fields and Margolis, 2015). 
 
1.3  A Role for Mu-Opioid Receptors in the Regulation of Ventral Tegmental Area Dopamine 
Transmission 
Decreased GABA release from local interneurons is one way in which the activity of VTA 
DA neurons can be increased. In the VTA, MORs are traditionally considered to be inhibitory on 
GABA neurons that project to VTA DA neurons (Johnson and North, 1992, Sesack and Pickel, 
1995, Garzon and Pickel, 2002). When activated, these MORs inhibit GABA transmission, 
subsequently increasing release of DA in the NAc (Fig. 1.3) and facilitating response to drugs of  
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Figure 1.3. Stimulation of VTA MORs Disinhibits VTA DA Neurotransmission. (A) In the 
VTA, the majority of MOR have an inhibitory effect on VTA GABA neurons, in particular, a sub-
population of GABA interneurons. In basal conditions, where VTA MORs are largely inactive, 
tonic GABA neurotransmission serves to inhibit local DA neurotransmission. (B) When VTA MOR 
receptors are stimulated on GABA neurons, either by an endogenous or exogenous agonist, they 
generally produce an inhibitory effect. This MOR-induced inhibition of VTA GABA neurons serves 
to disinhibit local DA neurotransmission (Johnson and North, 1992). While this schematic depicts 
pre-synaptic MORs, it is important to note that MORs can also be found post-synaptically, (see 
Chapter 1, Section 3.2 for details). Red circle: GABA neurotransmitter; green circle: DA 
neurotransmitter; blue circle: MOR; fuchsia cylinder: MOR agonist; number of red or green circles 
indicate degree of neurotransmission. 
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abuse (Fig. 1.3; Johnson and North, 1992, Bergevin et al., 2002; see also review of Dacher and 
Nugent, 2011). Some MORs have also been found on VTA DA neurons (Margolis et al., 2014), 
putting MOR signaling in a position to directly mediate the neurotransmission of both VTA DA and 
GABA neurons. Recent data have shown that some VTA MORs can actually be excitatory, and 
suggest that when activated separate receptors can simultaneously exert an excitatory and 
inhibitory effect on the same cell (Margolis et al., 2014). Ultimately, this means that VTA MORs 
are capable of influencing the changes in VTA DA transmission in two ways: through direct 
activity on DA neurons, or indirectly through modulation of local GABA transmission.  
 
2. Effects of Social Stress 
2.1 Behavioral Consequences of Social Stress 
The rodent social defeat stress paradigm serves as a naturalistic model of stress-induced 
changes in the behavior and pathology of humans. While many stress paradigms serve to 
increase anxiety and depression-like behaviors, the social defeat paradigm is unique due to the 
face validity in the social nature of its stressor, as well as the lack of habituation associated with 
repeated exposure (Covington and Miczek, 2005). Social defeat stress has been shown to 
produce increases in anxiety in rodents, as evidenced by: increased acoustic startle response 
(Pulliam et al., 2010), ultrasonic vocalizations (van der Poel and Miczek, 1991, Vivian and 
Miczek, 1999), and time spent freezing (Venzala et al., 2012). Many of the changes seen after 
social defeat stress; including hyperalgesia to hot and cold temperatures (Marcinkiewcz et al., 
2009, Hayashida et al., 2010) and increased analgesia (Siegfried et al., 1990, Williams et al., 
1990, Teskey and Kavaliers, 1991, Rodgers, 1995), suggest that MOR play a critical role in social 
stress-induced long-term neuroplasticity. 
The specific outcomes observed after social defeat stress are known to be influenced by 
the temporal pattern used during the administration of defeat (Miczek et al., 2008, Miczek et al., 
2011a). In general repeated episodes of social defeat have been shown to increase social 
avoidance of a novel conspecific (Razzoli et al., 2009, Venzala et al., 2012) and to induce deficits 
in weight gain (Meerlo et al., 1996, Fanous et al., 2010, Pulliam et al., 2010, Fanous et al., 2011, 
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Venzala et al., 2012). In contrast, while continuous social defeat reduces preference for sweet 
rewards, only intermittent social defeat stress induces the behavioral sensitization that can lead to 
increased drug use (Miczek et al., 2011a). More specifically, intermittent social defeat stress 
consistently produces cross-sensitization to psychomotor stimulants (Covington and Miczek, 
2001, Nikulina et al., 2005, Nikulina et al., 2012). Rodent studies have shown that repeated, non-
continuous, social defeat stress consistently produces social avoidance (Razzoli et al., 2009, 
Fanous et al., 2011) and augments the effect of psychomotor stimulants, a phenomena known as 
‘cross-sensitization’ (Covington and Miczek, 2001, Nikulina et al., 2004, Nikulina et al., 2012). In 
addition to psychomotor stimulants, repeated social stress also induces cross-sensitization to 
opiates, but does not increase binge-like responding for morphine (Cruz et al., 2011). Such 
behavioral sensitization to drugs of abuse is thought to reflect changes in the mesocorticolimbic 
circuit (Vanderschuren and Kalivas, 2000). 
 
2.2   Stress-Induced Alterations Across the Mesocorticolimbic Circuit  
Social defeat stress is known to have a significant impact on mesocorticolimbic 
expression of delta FosB and BDNF. Delta FosB is a transcription factor and the truncated form 
of FosB, a member of the Fos family of proteins. Much attention has been given to delta FosB 
because it gradually accumulates in response to repeated stimuli, such as stressor or drug, and 
can persist for long periods of time due to its high stability (see reviews of Nestler et al., 2001, 
Nestler, 2008, 2014). Generally BDNF is associated with brain regions rich in DA neurons, and in 
the VTA BDNF is known to co-localize with TH, a reliable marker for DA neurons (Gall et al., 
1992, Seroogy et al., 1994). Interestingly, social stress not only increases BDNF and delta FosB 
in the NAc and PFC, but it also increases the co-expression of the two molecules (Nikulina et al., 
2012). Both BDNF and delta FosB are thought to play an important role in responses to stress 
and drugs of abuse. As a key mediator of DA signaling in the VTA-NAc pathway, VTA BDNF is 
thought to mediate many stress- and drug-induced changes that occur in the NAc (see review of 
Nikulina et al., 2014). Although the expression of NAc delta FosB has not been shown to mediate 
mesolimbic DA transmission, this transcription factor has been well implicated as a downstream 
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indicator of augmented VTA DA activity (see reviews of Nestler et al., 2001, Nestler, 2008). Social 
defeat stress also induces a rapid and prolonged upregulation of VTA MORs (Nikulina et al., 
2005, Nikulina et al., 2008). After repeat social defeat stress, stimulation of VTA MOR’s by a 
MOR agonist has been shown to produce sensitized locomotor activity (Nikulina et al., 2005, 
Nikulina et al., 2008) during the same time period that social stress-induced cross-sensitization to 
psychomotor stimulants has been observed (Covington and Miczek, 2001, Nikulina et al., 2004, 
Nikulina et al., 2012). While it is unknown whether the expression of VTA MORs plays a role in 
stress-induced cross-sensitization to psychomotor stimulants, given that VTA MORs have the 
ability to mediate VTA GABA and DA transmission (Johnson and North, 1992, Margolis et al., 
2014), it is very possible that they too play a role in mediating stress-induced sensitization to 
drugs. The effect of social defeat stress on the expression of these three proteins, and their 
respective relationships to the behavioral outcomes of such social stress, will next be discussed 
in turn. 
 
2.2.1  Social Stress-Induced Expression of Delta FosB 
 Delta FosB is nuclear transcription factor and a truncated splice variant of FosB, as such 
it is a member of the Fos family of genes, which include: Fos, FosB, FosL1, and FosL2 
(Dobrazanski et al., 1991, Morgan and Curran, 1995). Like other members of the Fos family, delta 
FosB heterodimerizes with proteins belonging to the Jun family, predominantly JunD, to form 
activator protein-1 (AP-1) complexes which augment gene expression by binding to AP-1 sites on 
promoter sequences. The C-terminal of the full form of FosB contains two degron domains that 
direct normal protein ubiquitination and degradated by proteasomal-dependent and -independent 
complexes (Dobrazanski et al., 1991, Carle et al., 2007). The delta FosB splice variant is a 
product of a premature stop codon, which produces the delta FosB variant that is missing the 101 
amino acid C-terminus found in the full form of FosB (Dobrazanski et al., 1991). The C-terminus 
of FosB codes for the two degron domains, as such delta FosB lacks the two degron domains 
found in the missing C-terminus, which significantly prolongs the half-life of delta FosB (Carle et 
al., 2007). Further stability is conferred to delta FosB protein by phosphorylation of Ser27, by 
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either casein kinase 2 or calcium/calmodulin-dependent protein kinase II (CaMKII; Ulery et al., 
2006, Robison et al., 2013). In contrast to the marked stability associated with delta FosB protein, 
its mRNA is fairly unstable and degrades quickly (Hope et al., 1994, Chen et al., 1995, Kelz and 
Nestler, 2000). Due to the prolonged stability of delta FosB, this transcription factor has been 
widely studied in the context of drug addiction and stress, and it is considered a prolonged marker 
of neuronal activation and plasticity in the brain (Nestler, 2008, 2014). 
Repeated social defeat stress induces a prolonged increase of delta FosB throughout the 
mesocorticolimbic circuit (Nikulina et al., 2008, Nikulina et al., 2012). The time course of social 
stress-induced delta FosB expression in the mesocorticolimbic circuit has been well characterized 
and increased delta FosB expression persists for up to two weeks after the termination of stress 
procedures (Nikulina et al., 2008). Social stress-induced increases in delta FosB expression in 
the NAc generally last for around 10 days (Nikulina et al., 2012), a time period that corresponds 
to the expression of stress-induced amphetamine sensitization. However attempts to localize 
stress-induced changes in delta FosB expression in specific NAc structures have produced mixed 
findings. In particular, one study only detected a significant increase in delta FosB expression in 
the NAc shell (Nikulina et al., 2008), while another found significant increases in both the NAc 
shell and core at 10 days (Nikulina et al., 2012). Differences in delta FosB expression in the NAc 
core and shell after stress may be attributed to natural variability in the intensity of the social 
stress experience. Similar variability in delta FosB expression has been noted in the ventral 
striatum after cocaine self-administration, and it correlates with the intensity and duration of the 
drug stimulus (Larson et al., 2010). Of particular interest, the effects of delta FosB induction in the 
NAc appear to be specific to this splice variant, as overexpression of either the full form of FosB 
or the alternative splice variant delta2 delta FosB (Δ2FΔFosB), which is missing the 78 amino 
acid N-terminus, did not alter stress- or cocaine-induced behaviors in mice (Ohnishi et al., 2015).   
Compared to the NAc, social stress seems to induce comparable changes in delta FosB 
expression across sub-regions of the PFC. Increased delta FosB expression has been detected 
for up to 7-10 days after the last episode of stress in the infralimbic, prelimbic, and anterior 
cingulate regions of the PFC (Nikulina et al., 2008, Nikulina et al., 2012). In contrast to both the 
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NAc and PFC, social stress does not seem to induce changes in delta FosB expression in the 
VTA with a recent study failing to note a significant increase in VTA delta FosB expression 10 
days after the last episode of defeat (Nikulina et al., 2012). Given that 10 days after the 
termination of stress corresponds to the onset of psychostimulant sensitization (Nikulina et al., 
2012) and that social stress increases mesolimbic DA activity (Tidey and Miczek, 1996), it is 
interesting that stress-induced increases in VTA delta FosB expression were not noted at this 
time (Nikulina et al., 2012). While delta FosB is largely unaffected in the VTA after social stress, 
the stress-induced expression of NAc delta FosB is mediated by the release of BDNF in the NAc 
(Wang et al., 2013, Wang et al., 2014), the source of which is presumably the VTA (Berton et al., 
2006, Wang et al., 2013). 
 
2.2.2  Social Stress-Induced Expression of BDNF 
Social defeat stress is known to have huge impact on the expression of VTA BDNF, and 
the expression of this protein has been associated with the effects of both stress and drugs of 
abuse (see review of Nikulina et al., 2014). In fact, BDNF signaling with its receptor, tropomyosin-
related kinase B (TrkB) in the NAc has been shown to mediate the behavioral and neurochemical 
changes associated with social defeat stress (Wang et al., 2014). In the NAc, social stress 
presumably increases the expression of TrkB receptor on medium spiny neurons, however it is 
also possible that the receptor is increased on DA projections that originate in the VTA, as their 
cell bodies express and release BDNF into the NAc. While TrkB receptor is also found in the 
VTA, and its expression on VTA GABA neurons is implicated in the effects of opioids (Vargas-
Perez et al., 2009b, Vargas-Perez et al., 2014), it is not known whether social stress alters TrkB 
receptors in the VTA.  
Increased VTA BDNF expression has been implicated as a long-term mediator of social 
stress-induced cross-sensitization (Nikulina et al., 2012), and in the VTA this increase persists for 
at least 2 weeks after the last social stress exposure (Fanous et al., 2010, Nikulina et al., 2012). 
Social stress also induces a rapid and transient increase of BDNF expression in the PFC, lasting 
about a week (Fanous et al., 2010, Nikulina et al., 2012). Due to the rapid and transient nature of 
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BDNF expression in the PFC, it has been difficult to determine the functional implications of its 
expression in this region. However it is likely that the PFC is one of the first mesocorticolimbic 
areas affected by social stress and that stress-induced alterations PFC neurotransmission 
mediate subsequent changes in its projection targets. By contrast, social stress-induced 
expression of VTA BDNF is better understood and VTA BDNF is known to play a critical role in 
social stress-induced cross-sensitization to amphetamine (Wang et al., 2013, Wang et al., 2014) 
and social stress-induced social avoidance (Berton et al., 2006, Fanous et al., 2011).  
However, drawing similar conclusions across different models of social defeat stress in 
rats and mice warrants caution, as species differences have been noted. In particular, continuous 
social defeat stress reduces VTA BDNF in rats, while increasing it in mice (for details, see review 
of Nikulina et al., 2014), suggesting that BDNF may play a species-specific role in stress 
responses. Despite this, the expression of social stress-induced VTA BDNF in rats has been 
consistently correlated with cross-sensitization to amphetamine (Wang et al., 2013, Wang et al., 
2014). Specifically, overexpression of VTA BDNF has been shown to exacerbate (Wang et al., 
2013), while NAc knockdown of the BDNF receptor, TrkB, prevented social stress-induced cross-
sensitization to amphetamine (Wang et al., 2014). Similarly, viral deletion of VTA BDNF 
prevented social stress-induced social avoidance (Berton et al., 2006, Fanous et al., 2011). 
Taken together, these findings suggest that increased VTA BDNF expression is one of the most 
functionally important changes induced after social stress. 
 
2.2.3  Social Stress-Induced Upregulation of VTA MORs 
A rapid and prolonged upregulation of VTA MOR can be found during the same time 
period that social defeat stress-induced increases in delta FosB, VTA BDNF and cross-
sensitization to amphetamine occur (Nikulina et al., 2005, Nikulina et al., 2008, Nikulina et al., 
2012). In the VTA, MORs are predominantly expressed by GABA neurons (Sesack and Pickel, 
1995, Garzon and Pickel, 2002), which are hyperpolarized in response to MOR stimulation. Acute 
social defeat stress rapidly upregulates MOR mRNA expression in the VTA (Nikulina et al., 1999, 
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Nikulina et al., 2008), while repeated social stress exposure increases VTA MOR mRNA 
expression for up to 14 days after the last episode (Nikulina et al., 2008).  
There is a high correlation between MOR mRNA expression and levels of protein binding 
(Mansour et al., 1994), suggesting that stress-induced increases in VTA MOR expression 
correspond to in endogenous mu-opioid peptide activity in the VTA. While it is unknown whether 
endogenous mu-opioid peptides are more abundant in the VTA after stress, rats exposed to 
repeated social defeat stress and then challenged with an intra-VTA infusion of a MOR-specific 
agonist exhibited sensitized locomotor activity (Nikulina et al., 2005, Nikulina et al., 2008). This 
VTA MOR agonist-induced sensitized locomotor activity was present during the same time period 
that social stress-induced cross-sensitization to psychomotor stimulants has been observed 
(Covington and Miczek, 2001, Nikulina et al., 2004, Nikulina et al., 2012), suggesting that the 
stress-induced upregulation of VTA MORs potentiates an increase in VTA DA activity (Fig. 1.3). 
 Expression of MORs is important for social stress-induced behavioral alterations, as 
genetic MOR knockout mice do not exhibit social avoidance following continuous social defeat 
(Komatsu et al., 2011). Taken together, these findings support the involvement of VTA MORs in 
the regulation of VTA DA transmission and suggest that MORs may play a critical role in the long-
term neuroplasticity induced by social stress. 
 
2.2.4  Interaction of Stress-Induced Expression of BDNF, MORs and Delta FosB in the 
Mesolimbic Pathway 
While VTA MOR mRNA expression rapidly increases following social stress exposure 
(Nikulina et al., 2005, Nikulina et al., 2008), VTA BDNF expression is affected more slowly 
(Fanous et al., 2010). In contrast, the rapid increase of VTA MOR expression corresponds to 
social stress-induced mesocorticolimbic FosB expression (Nikulina et al., 2008). Similar to the 
prolonged expression of stress-induced delta FosB, VTA MOR expression is increased for 
roughly two weeks after stress termination (Nikulina et al., 2008). The stress-induced expression 
of these two proteins is related, as post-stress intra-VTA agonism of MORs exacerbated stress-
induced increases in NAc delta FosB expression (Nikulina et al., 2008). In addition, 
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overexpression of VTA BDNF and knockdown of NAc TrkB receptor respectively enhance or 
attenuate social stress-induced expression of delta FosB in the NAc (Wang et al., 2013, Wang et 
al., 2014). Based on the respective relationships that exist between BDNF, delta FosB, and 
MORs in the mesolimbic pathway, it is possible that intermittent social defeat stress-induced 
increases in VTA BDNF and NAc delta FosB expression are related to upregulation of VTA 
MORs. 
 
2.3 Neurological Correlates of Substance Abuse: Similarities to the Effects of Stress 
Similar to social stress, many drugs of abuse induce changes in the mesocorticolimbic. In 
particular, increased mesolimbic DA transmission is thought to underlie many of sensitizing and 
reinforcing properties of drugs of abuse (Kalivas and Stewart, 1991, Pierce and Kumaresan, 
2006, Thomas et al., 2008), and is implicated in the effects of social stress (Tidey and Miczek, 
1996). The involvement of delta FosB, BDNF/TrkB receptor, and MORs have been studied in the 
context of both opiate and psychostimulant drugs. The drug-induced changes in the 
mesocorticolimbic expression of these proteins will be discussed next, with special emphasis on 
changes in the mesolimbic DA pathway. 
 
2.3.1  Drugs of Abuse and Delta FosB Expression 
An accumulation of delta FosB in the NAc is one of the most notable responses to 
repeated administration of drugs effecting DA transmission and in many cases disruption of delta 
FosB signaling inhibits the development of addiction-associated behaviors, including sensitized 
locomotor behaviors (see reviews of Nestler et al., 2001, Nestler, 2008). The expression of delta 
FosB is important for the effects of psychomotor stimulants, specifically, sensitization to cocaine 
increases delta FosB expression in subregions of the NAc shell in rats (Brenhouse and Stellar, 
2006). By contrast, viral-mediated induction of delta FosB in the orbitofrontal cortex potentiates 
the locomotor stimulant properties of cocaine (Winstanley et al., 2009). Further support for the 
involvement of delta FosB in the effects of psychostimulant drugs comes from genetic knockout 
mice, notably, FosB knockout mice do not sensitize to cocaine (Hiroi et al., 1997). The expression 
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of delta FosB in the NAc has been consistently associated with the effects of psychostimulant 
drugs, specifically its expression is associated with acute cocaine treatment (Larson et al., 2010), 
and also withdrawal from chronic psychostimulant treatment (Murphy et al., 2003, Larson et al., 
2010). CaMKII is also implicated in the effects of psychostimulant drugs and is of particular 
interest, as it is both upstream and downstream of delta FosB expression in the NAc. Specifically, 
CaMKII is necessary for the cocaine-induced accumulation of delta FosB in the NAc, while delta 
FosB is both necessary and sufficient for the induction of CaMKIIα gene expression in NAc D1 
receptor-containing medium spiny neurons (Robison et al., 2013). In addition to conferring 
stability to delta FosB by phosphorylation of Ser27, CaMKII also phosphorylates delta FosB on 
Thr149, which regulates its transcriptional activity to control locomotor responses to cocaine 
(Cates et al., 2014). Specifically, phosphomimetic mutation of Thr149 increased AP-1 
transcriptional activity, while viral-mediated manipulation of NAc delta FosB at Thr149 controlled 
locomotor responses to cocaine (Cates et al., 2014). 
Opiate sensitization has also been associated with increased delta FosB expression in 
multiple brain regions associated with reward, learning, and stress. In particular, morphine 
sensitization has been found to increase the expression of delta FosB in the NAc core, as well as 
the infralimbic and prelimbic regions of the PFC (Kaplan et al., 2011). Additionally, 
overexpression of delta FosB in the NAc enhances sensitivity to the rewarding properties of 
morphine and exacerbates physical dependence (Zachariou et al., 2006). It is interesting that 
opposing behavioral phenotypes of morphine dependence and withdrawal have both been 
associated with increased delta FosB expression in nuclei of the brain stress system, including 
the NAc shell (Nunez et al., 2010). Of particular relevance to stress-induced changes in delta 
FosB and MOR expression, increased expression of delta FosB in the NAc shell of opioid-
dependent rats was prevented by adrenalectomy (Garcia-Perez et al., 2012). 
Other transcription factors have also been implicated in the effects of stress and drugs of 
abuse, such as cAMP response binding element (CREB), however in the NAc, CREB and delta 
FosB are thought to act in opposition to one another. Specifically CREB expression is thought to 
regulate a negative feedback mechanism through the induction of dynorphin, while delta FosB 
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expression in D1 receptor containing medium spiny neurons suppresses dynorphin and has pro-
reward behavioral effects (see review of Nestler, 2013). Consistent with this view, in rats 
intermittent social defeat stress is known to increase delta FosB (Nikulina et al., 2008, Nikulina et 
al., 2012) and to reduce levels of phosphorylated CREB in the NAc (Yap et al., 2014). Despite 
this, it is important to note that phosphorylation of CREB at the FosB promoter is necessary for 
cocaine-induced NAc Fosb/delta FosB expression (Vialou et al., 2012), an effect which appears 
to mediated by histone H3 lysine 9 (H3K9me2), a repressive histone modification (Heller et al., 
2014). Delta FosB is thought to act as either a transcriptional activator or repressor, depending on 
the nature of the target gene (Nestler, 2008, 2014). Although the expression of delta FosB does 
not necessarily mediate withdrawal or reinstatement, its expression is closely related to 
behavioral sensitization (Nestler et al., 2001, Kalivas and O'Brien, 2008, Nestler, 2008). Through 
regulating the expression of particular genes in the mesocorticolimbic circuit, delta FosB may 
represent one mechanism underlying changes associated with substance abuse (Nestler et al., 
2001, Nestler, 2008).  
 
2.3.2  Drugs of Abuse and BDNF – TrkB Receptor Signaling  
The effects of different classes of drugs of abuse have been found to involve BDNF 
expression in the VTA. In particular, increased expression of VTA BDNF is frequently observed 
as a consequence of psychostimulant administration (Horger et al., 1999, Grimm et al., 2003, 
Bolanos and Nestler, 2004, Corominas et al., 2007, Thomas et al., 2008). Specifically, increases 
in VTA BDNF expression have been implicated in cocaine self-administration and withdrawal 
(Grimm et al., 2003), and BDNF infusion into the VTA enhances cocaine induced locomotion 
(Pierce et al., 1999). A single VTA infusion of BDNF at the end of cocaine self-administration 
enhances responding to cocaine-cues for up to 30 days after termination of cocaine use (Lu et 
al., 2004). 
While less frequently reported, research has shown that chronic treatment with the 
exogenous opiates, such as morphine, also induces the expression VTA BDNF (Vargas-Perez et 
al., 2009b) . Additionally, increases in VTA BDNF expression have also been noted 7 days after 
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forced abstinence from morphine, but not at 2 h or 24 h (Mashayekhi et al., 2012). Of particular 
interest, in the context of opiates, BDNF seems to play different roles depending on drug history. 
Specifically, in drug-naïve rats, opiate effects are DA-independent, however VTA infusion of 
BDNF resulted in a shifted rats to a DA-dependent state associated with chronic morphine or 
heroin (Vargas-Perez et al., 2009b). It should also be noted that other studies have found that 
chronic morphine treatment either had no effect on VTA BDNF expression (Numan et al., 1998), 
or decreased its expression (Chu et al., 2007). However in light of the findings from the van der 
Kooy lab (Laviolette et al., 2004; Vargas-Perez et al., 2009, see also review by Ting and van der 
Kooy, 2012), it is possible that conflicting findings on opiate-induced VTA BDNF expression may 
be attributed to differences in drug history, as well as potential differences in the underlying 
endogenous VTA opioid system.  
Expression of the BDNF TrkB receptor in the NAc is also important for the effects of 
opiate and psychostimulant drugs. In particular, over-expression of BDNF or TrkB receptor in the 
NAc has been shown to exacerbate chronic cocaine-induced psychomotor sensitization, 
conditioned place preference, and reinstatement, while these changes were inhibited by 
expression of a dominant negative form of TrkB receptor in the NAc (Bahi et al., 2008). The 
results of another study further suggest that while BDNF expression in either the VTA or NAc is 
important for the maintenance of cocaine reward, this effect is mediated by BDNF activation of 
TrkB receptors in the NAc (Graham et al., 2009). In addition to being crucial for the effects of 
chronic cocaine, activity of the BDNF’s TrkB receptor is also necessary for the behavioral 
sensitization and conditioned place preference induced by a single injection of cocaine (Crooks et 
al., 2010). Using genome-wide interference of TrkB expression, this study found that cocaine 
increased TrkB receptor phosphorylation in the NAc (Crooks et al., 2010), which is consistent with 
the role of mesolimbic BDNF – TrkB receptor signaling in the effects of chronic cocaine (Bahi et 
al., 2008, Graham et al., 2009). In addition to its involvement in drug-induced changes, VTA 
BDNF has also been implicated as a long-term mediator of social stress-induced cross-
sensitization to psychomotor stimulants (Nikulina et al., 2012). In fact, overexpression of BDNF 
exacerbates social stress-induced cross-sensitization to amphetamine (Wang et al., 2013), and 
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BDNF signaling with its receptor, TrkB, in the NAc is necessary for the induction of stress-induced 
sensitization (Wang et al., 2014).  
In the medial PFC, BDNF expression was shown to increase 24 h after the last session of 
cocaine self-administration, however this increase was not present 7 days later (Fumagalli et al., 
2013). Thus, while psychostimulants induce increases in PFC BDNF expression, these increases 
seem to be temporally and functionally different from those found in the mesolimbic pathway. For 
example, while increased mesolimbic BDNF enhances many effects of psychostimulants (see 
reviews of Ghitza et al., 2010, Nikulina et al., 2014), infusion of BDNF into the PFC actually 
reduces cocaine seeking after 1 or 6 days of withdrawal (Berglind et al., 2007). Similarly, for 
cocaine, context-induced reinstatement is attenuated by inactivation of the dorsal, rather than the 
ventral, portion of the medial PFC, while the opposite is true for heroin (Badiani et al., 2011). 
  
2.3.3  Drugs of Abuse and MOR Expression and Activity 
A role for MORs in the effects of both exogenous opiates, such as heroin and morphine, 
as well as psychomotor stimulants, such as cocaine and amphetamine, has been long supported 
been supported by the literature. In particular, systemic injections of morphine cross-sensitize 
animals to amphetamine (Vezina et al., 1989), and intra-VTA MOR agonism produce sensitization 
to cocaine and amphetamine (DuMars et al., 1988). Additionally, the expression of amphetamine 
sensitization is associated with persistent VTA MOR upregulation, and can be blocked by a 
treatment with MOR antagonist (Magendzo and Bustos, 2003, Trigo et al., 2010). Similarly MOR 
receptor interference in the VTA – substantia nigra regions blocks the rewarding and locomotor 
effects of the exogenous opiate, heroin (Zhang et al., 2009). Traditionally, VTA MORs are thought 
to be found on GABA neurons (Sesack and Pickel, 1995, Garzon and Pickel, 2002), which are 
hyperpolarized in response to MOR stimulation, thus disinhibiting local DA transmission (Fig. 1.3) 
and facilitating response to drugs of abuse (Johnson and North, 1992; see also review by Dacher 
and Nugent, 2011, Bergevin et al., 2002). Consistent with this view, MOR knockout mice exhibit 
reduced cocaine self-administration and increased VTA GABA transmission (Mathon et al., 
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2005). In rats trained to seek cocaine and put through withdrawal, injection of heroin primes 
reinstatement of cocaine-seeking (Lu and Dempsey, 2004). 
While VTA MOR activity seems to allow for an interaction between opiate and 
psychostimulant drugs, it is important to note that these drugs are not entirely interchangeable. 
For example, in rats escalated self-administration of cocaine is not predictive of heroin escalation, 
and escalated self-administration of heroin is not predictive of cocaine (Lenoir et al., 2012). Of 
particular importance, while repeated social defeat stress induces locomotor sensitization to both 
opiates and psychomotor stimulants (Miczek et al., 2008), binge-like drug consumption has only 
been associated with cocaine, and not heroin (Cruz et al., 2011). 
 
2.3.4  Interactions Between Drug and Stress-Induced Alterations in Mesolimbic BDNF, MOR 
and Delta FosB Expression 
 Many of the mesocorticolimbic changes associated with drugs of abuse are also induced 
by social defeat stress (Fig. 1.4, Nikulina et al., 2014). The changes common to social stress and 
drugs of abuse may allow for a functional interaction between stress and drugs of abuse in the 
mesocorticolimbic circuit. As discussed in the previous two sections (1.2.2 and 1.2.3), the effects 
of stress, opiates and psychostimulants have been associated with increased mesolimbic 
BDNF/TrkB expression, VTA MOR expression, and NAc delta FosB expression. Stress- and 
drug-induced changes in the mesolimbic expression of these proteins are likely related at both 
the molecular and behavioral level.  
Behaviorally, analgesia is induced after exposure to either opiate drugs (Zachariou et al., 
2006, Solecki et al., 2008) or social stress (Siegfried et al., 1990, Williams et al., 1990, Teskey 
and Kavaliers, 1991, Rodgers, 1995), and in the case of morphine, analgesic tolerance is 
reduced in FosB knockout mice (Solecki et al., 2008), an effect which appears to be specific to 
the NAc (Zachariou et al., 2006). Additionally, after repeated social stress, delta FosB and BDNF 
are known to co-localize in the NAc and PFC 10 days after cessation of stress procedures  
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Figure 1.4. Effects of Drugs and Stress on VTA BDNF Expression and Mesolimbic Tone 
(from Nikulina et al., 2014). Under normal conditions, VTA GABA neurons express low levels of 
mu-opioid receptors (MORs) and tonically inhibit VTA dopamine (DA) neurons, producing low 
levels of DA neurotransmission to NAc medium spiny neurons (MSNs). After intermittent social 
defeat stress, MORs are upregulated on VTA GABAergic neurons, resulting in disinhibition of 
VTA DA neurons and enhanced BDNF expression (Johnston et al., 2015). In general, 
psychostimulant drugs increase DA in the synaptic cleft by blocking dopamine transporter (DAT) 
or releasing DA from pre-synaptic terminals which leads to induction of VTA BDNF and its 
release in the NAc (Graham et al., 2009, Wang et al., 2013, Wang et al., 2014), while opiates act 
on VTA GABA neurons, disinhibiting VTA DA signaling and increasing BDNF expression (Vargas-
Perez et al., 2009a, Ting et al., 2013). In summary, stress, psychostimulants, and opiates all 
increase DA and BDNF signaling, albeit through different mechanisms. Size of red/green arrows 
represent strength of GABA or DA neurotransmission; large red circle: GABA neuron; large green 
circle: DA neuron; small blue trapezoids: MORs; orange diamonds: endogenous opioids; pink 
diamonds: exogenous opiates; purple diamonds: psychostimulant drugs; purple cylinders: DAT; 
small yellow crescents: TrkB receptors; small yellow circles: BDNF molecules; red heptagon: 
MSN. 
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(Nikulina et al., 2012) and stress-induced increases in NAc delta FosB are dependent on local 
BDNF/TrkB receptor activity (Wang et al., 2014). Increased VTA BDNF expression is associated 
with both opiate and psychostimulant drugs of abuse, and also social stress (see review of 
Nikulina et al., 2014), and social stress-induced cross-sensitization to amphetamine is dependent 
on VTA BDNF – NAc TrkB receptor signaling (Wang et al., 2013, Wang et al., 2014). In addition, 
social stress-induced social avoidance is prevented by viral knockdown of VTA BDNF (Fanous et 
al., 2011), as well as in genetic MOR knockout mice (Komatsu et al., 2011). Moreover, 
augmented mesolimbic DA transmission is associated with sensitization to psychomotor 
stimulants and social stress (Fig. 1.4; Piazza and Le Moal, 1996, Sinha, 2001, Marinelli and 
Piazza, 2002, Cleck and Blendy, 2008, Nikulina et al., 2014), and both social stress and 
psychomotor stimulants increase the expression of MORs in the VTA (Magendzo and Bustos, 
2003, Trigo et al., 2010). Furthermore, MORs are known to play a functional role in the behavioral 
consequences of social stress (Komatsu et al., 2011), the expression of NAc delta FosB 
(Zachariou et al., 2006), and opiate- (Mashayekhi et al., 2012) and psychomotor stimulant- 
(Magendzo and Bustos, 2003, Trigo et al., 2010) induced VTA BDNF expression. Taken together, 
it is possible that upregulation of VTA MORs may represent one mechanism underlying social 
stress-induced cross-sensitization and changes in mesocorticolimbic BDNF and delta FosB 
expression. 
 
3. Ventral Tegmental Area Mu-Opioid Receptors 
The term “opioid” is used to broadly describe any compound which binds to any of the 
known opioid receptor sub-types, while “opiates” are a subclass of natural opioids derived from 
the opium poppy plant, Papaver somniferum (Zollner and Stein, 2007, Trescot et al., 2008, 
Chartoff and Connery, 2014). Opioid receptors are found throughout both the central and 
peripheral nervous systems, with MORs being most densely located in the brainstem and medial 
thalamus (Trescot et al., 2008). As described in the previous sections, in the VTA one type of 
opioid receptor, the mu-opioid receptor (MOR) is in a position to mediate stress-induced cross-
sensitization to drugs of abuse, as well as stress-induced changes across the mesocorticolimbic 
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circuit. Given their potential involvement in the consequences of social defeat stress, it is 
important to understand how MORs work and where they are found in the VTA. First, the general 
structure and properties of opioid receptors, with an emphasis on MORs, will be discussed. Next 
the traditional theory of MOR localization and activity in the VTA, as well as recent findings on 
novel MOR functions will be described. Finally, the implications of VTA MOR activity for 
sensitization and cross-sensitization to drugs of abuse will be discussed. 
 
3.1 Structure and Function of Mu-Opioid Receptors 
Opioid receptors belong to the superfamily of seven transmembrane-spanning (7TM) G-
protein-coupled receptors (GPCRs; Connor and Christie, 1999, Law and Loh, 1999, Waldhoer et 
al., 2004, Zollner and Stein, 2007, Trescot et al., 2008, Pradhan et al., 2012). More specifically, 
opioid receptors belong to the Rhodopsin (class A) family of Gi/Go protein-coupled receptors 
(Connor and Christie, 1999, Law and Loh, 1999, Waldhoer et al., 2004, Zollner and Stein, 2007, 
Lopez and Salome, 2009). Opioid receptors consist of an extracellular N-terminal domain and 
7TM helical domains (Connor and Christie, 1999, Law and Loh, 1999, Waldhoer et al., 2004, 
Zollner and Stein, 2007, Trescot et al., 2008, Lopez and Salome, 2009). The 7TM domains 
consist of three intracellular loops, three extracellular loops, and an intracellular C-terminal tail 
that is predicted to form a fourth intracellular loop with its putative palmitoylation sites (Law and 
Loh, 1999, Waldhoer et al., 2004, Zollner and Stein, 2007, Lopez and Salome, 2009).  
There are three major sub-types of opioid receptor: mu-opioid receptor (MOR; Fig. 1.5.), 
delta opioid receptor (DOR) and kappa opioid receptor (KOR); and each type of opioid receptor is 
under the control of a different gene (Connor and Christie, 1999, Law and Loh, 1999, Zollner and 
Stein, 2007, Trescot et al., 2008, Pradhan et al., 2012). Although located on different 
chromosomes, these opioid receptors have similar genomic structures. The three types of opioid 
receptor are approximately 60% homologous, with the most similarity seen in the 7TM regions, 
they also exhibit diversity in their extracellular loops, and N and C terminals (Law and Loh, 1999, 
Waldhoer et al., 2004, Zollner and Stein, 2007, Pradhan et al., 2012). Additionally, while all opioid  
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Figure 1.5. Inactive Versus Active MOR Structure and G-Protein Coupling. MORs are 7 
transmembrane spanning GPCRs that consist of an extracellular NH2-terminus (also, N-terminal 
or tail) and an intra-cellular COOH-terminus (also, carboxyl tail or C-terminal), and couple to Gαi/o 
and Gβγ G-protein subunits. (A) In their inactive state, MORs are coupled to their Gαi/o and Gβγ 
G-protein subunits. (B) Upon ligand binding (yellow), there is an exchange of GDP for GTP on the 
Gαi/o subunit, and the G-protein sub-units disassociate from the receptor to activate numerous 
intracellular signaling cascades (Connor and Christie, 1999, Waldhoer et al., 2004, Lopez and 
Salome, 2009). Blue circles with wavy lines: cell membrane; interconnected fuchsia cylinders: 
MOR receptor; yellow shape: MOR agonist; large blue and green circles: G-protein subunits; 
dotted arrows indicate disassociation of G-protein subunits from the ligand-bound receptor. 
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receptors consist of three exons, encoding the N-terminus and the 7TM structure, MORs differ 
from other opioid receptors in that they also contain a fourth exon that codes for 12 amino acids 
located at the tip of the C-terminus (Pasternak, 2014). While the greatest differences between 
MOR and DOR amino acid sequences are found in the C-terminal, exchange of this portion of the 
receptor does not give the MOR properties associated with the DOR (Law and Loh, 1999). These 
differences in opioid receptors are thought to underlie functional differences in the effects of 
opioid ligands. In particular, MOR- and DOR-agonists are rewarding and analgesic, while 
agonists selective for the KOR tend to be dysphoric (Waldhoer et al., 2004, Zollner and Stein, 
2007).  
While many features of the opioid-binding pocket are common to all opioid receptors, 
these receptors significantly differ in selectivity and affinity for both endogenous and exogenous 
compounds. The opioid-binding pocket is thought to be located within transmembrane helices 3, 
4, 5, 6, and 7, with the cavity being partially covered by the extracellular loops (Waldhoer et al., 
2004, Lopez and Salome, 2009). Differences in receptor conformation, due to the position of 
extracellular loops, are thought to play a part in mediating opioid receptor – ligand specificity (Law 
and Loh, 1999, Waldhoer et al., 2004). Ligand selectivity for the MOR has been attributed to the 
first and third extracellular loops, by contrast the second extracellular loop confers selectivity for 
KOR, while the third extracellular loops confer selectivity for DOR (Waldhoer et al., 2004). The 
endogenous opioid peptides are predominantly derived from several precursors: pro-
opiomelanocortin, proenkephalin, and prodynorphin (Waldhoer et al., 2004, Zollner and Stein, 
2007). After cleavage of these precursors by peptidases and post-translational modification, the 
active types of endogenous opioid ligands are generated for each receptor: endorphins (pro-
opiomelanocortin), enkephalins (pro-enkephalin), and dynorphins (pro-dynorphin; Waldhoer et al., 
2004, Zollner and Stein, 2007, Trescot et al., 2008). However in the case of the highly selective 
endogenous MOR peptides endomorphins 1 and 2, which are tetrapeptides structurally unrelated 
to other endogenous opioid peptides (Zadina et al., 1997), no precursor has been identified (see 
also reviews of Waldhoer et al., 2004, Zollner and Stein, 2007). The first four amino acid positions 
are identical for all endogenous opioid peptides, with the fifth position being either methionine (in 
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the case of Met-enkephalin and β-endorphin) or leucine (Leu-enkephalin and dynorphins; 
Pasternak, 2014). Specifically, the MOR has a high affinity for endomorphin (1 and 2) and β-
endorphin, while the DOR has a high affinity for enkephalin (Leu and Met) and β-endorphin, and 
the KOR binds to dynorphin (A and B; Waldhoer et al., 2004, Pasternak, 2014). Despite 
differences in high affinity for particular endogenous opioid peptides, all three opioid receptors do 
show some affinity for non-preferred opioid peptides. 
Investigation of the mechanisms underlying ligand-induced 7TM motions has suggested 
that binding to a GPCR results in exposure of the receptor’s intracellular loops, making them 
more accessible and facilitating interactions with G-proteins (Law and Loh, 1999, Waldhoer et al., 
2004, Zollner and Stein, 2007). In particular, intracellular loop three is considered a key 
determinant of coupling specificity to different G-protein alpha subunits, while intracellular loop 
two is thought to be more involved in the efficiency of G-protein activation (Gether, 2000). In the 
case of MORs, the conformational modifications following agonist binding involve the 
displacement of transmembrane helices 3, 6, and 7, which results in exposure of the intracellular 
loop domains and permits G-protein activation. The key determinant in MOR coupling specificity 
to G-proteins is intracellular loop three, while efficiency of G-protein activation is thought to be 
due to the second intracellular loop and C-terminal tail (Lopez and Salome, 2009). Similar to 
many other GPCRs, MORs display basal signaling activity in culture (Wang et al., 1994, Burford 
et al., 2000), and display increased constitutive activity following chronic morphine exposure 
(Wang et al., 1994). 
Evidence indicates that the intracellular signaling pathways activated by MORs are 
ligand-specific (see review of Pradhan et al., 2012), and that some of this specificity may be 
attributed to differences in receptor conformation and G-protein coupling. Like other GPCRs, 
opioid receptor activation induces intracellular signaling through G-proteins consisting of an alpha 
subunit (Gα) and a beta/gamma subunit complex (Gβγ; Fig. 1.5). In particular, opioid receptors are 
predominantly coupled to pertussis toxin (PTX) sensitive, heterotrimeric Gi/Go alpha proteins, 
although coupling to pertussis toxin-insensitive Gs/Gz/Gq proteins has also been reported 
(Connor and Christie, 1999, Waldhoer et al., 2004, Lopez and Salome, 2009). While opioid 
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receptors do not vastly differ in terms of the Gα proteins that they couple with, they do exhibit 
respective differences in the degree of coupling to various Gα subunits (Connor and Christie, 
1999), resulting in different G-protein complexes and possibly different effectors (Law and Loh, 
1999). In the case of MORs, once activated by an agonist, they are thought to preferentially 
couple to Gαo2 > Gαo1, and Gαi3 > Gαi2 or Gαi1 (Connor and Christie, 1999, Law and Loh, 1999). 
However more recently, others have noted different coupling preferences, with MORs 
preferentially coupling to Gαo1, Gαo2, Gαi2, Gαi3, and to a lesser extent, Gαi1 (Saidak et al., 2006; 
see also review of Lopez and Salome, 2009). In their resting state, MORs exist as heterotrimers 
of α, β, γ G-protein subunits, and coupled to a Gα bound to GDP, βγ complex (Gα(GDP)βγ complex; 
Lopez and Salome, 2009). Activation of MORs results in the catalytic exchange of GDP to GTP 
on Gα (Gα(GDP) to Gα(GTP)), and disassociation of the G-protein complex into separate Gα(GTP) and 
Gβγ subunits (Fig 1.5). After activation, MORs have been reported to act through G-protein 
subunits to effect intracellular signaling and cell state. In particular, MORs inhibit adenylyl 
cyclases through Gαi, while Gβγ subunits stimulate some isoforms of adenylyl cyclases 
(Chakrabarti et al., 2005). Additionally, MORs activate G-protein-activated inwardly rectifying K+ 
channels (GIRKs) and voltage-gated Ca2+ channels, indirectly activating phospholipase A2 
through the Gαo subunit (Connor and Christie, 1999, Clark et al., 2003, Waldhoer et al., 2004, 
Zollner and Stein, 2007, see also review of Lopez and Salome, 2009). The cell signaling that 
results through MOR activation is complicated by the receptor’s ability to simultaneously or 
concurrently couple with different G-proteins, and by the lifetime of Gα(GTP) complex, as return to 
receptor’s inactive state is dependent upon restoration of the Gα(GDP)βγ complex (Lopez and 
Salome, 2009). 
 
3.2 Classical View of Ventral Tegmental Area Mu-Opioid Receptor Effects: GABAergic 
Disinhibition of Dopamine  
In general, MORs are perisynaptic and can be found near synapses, either 
postsynaptically on dendrites and cell bodies, or presynaptically on axon terminals (Williams et 
al., 2001, Bergevin et al., 2002, Steffensen et al., 2006, see also reviews of Chartoff and 
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Connery, 2014; Zollner and Stein, 2007). While pre-synaptic MORs can be found near nerve 
terminals (Bergevin et al., 2002), plasmalemmal MORs are not typically synaptic in the VTA 
(Garzon and Pickel, 2002, Steffensen et al., 2006), suggesting that when not situated near a 
synapse, VTA MORs are activated by release of endogenous opioids into the extracellular space. 
The literature largely suggests that opioid receptor activation typically depresses neuronal firing to 
inhibit neurotransmission. When located presynaptically, opioid receptor activation inhibits Ca2+ 
influx and subsequent release of neurotransmitter and peptides from primary afferent terminals 
(Bergevin et al., 2002, Zollner and Stein, 2007).  Postsynaptic opioid receptors depress neuronal 
firing through GIRK-mediated hyperpolarization (Johnson and North, 1992, Zollner and Stein, 
2007, Margolis et al., 2014). On dendrites or cell bodies, MORs regulate neuronal excitability and 
transduce receptor activation to downstream signal transduction pathways (Williams et al., 2001, 
Chartoff and Connery, 2014). The MORs found on axon terminals serve to inhibit 
neurotransmitter release by activation of K+ conductance and/or inhibition of Ca2+ conductance 
(Williams et al., 2001, Chartoff and Connery, 2014).  
In the VTA, MORs are thought to be concentrated on GABA neurons (Sesack and Pickel, 
1995, Garzon and Pickel, 2002), where they inhibit GABA neurotransmission, consequently 
disinhibiting local DA neurons (Johnson and North, 1992). While predominantly localized to VTA 
GABA neurons, MORs can be act either pre-synaptically or post-synaptically. The original 
disinhibition hypothesis posited that MORs are post-synaptic and exert their effects through 
GIRK-mediated inhibition of VTA GABA neurons (Johnson and North, 1992). However rapidly 
inactivating K+ current (A-type) was found to be more characteristic of the action potentials in DA 
neurons than GABA neurons (Koyama and Appel, 2006), suggesting that MOR-mediated 
decreases in Ca2+ influx (Zollner and Stein, 2007) may also contribute to MOR-induced inhibition 
of GABA.  
The net result of MOR-mediated inhibition of GABA neurons is reduced GABA 
transmission at target sites, leading to disinhibition of excitatory targets, such as local DA 
neurons. Support for the role of VTA GABA neurons in the mediation of VTA DA transmission has 
been repeatedly validated. In particular, selective ablation of VTA GABA neurons increased 
30 
spontaneous locomotor activity (Shank et al., 2007), a sign of enhanced VTA DA transmission. 
Additionally, inhibition of VTA GABA neurons has been associated with increased basal activity of 
VTA DA neurons (Bocklisch et al., 2013). Conversely, optogenetic stimulation of VTA GABA 
neurons was shown to directly suppress the activity and excitability of neighboring DA neurons, 
and also reduced DA release in the NAc (van Zessen et al., 2012). These data show that VTA 
GABA neurons are capable of mediating the excitability of local DA neurons. Given that VTA 
MORs are concentrated on GABA neurons and have an inhibitory effect on neurotransmission, it 
is likely that MOR-mediated inhibition of VTA GABA transmission has a profound effect on VTA 
DA activity. This was demonstrated in a microdialysis study wherein VTA MOR agonism 
decreased GABA concentrations and increased DA overflow, while MOR knockout mice did not 
respond to MOR agonism, they exhibited increased levels of basal VTA GABA transmission 
(Chefer et al., 2009). This suggests that in the VTA endogenous MOR activity on GABA neurons 
may play a crucial role in the mediating tonic VTA GABA neurotransmission.  
 
3.3 Novel Mu-Opioid Receptors: Excitatory and Localized to Dopamine Neurons? 
While the canonical model of MOR action in the VTA proposed by Johnson and North 
(1992) is still largely upheld (Fig. 1.2), reports of conflicting findings are becoming more common. 
These recent findings disagree with the canonical model on two points, specifically: that VTA 
MOR expression is limited to GABA neurons, and that MOR activation produces an inhibitory 
effect (see review of Fields and Margolis, 2015). Together these contradictory reports highlight 
flaws in the original criteria used to classify neuronal types in the VTA. In particular, Johnson and 
North (1992) stated that neurons that were not inhibited by MOR stimulation were DA neurons. 
While these criteria have been widely used to delineate between DA and GABA neurons in the 
VTA, new evidence suggests that these criteria unreliable and produce false results.  
The canonical theory of MORs in the VTA assumes that DA and GABA are the only two 
neuronal types in the VTA, however VTA glutamate neurons have recently been identified (see 
reviews of Morales and Pickel, 2012, Morales and Root, 2014). Thus while the criteria of Johnson 
and North (1992) state that cells that are not inhibited by MOR stimulation are DA neurons, they 
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could also be glutamate neurons. Of particular concern for the canonical theory that MORs 
indirectly disinhibit DA neurons, a subset of VTA DA neurons show direct MOR-mediated post-
synaptic inhibition (Margolis et al., 2014). Moreover, in slice preparations, nearly half of all 
confirmed VTA DA neurons were inhibited by stimulation of MORs (Margolis et al., 2014). Thus, 
while the criteria of Johnson and North (1992) suggest that VTA cells inhibited by MOR 
stimulation are GABA neurons, they could also be DA neurons. It is unknown whether MORs also 
localize to the recently discovered VTA glutamate (Morales and Pickel, 2012, Morales and Root, 
2014), or if their functions differ on neurons capable of co-releasing neurotransmitters.  
The canonical model of Johnson and North (1992) also assumes that MOR activation 
always results in inhibition of neurotransmission. By contrast, a recent study beautifully illustrated 
that MORs can be either inhibitory or excitatory (Margolis et al., 2014). In fact 19% of VTA 
neurons are depolarized by bath application of the MOR agonist DAMGO, while 52% of neurons 
were inhibited by DAMGO (Margolis et al., 2014). The excitatory or inhibitory of function of VTA 
MORs is highly heterogenous, with both DA and non-DA neurons showing similar proportions of 
both types of receptor. Moreover, both excitatory and inhibitory MORs can be found on the same 
cell (Margolis et al., 2014). Thus the criteria of Johnson and North (1992), in terms of MOR-
induced inhibition, is not a reliable marker for either GABA or DA neurons. 
Taken together, these studies suggest that the traditional theory of MOR activity in the 
VTA is incomplete and more diverse than previously thought. Although the fact that MORs can 
have excitatory effects, and their presence on a small subset of VTA DA neurons, contradict the 
disinhibition hypothesis, they do not disprove it. It is important to note that tonic GABA release 
occurs in slice preparations, and that bath application of picrotoxin, a GABAA receptor antagonist, 
is sufficient to depolarize neurons (Margolis et al., 2014). Thus the machinery for disinhibition 
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exists within the VTA, and VTA MORs may act in a combination of ways, inhibitory or excitatory, 
to either directly or indirectly mediate VTA DA outputs (Fields and Margolis, 2015).  
 
3.4 Mu-Opioid Receptor – Mediation of VTA DA Transmission: Implications for Substance Abuse 
and Cross-Sensitization   
Both psychostimulants and social defeat stress upregulate the expression of VTA MORs, 
and social stress-induces cross-sensitization to psychomotor stimulants (Nikulina et al., 2014). 
Since VTA MORs can either directly or indirectly mediate DA transmission  (see review of Fields 
and Margolis, 2015), it is possible that social stress-induced expression of VTA MORs may 
mediate the induction of stress-induced cross-sensitization to psychomotor stimulants. While this 
possibility is intriguing, it is unknown whether the MORs upregulated by social defeat stress are 
excitatory or inhibitory, and what type of neuron they are localized to.  
If social stress increased the expression of inhibitory MORs on DA neurons, or excitatory 
MORs on GABA interneurons, the net effect would be reduced DA output. Decreased DA 
transmission has been associated with decreased response to psychostimulant drugs (Vezina 
and Stewart, 1989). In contrast, after social stress-induced upregulation, intra-VTA stimulation of 
MORs produces a sensitized locomotor response (Nikulina et al., 2005, Nikulina et al., 2008), 
suggesting that the upregulation of MORs potentiated VTA DA activity. Enhanced VTA DA activity 
is consistent with a potential upregulation of either inhibitory MORs on GABA interneurons, or 
excitatory MORs on DA neurons. It is important to note that while MORs are found VTA DA 
neurons, this appears to represent a small proportion of MORs (Garzon and Pickel, 2002), with 
an even smaller proportion of all VTA MORs being excitatory (< 20%; Margolis et al., 2014), 
suggesting that the net effect of VTA MOR activation is inhibitory on GABA neurons.  
Given that social stress-induced increases in VTA MOR expression are associated with 
enhanced VTA DA activity (Nikulina et al., 2005, Nikulina et al., 2008), and that excitatory MORs 
are uncommon (Margolis et al., 2014), it is probable that social stress predominantly upregulates 
inhibitory MORs on VTA GABA neurons. If the net effect of social stress-induced upregulation of 
VTA MORs is inhibitory on GABA neurons, then social stress should also increase VTA DA 
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transmission. In fact, increases in DA release in the NAc have been found after repeated social 
stress (Tidey and Miczek, 1996, Miczek et al., 2011a) and are associated with stress-induced 
cross-sensitization to psychomotor stimulants. Given their role in modulating VTA DA output, the 
VTA MORs upregulated by social stress may play a critical role in the behavioral and cellular 
consequences of stress. Moreover, it is possible that preventing social stress-induced increases 
in VTA MORs will prevent stress-induced cross-sensitization to psychomotor stimulants. As such, 
VTA MORs may represent a novel therapeutic target for treating stress-induced vulnerabilities to 
drugs of abuse. 
 
4. Ventral Tegmental Area Mu-Opioid Receptor – pAKT Signaling 
Ventral tegmental MOR activity is important for the effects of both stress and drugs of 
abuse, thus it is possible some of these effects are mediated by MOR-activated intracellular 
signaling cascades. As previously discussed, the cellular inhibition typically associated with MOR-
activation is thought to be largely mediated by GIRKs, likely through their beta/gamma G-protein 
subunit complex (Johnson and North, 1992, Margolis et al., 2014). However, in addition to their 
inhibitory effects, MOR activation likely mediates other cellular functions. MORs are GPCRs, 
which means that they are capable of activating numerous intracellular signaling cascades via 
their G-proteins. Of the intracellular signaling pathways activated by MORs, several have been 
well characterized, including: protein kinase A (PKA), protein kinase C (PKC) and mitogen-
activated protein kinase (MAPK) – extracellular signal-regulated kinase (ERK) cascades (Williams 
et al., 2001). 
While the functional implications remain to be fully elucidated, MORs also consistently 
activate the phosphoinositide 3-kinase (also, phosphatidylinositol 3-kinase; PI3K) signaling 
cascade (Polakiewicz et al., 1998, Iglesias et al., 2003). After activation of the intracellular PI3K 
signaling pathway, AKT is one of the first molecules to be phosphorylated (pAKT), and its 
phosphorylation is associated with alterations in GABA transmission (Wang et al., 2003). 
Moreover, changes in AKT phosphorylation have been implicated in stress- (Krishnan et al., 
2007, Krishnan et al., 2008), psychostimulant- (Izzo et al., 2002, Iniguez et al., 2008), and opiate-
34 
induced (Russo et al., 2007, Mazei-Robison et al., 2011) behavioral alterations. Since social 
defeat stress-induces an upregulation of VTA MORs at a time corresponding to the onset of 
cross-sensitization, it is possible that social defeat stress increases AKT phosphorylation 
downstream of MOR upregulation in the VTA.  
 
4.1   Overview of AKT Phosphorylation 
4.1.1 General Structure 
The evolutionarily conserved gene for the AKT kinase was first identified in the mice 
infected with the AKT8 retrovirus, and is the cellular homolog of the v-akt oncogene transduced 
by the AKT8 retrovirus (Staal et al., 1977, Staal, 1987). Independent characterization and cloning 
of the AKT kinase has revealed that it exists in three isoforms that are encoded by different 
genes: AKT1, AKT2, and AKT3 (Scheid and Woodgett, 2001, Chong et al., 2005, Franke, 2008). 
Early on, AKT was also frequently referred to as protein kinase B (PKB), due to its similarity to 
protein kinases A and C (PKA and PKC respectively; Manning and Cantley, 2007, Franke, 2008, 
Pearce et al., 2010). All three isoforms of AKT are comprised of similar structures. In particular, 
they consist of an N-terminal regulatory domain, a hinge region, and a C-terminal region (Franke, 
2008). The C-terminal is largely responsible for determining the induction and maintenance of 
AKT’s kinase activity (Chong et al., 2005, Franke, 2008). The N-terminal of AKT includes a 
pleckstrin homology (PH) domain, which is connected to the kinase domain by the hinge region 
(Chong et al., 2005, Franke, 2008). AKT shares extensive homology with protein kinases A, G, 
and C, thus it is a member of the AGC superfamily of protein kinases and requires 
phosphorylation to achieve its active state (Scheid and Woodgett, 2001, Chong et al., 2005, 
Manning and Cantley, 2007, Pearce et al., 2010). Under normal conditions, AKT1 is expressed at 
low levels in the brain, however the expression of AKT greatly increases in neuronal cells 
following cellular stress or injury (Chong et al., 2005). Since AKT1 expression is dependent on 
changes in the cellular environment and because its actions have been well documented in the 
brain, particular emphasis will be devoted to this variant and discussion of site-specific 
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phosphorylation changes will reference AKT1. The kinase domain of AKT is specific for serine 
(Ser) and threonine (Thr), as such it has two phosphorylation sites: Ser473 and Thr308 for AKT1. 
 
4.1.2. Upstream Activators of AKT - PI3K Signaling 
While the exact pathway leading to AKT activation differs slightly depending on the type 
of receptor stimulating AKT, given their homologous structures, it is not surprising that all three 
AKT isoforms utilize the same activation mechanisms. The PH domain of AKT is specific for 3’-
OH (D3) phosphorylated phosphoinositide products of PI3K, as well as 3-phosphoinositide-
dependent kinase-1 (PDK1; Chong et al., 2005, Franke, 2008, Okkenhaug, 2013). At the plasma 
membrane, PI3K phosphorylates phosphoinositides on the D3 position of the inositol ring, 
generating the second messengers phosphatidylinositol-3, 4-biphosphate (PI(3,4)P2; also PIP2) 
and phosphatidylinositol-3, 4,5-triphosphate (PIP3; Chong et al., 2005; Franke, 2008; Okkenhaug, 
2013). Although several classes of PI3K exist, Class 1A-B are most implicated in the receptor 
activation of AKT due to their generation of PIP3 and PI(3,4)P2 (Franke, 2008, Okkenhaug, 2013). 
In general, Class 1A PI3Ks are thought to mediate receptor tyrosine kinase (TRK) activation of 
AKT, while Class 1B PI3K is regulated by the βγ subunits of GPCRs (Franke, 2008, Iwanami et 
al., 2009). While p110 is the catalytic subunit of all PI3Ks, different isoforms of this subunit exist, 
with p110-α, -β, and -δ belonging to Class 1A and p110-γ belonging to Class 1B (Okkenhaug, 
2013).  
Class 1A isoforms of PI3K also consist of a Src homology (SH2)-containing regulatory 
subunit, and while there are different types, they can be collectively referred to as “p85” (Liu et al., 
2009, Okkenhaug, 2013). The p85 SH2 domains of Class 1A PI3Ks recruit the p110 subunit to 
the membrane-associated proteins that have been phosphorylated by tyrosine kinases (Liu et al., 
2009, Okkenhaug, 2013). In contrast the regulatory subunits of Class 1B PI3Ks, p101 and p84, 
bind to the βγ subunit of GPCRs and recruit p110γ to the activated receptor at the membrane 
surface (Liu et al., 2009, Okkenhaug, 2013). Like its Class 1B analog, p110β can also bind to the 
Gβγ subunits to be activated by GPCRs, especially in cells that do not express high levels of 
p110γ (Okkenhaug, 2013). Particular types of PI3K are named according to their catalytic 
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subunit, and of these variants, only PI3K-β and PI3K-γ appear capable of phosphorylating AKT, 
and they may do so through either activation of RTKs or GPCRs (Okkenhaug, 2013). Since 
p110γ is mainly limited to immune cells, while p110β is broadly expressed in most cell types and 
can be efficiently activated by GPCRs in the absence of p110γ (Liu et al., 2009, Okkenhaug, 
2013), it is likely that in the brain, AKT is phosphorylated downstream of PI3K-β.  
 
4.1.3. Phosphorylation of AKT 
While PI3K signaling is necessary, it is not sufficient for the full activation of AKT, and 
AKT does not reach full catalytic potential until it has undergone phosphorylation, locking the 
enzyme into its active conformation. Rather, increases in the phosphoinositide products of PI3K 
recruit AKT from the cytoplasm to the membrane, where it undergoes a conformational change, 
exposing its active loop and enabling phosphorylation (Fig 1.6; Stephens et al., 1998, Scheid and 
Woodgett, 2001, Chong et al., 2005, Franke, 2008, Iwanami et al., 2009). The phosphorylation 
sites of AKT are differentially located, with the residue for Thr308 being found in the kinase 
domain, while the residue for Ser473 is found in the hydrophobic motif of the C-terminal tail 
(Scheid and Woodgett, 2001, Franke, 2008).  
The phosphoinositide products of PI3K interact with AKT, relaxing its conformation and 
allowing for phosphorylation of Thr308 by PDK1 (Scheid and Woodgett, 2001, Chong et al., 2005, 
Franke, 2008, Iwanami et al., 2009). Under normal physiological conditions, PDK1 is 
constitutively active at the cell membrane, however it cannot interact with AKT unless AKT has 
been recruited to the membrane by the phosphoinositide products of PI3K (Franke, 2008). Like 
AKT, PDK1 also contains a PH domain, however rather than being located within the N-terminal, 
PDK1’s PH domain is located within its C-terminal (Franke, 2008). While the phosphoinositide 
products of PI3K can directly phosphorylate AKT at Thr308 through PIP3 and PI(3,4)P2, 
phosphorylation is more likely to occur through PDK1 (Fig. 1.6), as its PH domain, compared to 
that of AKT, has a much higher affinity for PI3K’s phosphoinositide products (Franke, 2008).  
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Figure 1.6. Overview of 
MOR-Mediated Activation 
of pAKT Signaling. In 
order for AKT to be 
activated, it must be 
phosphorylated at two 
distinct sites: Thr 308 and 
Ser 473. AKT is 
phosphorylated at Ser 473 
by mTORC2, which exists 
as a complex of five 
proteins, and whose 
upstream regulation is 
poorly understood 
(Sarbassov et al., 2005, 
Franke, 2008, Iwanami et al., 2009, Liu et al., 2009, Okkenhaug, 2013, Lipton and Sahin, 2014). 
Phosphorylation of Ser 473 is necessary for the full catalytic activation of pAKT (Bellacosa et al., 
1998, Scheid and Woodgett, 2001, Iwanami et al., 2009). AKT is phosphorylated at Thr 308 
downstream of GPCR stimulation, as in the case of agonist-bound MORs, through induction of 
PI3K by βγ G-protein subunits. G-protein recruitment of PI3K to the cell membrane generates the 
phosphoinositide product, PIP3, which binds to PDK1 to phosphorylate AKT at Thr 308 (Chong et 
al., 2005, Franke, 2008, Iwanami et al., 2009, Liu et al., 2009, Okkenhaug, 2013). While Thr 308 
of AKT is also responsive to PIP3, PIP3 has a much higher affinity to PDK1, which is considered 
the primary activator of pAKT at Thr 308 (Scheid and Woodgett, 2001, Chong et al., 2005, 
Franke, 2008, Iwanami et al., 2009). Upon phosphorylation, pAKT activates mTORC1, which 
exists as a complex of four proteins, which can indirectly inhibit PI3K through its downstream 
effectors to negatively regulate PI3K – pAKT activity (Vander Haar et al., 2007, Franke, 2008, 
Iwanami et al., 2009, Liu et al., 2009, Lipton and Sahin, 2014). Solid arrows indicate direct 
activation, while dotted lines indicate either indirect or inhibitory regulation of downstream targets; 
brackets indicate protein complexes. 
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Although PDK1 phosphorylates AKT at Thr308, it does not phosphorylate Ser473 (Chong et al., 
2005). Importantly, phosphorylation of Ser473 always parallels the full activation of AKT, and it 
has been suggested that phosphorylation of Ser473 is necessary for the full catalytic activation of 
AKT (Bellacosa et al., 1998, Scheid and Woodgett, 2001, Iwanami et al., 2009). Since Ser473 is 
situated in the C-terminal, which determines the induction and maintenance of AKT activity 
(Franke, 2008), it is important to understand the mechanism by which Ser473 is phosphorylated. 
 
4.1.4. Regulation of pAKT by Mammalian Target of Rapamycin Complexes  
Until recently, the kinase that phosphorylated Ser473 was largely unknown and simply 
referred to as “PDK2” (Scheid and Woodgett, 2001, Chong et al., 2005, Franke, 2008). The 
serine threonine kinase mammalian target of rapamycin (mTOR) can act as both an activator and 
target of AKT (Fig. 1.6), the function of mTOR is dependent upon the specific complex it forms 
(Franke, 2008, Liu et al., 2009, Okkenhaug, 2013). There are two mTOR complexes: mTOR 
complex 1 (mTORC1), which is a target of AKT signaling, and mTOR complex 2 (mTORC2), 
which is upstream of pAKT (Franke, 2008, Liu et al., 2009, Okkenhaug, 2013). The mTORC1 
complex is rapamycin-sensitive and consists of mTOR, proline-rich AKT substrate of 40 kDA 
(PRAS40), raptor, and mammalian lethal with sec12 protein 8 (mLST8, also known as GβL); 
while the mTORC2 complex is largely rapamycin-insensitive and consists of mTOR, rictor, protor, 
mammalian stress-activated mitogen activated protein kinase-interacting protein 1 (mSIN1), and 
mLST8 (Iwanami et al., 2009, Liu et al., 2009, Lipton and Sahin, 2014). While many had long 
suspected that PDK2 is really mTORC2, this theory was only recently proven (Sarbassov et al., 
2005, Iwanami et al., 2009, Liu et al., 2009, Okkenhaug, 2013). Thus not only is mTORC2 
upstream of pAKT, it directly phosphorylates AKT at Ser473 and enhances phosphorylation of 
AKT by PDK1 (Sarbassov et al., 2005; see also review of Franks, 2008). 
In contrast to mTORC2, mTORC1 is a downstream target of AKT phosphorylation (Fig. 
1.6). Activity of mTORC1 is controlled by a small GTPase, Ras homolog enriched in the brain 
(Rheb), which is under tonic inhibition by the tuberous sclerosis complex (also tuberin; TSC; 
Franke, 2008, Iwanami et al., 2009, Lipton and Sahin, 2014). Phosphorylation of AKT inhibits the 
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TSC1/TSC2 complex, disinhibiting Rheb and inducing mTORC1 activity (Franke, 2008, Iwanami 
et al., 2009, Lipton and Sahin, 2014). In addition to regulating mTORC1 activity through TSC2, 
pAKT can directly activate mTORC1 by inhibiting PRAS40 (Vander Haar et al., 2007, Liu et al., 
2009, Lipton and Sahin, 2014). While mTORC1 has many of its own downstream signaling 
targets, of particular interest is its ability to negatively regulate PI3K – pAKT signaling (Fig. 1.6; 
Franke, 2008, Iwanami et al., 2009, Liu et al., 2009, Okkenhaug, 2013). Based on this, blocking 
AKT phosphorylation through inhibition of either PI3K or PDK2 could potentially depress this 
negative mTORC1 feedback loop, resulting in increased PI3K (and subsequent PDK1) activity 
and ultimately failure to prevent AKT phosphorylation. This suggests that the most successful 
way to prevent phosphorylation of AKT is to inhibit both mTORC2, preventing phosphorylation of 
Ser473, and mTORC1, preventing increased phosphorylation of Thr308. Cross-talk between 
mTORC2 – pAKT and pAKT – mTORC1 signaling has complicated study of AKT and mTORC 
intracellular signaling cascades, and while the signaling of mTORC1 is better understood, the 
upstream activator of mTORC2 is still unknown. One of the most interesting downstream effects 
of AKT phosphorylation, is the kinase’s ability to insert GABAA receptors into the cell membrane 
(Wang et al., 2003), and to promote protein synthesis and long-term depression (LTD) through 
mTORC1 activation (see review of Lipton and Sahin, 2014). These findings are of particular 
interest, as they suggest that phosphorylated AKT is in a position to mediate neuronal excitability, 
possibly representing a mechanism by which pAKT interacts with drugs of abuse. 
 
4.2   Support for MOR – pAKT/mTOR Signaling 
As previously described in section 3, MORs belong to the Gi/Go family of GPCRs and 
activate intracellular signaling cascades through interactions with their G-protein subunits. 
Although PI3K – pAKT signaling is not a classical MOR-mediated intracellular signaling cascade, 
in recent years this pathway has been shown to be a consistent target of MOR activation 
(Polakiewicz et al., 1998, Iglesias et al., 2003, Russo et al., 2007, Mazei-Robison et al., 2011). In 
lymphocytes, morphine was found to increase phosphorylated PI3K and phosphorylated AKT, as 
well as the expression of MORs, in fact increases in MOR expression were dependent on PI3K – 
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pAKT signaling (Liu et al., 2010). That MOR stimulation increases AKT phosphorylation has also 
been demonstrated in other tissues, including cardiac cells (Xu et al., 2011) and cortical cells 
(Iglesias et al., 2003). As is the case with other GPCRs, MOR-induced pAKT is largely thought to 
occur after its βγ subunits disassociate from the G-protein complex and phosphorylate PI3K (Fig. 
1.6). Thus it appears that all MORs and GPCRs may be capable of activating AKT signaling 
through their βγ G-protein subunits. Upon activation of PI3K, AKT is recruited to the membrane 
where it undergoes phosphorylation, after phosphorylation, pAKT has the ability to translocate 
into the cytoplasm or nucleus (Andjelkovic et al., 1997, Meier et al., 1997; see also review of Du 
and Tsichlis, 2005). 
In the brain, the ability of opioid receptors to increase AKT phosphorylation has been 
most clearly demonstrated for the DOR. In the VTA DORs have been shown to upregulate 
GABAA receptor insertion into the membrane in a manner dependent on PI3K – pAKT signaling 
(Margolis et al., 2011). While this was shown with DORs and MORs have not been directly shown 
to increase AKT phosphorylation in brain tissues, given the large degree of homology between 
MORs and DORs, it is highly likely that MORs can utilize the same mechanisms to phosphorylate 
AKT and insert GABAA receptors into the membrane (Margolis et al., 2011). Although this study 
by Margolis et al. (2011), as well as the above cell culture studies, clearly indicate that opioid 
receptor activation induces AKT phosphorylation, the in vivo effects of MOR activation have not 
been as clear, likely due to differences in drug history and heterogeneity of cell types in Western 
blot measures of AKT activity. For example, using Western blot analyses, studies have suggested 
that chronic morphine downregulates AKT signaling in the VTA (Russo et al., 2007, Mazei-
Robison et al., 2011). However these findings must be interpreted with caution, as their use of 
Western blot homogenates is biased towards DA neurons, which are the prevailing VTA cell type 
(50-65%), since Western blots represent a regional average, they are unlikely to detect changes 
in a small population of neurons, such as the VTA GABA neurons (30-35%) that contain higher 
densities of MOR (see review of Nikulina et al., 2014).  
The in vivo study of MOR signaling in response to opiate drugs of abuse has been further 
complicated by differences in drug history, specifically differing histories of morphine exposure 
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produce different effects on AKT phosphorylation in the NAc (Muller and Unterwald, 2004). Given 
the work of Derek van der Kooy’s laboratory in showing that mesolimbic signaling differs in the 
drug-naïve (DA-independent) vs. drug-dependent (DA-dependent) states (see review of Ting and 
van der Kooy, 2012), it is not surprising that activity of MOR intracellular signaling cascades also 
differ with drug history. 
 
4.3   Implications of pAKT for Stress-Induced Amphetamine Sensitization 
Repeated social defeat stress upregulates MOR expression in the VTA and produces 
cross-sensitization to psychomotor stimulants (see review of Nikulina et al., 2014), suggesting 
that MORs may mediate some of the behavioral consequences of social stress. In support of this, 
MOR knockout mice do not show social defeat stress-induced social avoidance (Komatsu et al., 
2011). Since MORs appear to mediate at least some behavioral consequences of social stress, 
then it is possible that they do so through phosphorylation of AKT. In favor of this, signaling 
through pAKT – mTORC1 has been implicated in drug-induced sensitization to psychomotor 
stimulants. In particular, cocaine was associated with increases in mTORC1 activity, a 
downstream target of pAKT, in the mesocorticolimbic circuit, and systemic inhibition of mTORC1 
was sufficient to block both the induction and expression of cocaine-sensitized locomotor activity 
(Wu et al., 2011). More specific manipulations have revealed that intracerebroventricular 
inhibition of PI3K, an upstream activator of pAKT, is necessary for the expression, but not the 
induction of sensitization to cocaine (Izzo et al., 2002). Social defeat stress upregulates VTA 
MORs, which are generally situated on GABA neurons and decrease GABA transmission, 
disinhibiting DA and increasing mesolimbic DA release (Fig. 1.4; see review of Nikulina et al., 
2014). Since increases in mesolimbic DA release are also implicated in the effects of 
psychomotor stimulants, it is possible that repeated social stress-induced cross-sensitization to 
psychomotor stimulants may be due to upregulation of MOR and subsequent phosphorylation of 
its downstream kinase, AKT.  
While MORs are clearly implicated in the behavioral consequences of social defeat stress 
(Komatsu et al., 2011), and its downstream targets PI3K – pAKT signaling have been well 
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implicated in sensitization to psychomotor stimulants (Izzo et al., 2002, Iniguez et al., 2008, Wu et 
al., 2011), one study suggests that VTA AKT phosphorylation may reduce the behavioral 
consequences of social defeat stress. In particular, this study blocked AKT phosphorylation in the 
VTA, which enhanced the negative behavioral outcomes of continuous social defeat stress in 
mice (Krishnan et al., 2008). When mice were classified as “susceptible” or “resilient” according to 
their post-stress behavioral phenotypes, Western blots of the VTA revealed that levels of 
phosphorylated AKT were reduced in susceptible mice (Krishnan et al., 2008). A major limitation 
of this study is its use of homogenate samples in Western blot, which precludes identification of 
neuron-type specific changes in AKT phosphorylation after stress. As such, the results of this 
study are heavily biased towards the majority population of DA neurons in the VTA, and must be 
interpreted with caution. While differences exist between the continuous and intermittent social 
defeat models, as well as in rats and mice (see review of Nikulina et al., 2014), the findings of 
Krishnan et al. (2008) suggest that intermittent social defeat stress will not increase AKT 
phosphorylation in VTA DA neurons. Since VTA MORs are largely localized to GABA neurons 
(Sesack and Pickel, 1995, Garzon and Pickel, 2002) and typically serve to indirectly disinhibit 
VTA DA neurons (Johnson and North, 1992), then it is possible that AKT phosphorylation may be 
increased in VTA GABA neurons, downstream of the social stress-induced upregulation of VTA 
MORs. Given that VTA MORs and pAKT phosphorylation have both been implicated in 
sensitization to psychomotor stimulants, it is possible that social defeat stress-induced cross-
sensitization to psychomotor stimulants is mediated by stress-induced upregulation of MOR – 
pAKT signaling in VTA GABA neurons. 
 
5. Research Objectives and Organization of Dissertation 
Both globally and nationally, drug abuse represents a serious economic and societal 
problem. While a great deal of money is spent trying to intervene and treat substance abuse, 
treatment is not always available or affordable, and even with treatment, many addicts are likely 
to relapse. Based on these features, in addition to addiction itself, research on substance abuse 
also focuses on the variables that confer vulnerability to drugs of abuse. Most notably, stress 
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induces cross-sensitization to both opiates and psychostimulant drugs, the effects of which 
largely implicate the mesocorticolimbic circuit.  
Through studying the functional effects of stress-induced changes in the 
mesocorticolimbic circuit, it is possible to develop new targets for the therapeutic intervention of 
substance abuse. The literature reviewed in this chapter clearly implicates MORs in the mediation 
of VTA DA transmission and the effects of drugs of abuse. Thus this dissertation will investigate 
the implications of VTA MOR signaling for the behavioral and cellular consequences of social 
stress, with emphasis on those changes related to stress-induced cross-sensitization to 
psychostimulant drugs.  
The experiments described in the following chapters utilized the rat model of intermittent 
social defeat stress to investigate whether stress-induced VTA MOR upregulation is necessary 
for: 1) the behavioral effects of social stress, namely cross-sensitization to amphetamine (Chapter 
2), and 2) stress-induced alterations in the mesocorticolimbic circuit, specifically, enhanced 
mesolimbic BDNF signaling (Chapter 3). This dissertation also investigated 3) social defeat stress 
increases MOR – pAKT signaling in VTA GABA and DA neurons, and whether inhibition of VTA 
AKT phosphorylation is sufficient to prevent stress-induced cross-sensitization to amphetamine 
and deficits in weight gain (Chapter 4). The final chapter of this dissertation (Chapter 5) is a 
general discussion of the implications of the research described in Chapters 2 – 4. 
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CHAPTER 2: KNOCKDOWN OF VENTRAL TEGMENTAL AREA MU-OPIOID RECEPTORS 
MEDIATES EFFECTS OF SOCIAL DEFEAT STRESS: IMPLICATIONS FOR AMPHETAMINE 
CROSS-SENSITIZATION, SOCIAL AVOIDANCE, AND WEIGHT REGULATION 1  
 
ABSTRACT 
Social defeat stress is naturalistic model that induces social avoidance and long-lasting 
cross-sensitization to drugs of abuse, as well as a corresponding upregulation of ventral 
tegmental area (VTA) mu-opioid receptor (MOR) mRNA. In the VTA, MOR activation is generally 
thought to inhibit a subpopulation GABA neurons thus disinhibiting VTA dopamine neurons and 
providing a role for VTA MORs in the regulation of psychostimulant sensitization. The present 
study determined the effect of lentivirus-mediated MOR knockdown in the VTA on the 
consequences of intermittent social defeat stress, a salient and profound stressor in humans and 
rodents. Social stress exposure induced social avoidance and attenuated weight gain in animals 
with non-manipulated VTA MORs, but both these effects were prevented by VTA MOR 
knockdown. Rats with non-manipulated VTA MOR expression exhibited cross-sensitization to 
amphetamine challenge (1.0 mg/kg, i.p.), evidenced by a significant augmentation of locomotion. 
By contrast, knockdown of VTA MORs prevented stress-induced cross-sensitization without 
blunting the locomotor-activating effects of amphetamine. Elucidating VTA MOR regulation of 
stress effects on the mesolimbic system may provide new therapeutic targets for treating stress-
induced vulnerability to substance abuse. 
 
INTRODUCTION 
In humans, stress is one variable that influences the transition from recreational drug use 
to abuse, and it has been correlated with increased risk of substance abuse and relapse (Sinha, 
2001, 2008, Razzoli et al., 2009, Sinha, 2011). Rodent studies have shown that repeated social 
                                               
1 All of the data in this chapter have been published, however this chapter does not include the 
immunohistochemical data included in Johnston et al. (2015) – to see this publication in its 
entirety, please refer to Appendix A. 
45 
defeat stress exposure consistently produces social avoidance (Berton et al., 2006, Krishnan et 
al., 2007, Fanous et al., 2011, Komatsu et al., 2011) and augments the effect of psychomotor 
stimulants, a phenomena known as ‘cross-sensitization’ (Covington and Miczek, 2001, Nikulina et 
al., 2004, Miczek et al., 2011a, Nikulina et al., 2012). Genetic mu-opioid receptor (MOR) knockout 
mice do not exhibit social avoidance following continuous social defeat (Komatsu et al., 2011), 
suggesting that MORs play a critical role in stress-induced changes in long-term neuroplasticity. 
In fact, even acute social defeat stress has been shown to rapidly upregulate MOR mRNA 
expression in the ventral tegmental area (VTA; Nikulina et al., 1999), while repeated social stress 
exposure increases VTA MOR mRNA expression for up to 14 days after the last episode 
(Nikulina et al., 2008).  
In the VTA MORs are expressed by gamma-aminobutyric acid (GABA) neurons (Sesack 
and Pickel, 1995, Garzon and Pickel, 2002), which are hyperpolarized in response to MOR 
stimulation, thus disinhibiting local dopamine (DA) transmission and facilitating response to drugs 
of abuse (Johnson and North, 1992, Bergevin et al., 2002, Vargas-Perez et al., 2009b, Dacher 
and Nugent, 2011). Rats exposed to repeated social defeat stress, then challenged with an intra-
VTA infusion of a MOR-specific agonist exhibited sensitized locomotor activity (Nikulina et al., 
2005, Nikulina et al., 2008). This VTA opiate-induced sensitized locomotor activity was present at 
the same time point that social stress-induced cross-sensitization to psychomotor stimulants was 
observed (Covington and Miczek, 2001, Nikulina et al., 2004, Nikulina et al., 2012). Taken 
together, these findings indicate that increased VTA MOR expression might play a role in social 
stress-induced psychostimulant sensitization. Consistent with this view, MOR knockout mice 
exhibit reduced cocaine self-administration and increased VTA GABA transmission (Mathon et 
al., 2005). Furthermore, the expression of amphetamine sensitization is associated with 
persistent VTA MOR upregulation, and can be blocked by a treatment with MOR antagonist 
(Magendzo and Bustos, 2003, Trigo et al., 2010). 
Although research has implicated VTA MORs in drug sensitization and social behaviors 
(Van Ree et al., 2000, Miczek et al., 2011l, Nikulina et al., 2014, Pitchers et al., 2014), it is 
unknown whether upregulation of VTA MORs causes the behavioral and biological effects of 
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social defeat stress exposure. To address this question, the present study used lentivirus-
mediated gene transfer and RNA interference to knockdown MORs in the VTA, and then 
assessed social stress-induced cross-sensitization to amphetamine. Given that social avoidance 
is altered in MOR knockout mice after continuous social stress (Komatsu et al., 2011), the effect 
of VTA MOR knockdown on social stress-induced social avoidance was also examined. Finally, 
the effect of VTA MOR knockdown on stress-induced deficits of weight gain was investigated. 
 
METHODS 
2.1 Subjects 
Experimental animals were male Sprague-Dawley rats (N = 71; Charles River 
Laboratories, Hollister, CA) weighing 200-250 g on arrival. Three days before social stress 
exposure, subjects were individually housed in standard plastic cages (25x50x20 cm3). Twelve 
additional age-matched Sprague Dawley rats were group-housed 3 per cage and served solely 
as novel stimulus subjects during the social approach and avoidance test. Male Long-Evans rats 
(weighing 550-700 g), termed ‘residents’, were pair-housed with a tubal-ligated female in large 
plastic cages (37x50x20 cm3). All rats were maintained on a 12-12 reverse light-dark cycle (lights 
out at 0900 h) with free access to food (Purina Rodent Diet, Brentwood, MO) and water. 
Residents were previously screened for aggressive behavior and were used to induce social 
defeat stress in experimental “intruder” rats. All experimental procedures were approved by the 
Institutional Animal Care and Use Committees at the Arizona State University and the University 
of Arizona. All studies were conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (National Research Council, 2011),  and every effort was made to minimize 
pain and suffering, as well as the number of animals used. 
 
2.2 Experimental Design 
2.2.1 General Procedure 
 Upon arrival, experimental rats were habituated to laboratory conditions for 7 days before 
surgery to manipulate regional MOR level. Rats were randomly assigned to one of four 
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experimental conditions: Non-Manipulated MOR+Handled, Non-Manipulated MOR+Stressed, 
MOR Knockdown+Handled, MOR Knockdown+Stressed. Three experiments were conducted in 
parallel (Fig. 2.1A); one group of subjects (n = 25) received an amphetamine challenge 10 days 
after the last episode of intermittent social stress or handling to study the effects of VTA MOR 
knockdown on social stress-induced cross-sensitization. Seven days later, VTA tissue from this 
group of subjects was flash frozen for radioligand binding to verify the efficacy of MOR 
knockdown. Social approach and avoidance testing was performed two days after termination of 
social stress or handling procedures in both the above rats, as well as another cohort of rats (n = 
46). A separate cohort of rats of rats (n = 25) were weighed prior to each episode of intermittent 
social stress and handling, and again 10 days later to investigate the influence of VTA MOR 
knockdown on social stress-induced deficits in weight gain. 
 
2.2.2 Bilateral VTA Infusion of Lentiviral Constructs 
Rats assigned to control viral groups received infusions of lentivirus that expresses green 
fluorescent protein (GFP) and a short hairpin RNA (shRNA) that does not target any known rat 
gene, while rats assigned to VTA MOR knockdown groups received a lentivirus that expresses 
GFP and a shRNA that targets MOR (shMOR) for RNA interference. Lentiviral constructs were 
prepared as previously described (Lasek et al., 2007). The shMOR lentivirus reduces VTA MOR 
expression by 88-97% (Lasek et al., 2007). Therefore, the viral titre was diluted by 50% with cold 
sterile saline to reduce the efficacy. After random assignment to GFP or shMOR knockdown 
conditions, rats were anesthetized using isoflurane and positioned in a stereotaxic frame (Leica 
Angle Two; Richmond, IL). The appropriate lentiviral construct (1.0 µl each) was infused 
bilaterally into the VTA (AP -5.15, ML ±2.15, DV -8.7, Tilt 10°; Paxinos and Watson, 2007) at a 
flow rate of 0.1 µl/min, and allowed to diffuse for 10 min before withdrawal of the syringe 
(Hamilton; Model 7105 KH; 24 gauge tip; Reno, NV) . The accuracy of each infusion was later  
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Figure 2.1. Timeline of Experimental Events and Schematic of Social Approach and 
Avoidance Test Procedure. (A) Two cohorts of rats were given 7 days to recover from surgery, 
and were then exposed to intermittent (4x in 10 days) social defeat or handling procedures. Two 
days after the last episode of defeat, all rats were given the social approach and avoidance test. 
Ten days after the last episode of defeat, one cohort of subjects was administered an 
amphetamine challenge. Five days after receiving the challenge, brains from these rats were 
removed and processed for in vitro [3H]DAMGO autoradiography to verify the location and 
efficacy of MOR knockdown. (B) Subjects were assessed for social approach and avoidance 
using a procedure adapted from Berton et al. (2006). Left: Virtual arena dividing the chamber into 
2 virtual zones: Interaction Zone (IZ), comprising of the 1019.35 cm2 area immediately 
surrounding the containment cage, and Avoidance Zone (AZ), which comprised the two corners, 
combined 52.2 cm2, opposite the containment cage. Right: Schematic of the timeline for the 
social approach and avoidance procedure. 
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verified using localization of GFP expression. Subjects were given 7 days to recover before the 
start of intermittent social stress or handling procedures (Fig. 2.1A). 
 
2.2.3 Intermittent Social Defeat Stress and Handling Procedures 
Social defeat stress was induced by a short confrontation between an aggressive 
resident and an experimental intruder rat, as previously described (Tidey and Miczek, 1996, 
Nikulina et al., 2004, Nikulina et al., 2012). After removing the female from the resident’s home 
cage, an experimental rat was placed inside the resident’s home cage for 5 min within the 
confines of a protective metal cage (15x25x15 cm3). The protective cage was then removed, 
allowing the resident to attack the experimental intruder rat until it displayed supine posture for at 
least 4 sec (see Chapter 1, Fig. 1.1). Once submissive posture was exhibited, the experimental 
rat was placed back in the protective cage and exposed to threat from the resident for an 
additional 20 min before being returned to its own home cage. Intermittent social stress 
procedures were administered every third day for 10 days (Fig. 2.1A). At each corresponding time 
point, rats in the control groups were handled for approximately 2.5 min and then returned to their 
home cages.  
 
2.3 Behavioral Assessments 
2.3.1 Social Interaction 
The social approach and avoidance test was conducted in a large plastic container 
(58x38x41 cm3) equipped with a lightweight containment cage. Experimental rats were habituated 
to the empty test chamber for 5 min, then reintroduced when a novel stimulus rat was within the 
containment cage (Fig. 2.1B). The behavior of experimental rat was recorded for 5 min using 
TopScan (Clever Systems Inc.; Reston, VA). The software divided the chamber into virtual zones: 
Interaction, which comprised the area surrounding the containment cage, and Avoidance, which 
comprised the two corners opposite the containment cage (Fig. 2.1B; arena adapted from Berton 
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et al., 2006). The number of respective entries into the avoidance and interaction zones was 
recorded, as was the distance (cm) moved in each zone. 
 
2.3.2 Amphetamine Challenge 
A low dose d-amphetamine challenge was administered to test for social stress-induced 
cross-sensitization (Nikulina et al., 2004, Nikulina et al., 2012). For two days prior to the 
challenge, rats were injected with vehicle (0.9% sterile saline; 1.0 ml/kg, i.p.), and were 
acclimated in their home cage to the procedure room for 1 h. On the day of the challenge, rats 
were moved in their home cage to the procedure room, and locomotor activity was recorded at 10 
min intervals using video tracking software (Videotrack, Viewpoint Life Sciences; Montreal, 
Canada). Locomotor activity was detected as the number of and distance travelled during 
movements (>10 cm) across 170 min consisting of 3 phases: Baseline, Saline, and 
Amphetamine. Baseline data were recorded for 30 min, after which a saline injection (1.0 ml/kg, 
i.p.) was given and locomotor activity was recorded for 60 min. Finally, rats received an injection 
of d-amphetamine sulfate (1.0 mg/kg, i.p.; Sigma-Aldrich; St. Louis, MO), and locomotor data 
were recorded for 80 min. Video tracking and data collection were paused during the 
administration of saline and amphetamine injections. Rather than stereotypical behaviors, this 
dose of amphetamine has been shown to primarily induce large ambulatory movements (Geyer et 
al., 1987). In order to quantify amphetamine sensitization, ambulatory movements (> 10 cm) were 
measured in terms of the number of movements initiated and the distance travelled (cm) during 
such movements. 
 
2.4 Tissue Harvesting 
2.4.1 Fresh Frozen VTA Tissue for Radioligand Binding 
Rats were anesthetized with isoflurane, and their brains were rapidly removed and frozen 
in -35°C 2-methylbutane for 15 sec, then stored at -80°C prior to sectioning. On a cryostat, serial 
20 μm sections through the VTA were collected (from AP -4.8 to -5.5; Paxinos and Watson, 2007) 
for radioligand binding and localization of GFP expression. Sections were thaw-mounted onto 
51 
glass microslides (Superfrost Plus; Fisher Scientific; Waltham, MA), dried in a vacuum chamber 
at 4°C, and stored at -80°C prior to processing. Separate slides were used to verify the accuracy 
and distribution of lentiviral infusions based on fluorescent detection of GFP expression. 
 
2.5 [3H]DAMGO Autoradiography 
2.5.1 Radioligand Binding 
Fresh frozen brain sections were used to verify shMOR knockdown in the VTA using 
tritiated [D-Ala2,N-MePhe4,Gly-ol5] enkephalin ([3H]DAMGO; NIDA Drug Supply Program; 
Bethesda, MD), as described by Zhou and Hammer (1995). Briefly, slides were placed in pre-
incubation solution (15 mM Tris HCl, 150 mM NaCl, 1.0 mg/ml BSA) for 30 min at 4°C, then were 
incubated in 10 nM [3H]DAMGO solution (50 mM Tris buffer, 3.0 mM Mn acetate, 1.0 mg/ml BSA) 
with or without the addition of naloxone (10 μM; NIDA Drug Supply Program) for 60 min at 22°C. 
Slides were washed with a 50 mM Tris buffer at 4°C, then dried and exposed on Kodak BIO Max 
MR X-ray film (Carestream; Sigma-Aldrich; St. Louis, MO) for 10 weeks at room temperature. 
Sections incubated in 1000-fold excess unlabeled naloxone were utilized to determine non-
specific binding in subsequent autoradiography.  
 
2.5.2 Autoradiography Analysis 
Autoradiograpy film was developed and scanned at high resolution. In order to determine 
whether the shMOR viral construct infected regions outside of the VTA, the substantia nigra pars 
compacta (SNc) was chosen as a control region due to its close proximity to the VTA, and 
because social stress does not affect MOR expression in substantia nigra regions (Nikulina et al., 
1999, Nikulina et al., 2005). The SNc, not to be confused with the medial terminal nucleus 
accessory optic tract (MT),  contains a higher density of MOR labeling than either the substantia 
nigra pars reticulata (SNr) or VTA (Herkenham and Pert, 1982). Using this difference in 
expression, the SNc could be clearly demarcated on scans of autoradiographs by measuring the 
area directly above the SNr, lateral to the MT, and ventrolateral to the medial lemniscus. Optical 
densities for these regions were measured bilaterally in 2-3 sections using ImageJ (National 
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Institutes of Health, USA, http://imagej.nih.gov/ij), and then converted to μCi/g using calibrated 
[3H] radiostandards (ART-123, ARC Inc.; St. Louis, MO) co-exposed with sections. For each 
subject, bilateral measurements were averaged across sections to yield total ligand binding in the 
VTA and SNc, respectively. 
 
2.6 Statistical Analyses 
The results of each measure are expressed as mean ± standard error (SEM) and a p 
value ≤ 0.05 was considered to be significant. All statistical analyses were run using SPSS 
software, version 18 (SPSS Inc., Chicago, IL), and Tukey’s HSD was considered the preferred 
post hoc test across experiments. An exception was made in the case of the amphetamine 
challenge, where Fisher’s LSD was used because violations of sphericity necessitated the use of 
a more conservative test of the main effects. Data from subjects were excluded only in the case 
of error during video tracking or loss of data due to damaged tissue sections: no statistical outliers 
were excluded. The locomotor and social approach and avoidance assays relied on automated 
video tracking systems, requiring that the animals be housed in black bedding to block light from 
reflecting off the cage bottom. However in some instances, rats exposed the cage floor while 
moving, causing illumination artifacts that necessitated the removal of individual bin data due to 
inaccurate tracking. More specifically in the locomotor and social approach and avoidance 
assays, which relied on automated video tracking systems, individual bin data were removed in 
those instances where reflection artifacts prevented accurate tracking. For analyses of mounted 
tissue sections, the sample size of each group was also reduced in cases where tissue was 
damaged in the course of processing.  
 
2.7.1 Weight Gain Data 
The initial weight obtained at the start of social stress procedures was used to normalize 
all subsequent data (n = 25) to weight gained from that time onward; no subjects were excluded 
from the analysis. A one-way analysis of variance (ANOVA) was performed to assess differences 
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in weight at each time point, and all significant main effects were analyzed using Tukey’s test for 
post hoc comparisons among the means.  
 
2.7.2 Social Interaction 
Social approach and avoidance data were analyzed in terms of the number of entries to, 
and the distance travelled (cm) within the interaction and avoidance zones (Fig. 2.1B). Where 
illumination artifacts interfered with tracking, data were lost in a zone-specific manner. For 
example, avoidance zone entry data were analyzed from 40 subjects because illumination 
artifacts resulted in the exclusion of subjects from the following groups: GFP-Handled: 1; GFP-
Stressed: 3; shMOR-Handled: 2. For distance travelled in the avoidance zone, an additional 
tracking error which occurred after a subject entered the zone further reduced the number of 
analyzed subjects to 35; subjects were excluded from the following groups: GFP-Handled: 2; 
GFP-Stressed: 1; shMOR-Handled: 5; shMOR-Stressed: 3. Illumination artifacts and tracking 
error reduced the number of subjects in the interaction zone to 37;  subjects were excluded from 
the following groups: GFP-Stressed: 3; shMOR-Handled: 4; shMOR-Stressed: 2. A one-way 
ANOVA was run on data pertaining to each zone and any significant main effects were followed 
by an analysis of post hoc comparisons with Tukey’s test.  
 
2.7.3 Locomotor Activity 
 Locomotor data were analyzed using separate multivariate analysis of variance (MANOVA) 
for the mean number and distance (cm) travelled during ambulatory movements. In order to 
overcome violations of sphericity in the output of repeated measures ANOVA, MANOVA was 
used to analyze the number and distance of ambulatory movements exhibited throughout the 
amphetamine challenge. Significant multivariate effects were followed by univariate analyses to 
determine which time points produced significant group differences. Significant univariate effects 
were further analyzed for post hoc comparisons using Fisher’s Least Significant Difference (LSD) 
test. Data were analyzed from 21 subjects for both dependent measures of ambulatory 
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movements. Some subjects’ data were excluded from analysis due to the presence of illumination 
artifacts that interfered with tracking: GFP-Stressed: 2; shMOR-Handled: 1; shMOR-Stressed: 1. 
 
2.7.4 MOR Binding 
The results of radioligand binding with [3H]DAMGO in the VTA and SNc were analyzed 
using separate one-way ANOVAs, and where necessary, significant main effects were followed 
by post hoc comparisons with Tukey’s test. In the case of VTA [3H]DAMGO results, a violation of 
homogeneity was corrected for with Welch’s F test.  Sample sizes were reduced after the target 
region was damaged during processing during [3H]DAMGO binding for 1 shMOR treated subject. 
Consequently, receptor autoradiography was analyzed from 25 subjects in the VTA and 24 
subjects in the SNc.  
  
RESULTS 
Verification of MOR Knockdown Using [3H]DAMGO Autoradiography 
Fluorescent detection of virally expressed GFP revealed that lentiviral infusions were 
specific to the VTA (Fig. 2.2A), and GFP was not detected in either SN region (data not shown). 
While lentiviral constructs were infused at AP -5.15, GFP expression indicated infusions to the 
target site varied by ±0.1 mm, and that the average spread of GFP was within AP -4.8 to -5.5 and 
Lateral 0.4 mm to 1.4 mm (Fig. 2.2B). Quantitative in vitro autoradiography with [3H]DAMGO was 
used to determine the functionality of VTA MORs after lentivirus-mediated knockdown. Compared 
to the control GFP lentiviral construct, the subjects infused with the shMOR construct showed 
reduced [3H]DAMGO binding (Fig. 2.2C). One-way ANOVA revealed that this effect was 
significant in the VTA (n = 25, F1,20.13 = 102.46, p < 0.0001), but not the SNc  (n = 24, F1,22 = 1.63, 
p > 0.22; Fig. 2.2D). Thus, surgeries were accurate and bilateral shMOR knockdown selectively 
reduced VTA MOR binding density. 
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Figure 2.2. [3H]DAMGO Autoradiography Revealed That the shMOR Construct, but Not the 
Scrambled GFP Construct, Significantly Reduced MOR Binding in the VTA, but Not the 
SNc. (A) Left: Representative image of reporter GFP expression in infected VTA cells (fr: 
fasciculus retroflexus; scale bar = 100 µm). Right: Plate 37, modified from Paxinos and Watson 
(2007). (B) Parasagittal illustrations showing the extent of GFP expression across the VTA drawn 
in green (lateral plates 0.40 - 1.4, modified from Paxinos and Watson, 2007). (C) Representative 
autoradiographs of [3H]DAMGO binding in the VTA after infusion of either scrambled-GFP or 
shMOR lentiviral constructs (MT: medial terminal nucleus of the accessory optic system; scale 
bar = 500 µm). (D) The shMOR lentiviral construct (n = 14) significantly (* - p < 0.0001) reduced 
MOR binding in the VTA compared to the scrambled-GFP construct (n = 11), without affecting 
MOR binding of either the GFP (n = 11) or shMOR (n = 14) groups in the adjacent SNc (p > 
0.22). 
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Effect of VTA MOR Knockdown on Intermittent Social Stress-Induced Deficit of Weight Gain 
Weight gain data (n = 25) revealed a significant main effect during social stress exposure 
(F3,21 = 10.15, p < 0.0003), and 10 days after the last stress episode (F3,21 = 9.46, p < 0.0004; Fig. 
2.3). Post hoc comparisons at this time point show that the GFP-Stressed group experienced less 
weight gain than either the GFP-Handled or shMOR-Handled groups (p < 0.006), while the 
shMOR-Stressed group only differed from the shMOR-Handled group (p < 0.02). Ten days after 
the final episode of social stress, the GFP-Stressed group showed significantly lower body 
weights compared not only to GFP-Handled and shMOR-Handled  groups (p ≤ 0.006), but also 
the shMOR-Stressed group (p < 0.05). These data suggest that social stress significantly reduces 
body weight, and that while VTA MOR knockdown attenuated this effect during social stress 
exposure, it rescued this effect 10 days after termination of stress. 
 
Effect of VTA MOR Knockdown on Intermittent Social Stress-Induced Social Avoidance 
The social approach and avoidance test revealed a main effect of experimental group on 
number of entries to the avoidance zone (n = 40, F3,36 = 5.89, p = 0.002), with significantly more 
entries by GFP-Stressed rats compared to both GFP-Handled (p < 0.005) and shMOR-Stressed 
(p < 0.004) groups (Fig. 2.4A). Similarly, there was a significant main effect of experimental group 
on the distance traveled in the avoidance zone (n = 35, F3,31 = 4.77, p = 0.008; Fig. 2.4B), with 
significantly more activity in the GFP-Stressed group than the GFP-Handled (p = 0.011), shMOR-
Handled (p < 0.05), or shMOR-Stressed (p < 0.05) groups. There was no main effect of 
experimental group on the number of entries to the interaction zone (n = 37, F3,26 = 1.14, p = 
0.351; Fig. 2.4C). These data suggest that prior social stress exposure significantly increases 
social avoidance, and local VTA depletion of MOR prevents social stress-induced social 
avoidance without significantly altering social interaction.  
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Figure 2.3. Knockdown of VTA MORs Prevents Social Stress-Induced Deficit of Weight 
Gain. While undergoing social stress or handling, GFP-Stressed rats (n = 5) exhibited 
significantly (** - p < 0.05) less weight gain than did GFP-Handled (n = 6) or shMOR-Handled (n = 
7) rats. By contrast, shMOR-Stressed rats (n = 7) did not differ from GFP-Handled or -Stressed 
rats, showing significantly (α - p < 0.05) less weight gain than shMOR-Handled rats. Ten days 
after the last episode of exposure, GFP-Stressed rats had gained significantly (*** - p < 0.05) less 
weight than all other groups. 
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Figure 2.4. Knockdown of VTA MORs Prevents Social Stress-Induced Social Avoidance. 
(A) GFP-Stressed rats (n = 7) made significantly (** - p < 0.005) more entries to the avoidance 
zones than did GFP-Handled (n = 7) or shMOR-Stressed rats (n = 14). (B) GFP-Stressed rats (n 
= 9) were significantly (*** - p < 0.05) more active in the avoidance zones than GFP-Handled (n = 
7), shMOR-Handled (n = 8), or shMOR-Stressed (n = 11) rats. (C) GFP-Stressed rats (n = 7) 
showed a slight tendency to spend less time in the interaction zone, but there was no significant 
(p > 0.3) main effect compared to GFP-Handled (n = 9), shMOR-Handled (n = 9), or shMOR-
Stressed (n = 12) groups. 
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Effect of VTA MOR Knockdown on Intermittent Social Stress-Induced Cross-Sensitization 
There were significant main effects of experimental group on the number of ambulatory 
movements (n = 21, Wilks’ λ = 3.78x10-7, F51.0,17 = 10.57, p = 0.019, η2 = 0.993, observed power = 
0.87) and distance travelled during ambulatory movements(n = 21, Wilks’ λ = 1.26x10-6, F51.0,17 = 
7.03, p = 0.039, η2 = 0.989, observed power = 0.87) across all time points. The number of 
movements differed significantly only, at 30 (F 3,17 = 3.66, p = 0.034), 40 (F3,17 = 3.36, p = 0.043), 
and 50 (F3,17 = 4.46, p = 0.017) min after amphetamine injection, but there were no differences 
across groups before or after saline injection (p > 0.05 at all other time points). Post hoc testing 
(Fig. 2.5A) showed that the GFP-Stressed group exhibited significantly greater number of 
movements compared to GFP-Handled (p < 0.005) and both shMOR-Handled and -Stressed 
groups (p < 0.05) at 30 min after amphetamine injection, compared to GFP-Handled (p < 0.01) 40 
min post-amphetamine, and compared to GFP-Handled (p < 0.002) and both shMOR-Handled 
and -Stressed groups (p < 0.03) 50 min after amphetamine.  
Similarly, distance travelled exhibited significant main effects only 20 (F3,17 = 3.51, p = 
0.038), 30 (F3,17 = 6.83, p = 0.003), and 40 (F3,17 = 4.86, p = 0.013) min after amphetamine 
injection. Post hoc analyses (Fig. 2.5B) showed that the GFP-Stressed group moved a 
significantly greater distance compared to the GFP-Handled, shMOR-Handled, and shMOR-
Stressed groups (p < 0.02)  20 min after amphetamine injection, compared to GFP-Handled and 
both shMOR groups (p < 0.002) 30 min post-injection, and compared to the GFP-Handled and 
both shMOR groups (p < 0.03) groups 40 min post-amphetamine. Thus, the GFP-Stressed group 
showed social stress-induced cross-sensitization following amphetamine challenge, but the 
shMOR-Stressed group did not. 
 
DISCUSSION 
These data show that lentivirus-mediated overexpression of shMOR successfully 
reduced MOR binding activity in the VTA, and that the affected region was limited to the VTA. 
Furthermore, the results of this study indicate that intermittent social stress induction of VTA  
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Figure 2.5. 
Knockdown of 
VTA MORs 
Prevents Social 
Stress-Induced 
Amphetamine 
Cross-
Sensitization 
Without 
Affecting 
Baseline 
Activity. 
Multivariate 
analyses revealed 
that the only 
significant main 
effects occurred 
during the 
amphetamine 
phase of the 
assay. Data 
collection and 
video tracking 
were paused to 
administer saline 
and 
amphetamine, 
vertical arrows 
denote the time point when injection occurred. (A) GFP-Stressed rats (n = 4) exhibited 
significantly (*** - p < 0.05) more movements at 120 and 140 min compared to GFP-Handled (n = 
5), shMOR-Handled (n = 6), and shMOR-Stressed (n = 6) rats, and differed significantly (* - p < 
0.02) from GFP-Handled rats at 130 min. (B) GFP-Stressed rats travelled a significantly (*** - p < 
0.03) greater distance at 110, 120, and 130 min compared to all other groups. 
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MORs is required for various stress-induced changes. For example, lentivirus-mediated 
knockdown of VTA MORs blocks intermittent social stress-induced social avoidance, cross-
sensitization to amphetamine, and deficit of weight gain.  
 
VTA MOR Upregulation is Necessary for Intermittent Social Stress-Induced Weight Gain Deficits  
Exposure to social stress attenuated weight gain both during and 10 days after social 
stress exposure, which is consistent with previous findings (Meerlo et al., 1996, Pulliam et al., 
2010, Fanous et al., 2011, Venzala et al., 2012). VTA MOR knockdown rescued the deficit of 
weight gain 10 days after the last episode of stress, but not during stress exposure. That 
knockdown of VTA MORs attenuated and promoted recovery from social stress-induced weight 
gain deficit is consistent with a report of increased body weight in MOR knockout mice (Han et al., 
2006). Another study using the same lentiviral construct in the VTA (Lasek et al., 2007) also 
showed no significant effect on weight, indicating that VTA MOR knockdown is not sufficient to 
alter weight gain in the absence of social stress. 
The role of MORs in the regulation of food intake and weight gain is complex, making it 
difficult to separate MOR effects on food palatability, food intake, and a more general increase of 
hedonic value. Pharmacological stimulation of MORs has frequently been associated with 
increased hedonic value of food and drug stimuli (Badiani et al., 1995, Nathan and Bullmore, 
2009), while MOR antagonism has been associated with decreased consumption of highly 
palatable food (Segall and Margules, 1989), as well as decreased sensitivity to natural reward 
(Pitchers et al., 2014). Stimulation of VTA MORs has been found to facilitate food consumption in 
a dopamine D1 receptor-dependent manner (Badiani et al., 1995, MacDonald et al., 2004), while 
antagonism reduced consumption of palatable foods (Segall and Margules, 1989). Based on this, 
one might expect that VTA MOR knockdown would further reduce weight gain by altering feeding 
behaviors. By contrast, the present data show that VTA MOR knockdown rescues the stress-
induced deficit in weight gain without affecting normal weight gain.  
If knockdown of VTA MORs rescued the stress-induced reduction of weight gain by 
attenuating the psychological effects of stress, one might expect to see signs of increased reward 
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or hedonic value in the amphetamine challenge or social approach and avoidance test. However, 
compared to GFP-Handled rats, subjects in the shMOR-Handled group did not show increased, 
or impaired response to amphetamine, or differ in social interaction. That subjects with VTA MOR 
knockdown, regardless of stress treatment, did not exhibit significant differences in weight gain 
compared to control GFP-Handled subjects, suggests that the rescue of weight gain is likely due 
to the prevention of downstream stress-induced changes in the mesolimbic circuit. For example, 
social stress also increases VTA brain-derived neurotrophic factor (BDNF) expression, however 
this begins at after upregulation of VTA MORs (Nikulina et al., 2008, Fanous et al., 2010, Nikulina 
et al., 2012). Since VTA BDNF expression is also necessary for the stress-induced weight gain 
deficit (Fanous et al., 2011), it is possible that knockdown of VTA MORs rescued the stress-
induced weight gain deficit by augmenting VTA BDNF expression.  
The current study did not measure food consumption, so it is not possible to ascertain 
whether altered food intake contributed to the weight gained after stress, with or without VTA 
MOR knockdown. However, if the stress-induced deficit of weight gain were related to VTA MOR-
mediated changes in food intake, one would expect both Handled- and Stressed-shMOR 
knockdown groups to show significant differences in weight gain compared to GFP-Handled rats, 
which was not the case. There is some evidence to suggest that that MOR activity can alter 
weight gain without producing deficits in food consumption. In particular, daily morphine injection 
for 8 days had no effect on weight gain or food intake, while a parallel group of subjects that 
received escalating doses of morphine exhibited reduced weight gain without significant any 
significant effect on food consumption (Ren et al., 2013). In the same study, injections of 
escalating doses of morphine led to activation of cAMP responsive binding element protein 
(pCREB) in the VTA, implicating this region in MOR-mediated reduction of weight gain, but not 
food intake. Based on this, it is possible that escalating endogenous mu-opioid activity in the VTA 
underlies the weight gain deficit seen after social stress. 
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Upregulation of VTA MORs is Necessary for Intermittent Social Stress-Induced Social Avoidance 
Rodents with non-manipulated VTA MORs and a history of social stress engaged in 
significantly more social avoidance (Berton et al., 2006, Fanous et al., 2010, Komatsu et al., 
2011). However, MOR knockout mice do not show social avoidance after continuous social stress 
(Komatsu et al., 2011), just as knockdown of VTA MORs prevented intermittent social stress-
induced social avoidance in the current study. MORs have been implicated in the rewarding 
components of social behavior, while MOR antagonists are associated with reduced social play 
(Vanderschuren et al., 1997) and experience-induced facilitation of sexual behavior (Pitchers et 
al., 2014), allowing for the possibility that VTA MOR knockdown might alter normal social 
interaction. However, the current results showed that VTA MOR knockdown in handled rats did 
not alter any measures of social interaction, suggesting that VTA MORs affect social behavior 
only upon the impact of stress exposure. 
Previous research has also indicated that social history alone (isolation vs. social 
housing) or in conjunction with a social interaction test has a profound effect on MOR expression 
(Vanderschuren et al., 1995). Specifically, long-term social isolation increased MOR binding 
density in the VTA, while an acute social interaction reduced VTA MOR binding. Taken together, 
it is possible that positive and negative social situations alter VTA MOR expression, respectively 
decreasing or increasing VTA MOR activity.  
 
Knockdown of VTA MORs Prevents Intermittent Social Stress-Induced Cross-Sensitization 
Stressed rats with non-manipulated VTA MORs exhibited significantly greater locomotor 
activity after a low dose amphetamine challenge, confirming prior reports that intermittent social 
stress induces amphetamine cross-sensitization 10 days after the last stress episode (Covington 
and Miczek, 2001, Nikulina et al., 2012). By contrast, knockdown of VTA MORs prevented social 
stress-induced cross-sensitization without blocking amphetamine-induced locomotion. VTA 
MORs are presynaptically expressed by GABA neurons (Sesack and Pickel, 1995, Garzon and 
Pickel, 2002), and when activated, reduce GABAergic inhibition of VTA DA neurons (Johnson 
and North, 1992, Bergevin et al., 2002, Vargas-Perez et al., 2009b, Trigo et al., 2010, Dacher and 
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Nugent, 2011) and facilitate response to psychomotor stimulants. Thus, if stimulation of MORs in 
the VTA indirectly increases VTA DA activity by reducing GABA transmission, then it is likely that 
knockdown of VTA MORs increases GABA release. In fact, MOR knockout mice showed 
enhanced VTA GABA release onto local DA neurons, resulting in reduced cocaine self-
administration (Mathon et al., 2005).  
While this theory of inhibitory MOR activation is well accepted, it was recently 
demonstrated that MORs can also be found on VTA DA neurons, and can even have excitatory 
functions (Margolis et al., 2014). Given that intra-VTA agonism of MORs, after stress-induced 
upregulation, produces a sensitized locomotor response (Nikulina et al., 2005, Nikulina et al., 
2008) that is associated with increased VTA DA activity, thus it is unlikely that social stress 
upregulates inhibitory MORs on DA, or excitatory MORs on GABA. However if stress increased 
the expression of excitatory MORs on VTA DA neurons, it would produce a direct increase in DA 
activity, similar to the indirect increase associated with inhibitory MORs on VTA GABA neurons. 
Thus it is possible that knockdown of VTA MORs mediated VTA DA output in two ways: either 
through direct excitation of DA neurons, or classical disinhibition of DA via inhibitory MORs on 
GABA neurons.  
Although treatment with a MOR antagonist has been shown to abolish amphetamine 
responses (Magendzo and Bustos, 2003), this study showed that knockdown of VTA MORs did 
not block psychomotor activation following amphetamine challenge. This suggests that 
knockdown of VTA MORs does not produce unnatural alterations of mesolimbic tone. The results 
of this study reveal that VTA MOR upregulation is necessary for intermittent social stress-induced 
cross-sensitization to amphetamine. As such, in the VTA social stressors may function to 
increase endogenous MOR activity on GABA neurons, thus reducing the GABAergic inhibition of 
local DA neurons and facilitating behavioral sensitization to psychostimulant drugs. 
 
Concluding Remarks 
  Since increased mesolimbic BDNF – TrkB receptor activity has been associated with the 
behavioral consequences of social stress, as well as stress- and drug-induced sensitization (see 
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review of Nikulina et al., 2014), it is possible that VTA MOR knockdown prevented the behavioral 
effects of social stress by augmented stress-induced changes in mesolimbic BDNF – TrkB 
receptor signaling. Given that in the present study, VTA MOR knockdown likely functioned to 
block stress-induced increase of dopaminergic tone, this manipulation also might prevent stress-
induced changes in the NAc, such as increases in TrkB receptor expression. Future studies are 
needed to determine whether VTA MOR knockdown alters stress-induced increase of mesolimbic 
BDNF – TrkB receptor activity.  
In conclusion, the results of this study indicate that social stress exposure increases VTA 
MOR activity, potentially disinhibiting VTA dopaminergic tone to facilitate response to drugs of 
abuse. The present data suggest that upregulation of VTA MORs following social stress exposure 
may underlie vulnerability to psychostimulant drugs in some individuals, thereby providing a 
potential target for therapeutic intervention during abuse of these drugs. 
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CHAPTER 3: KNOCKDOWN OF VENTRAL TEGMENTAL AREA MU-OPIOID RECEPTORS: 
IMPLICATIONS FOR SOCIAL STRESS-INDUCED CHANGES ACROSS THE 
MESOCORTICOLIMBIC CIRCUIT 2 
 
ABSTRACT 
Social defeat stress induces prolonged cross-sensitization to drugs of abuse, as well as a 
corresponding upregulation of ventral tegmental area (VTA) mu-opioid receptor (MOR) mRNA. 
Previously lentivirus-mediated knockdown of VTA MORs was found to prevent the behavioral 
consequences of social stress. The present study used lentivirus-mediated interference to 
investigate whether intermittent social stress-induced upregulation of VTA MORs mediates 
stress-induced changes throughout the mesocorticolimbic circuit. At the time point corresponding 
to amphetamine challenge, immunohistochemical analyses were performed to examine the effect 
of VTA MOR knockdown on stress-induced brain-derived neurotrophic factor (BDNF) expression 
in the VTA and prefrontal cortex (PFC), as well as delta FosB and tropomyosin-related kinase B 
(TrkB) receptor expression in the nucleus accumbens (NAc), all of which have been implicated in 
stress-induced drug sensitization. Prior stress exposure increased the expression of BDNF in the 
VTA and its receptor TrkB in the NAc of rats with non-manipulated VTA MOR expression, while 
VTA MOR knockdown prevented stress-induced expression of VTA BDNF and NAc TrkB 
receptor. Although social stress alone significantly increased the expression of delta FosB in the 
NAc core, this effect was only somewhat attenuated by VTA MOR knockdown. By contrast, there 
was no effect of either stress or VTA MOR knockdown on BDNF expression in the PFC. Taken 
together, these results suggest that upregulation of VTA MOR is necessary for increased 
mesolimbic expression of BDNF and its TrkB receptor. These data extend what is known about 
                                               
2 The BDNF immunohistochemistry performed in this chapter was published in Johnston et al. 
(2015), to see this manuscript in its entirety, please refer to Appendix A. In-text references to 
Johnston et al. (2015) refer to the behavioral data presented in Chapter 2. 
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the directionality of stress-induced signaling in the VTA, and suggest that VTA MORs may serve 
as the starting point for the effects of stress in the mesolimbic pathway.  
 
INTRODUCTION 
Stress is one variable that influences the transition from recreational drug use to abuse in 
humans, and it has been correlated with both increased risk of substance abuse and relapse 
(Sinha, 2001, 2008, 2011). Rodent studies have shown that intermittent social defeat stress 
consistently confers vulnerability to drugs of abuse, a phenomena known as stress-induced 
cross-sensitization (Covington and Miczek, 2001, Nikulina et al., 2004, Nikulina et al., 2012). 
Moreover social stress-induced upregulation of ventral tegmental area (VTA) mu-opioid receptors 
(MORs) was recently shown to be necessary for the development of cross-sensitization to 
amphetamine (Johnston et al., 2015). In the VTA, MORs are generally expressed by gamma-
aminobutyric acid (GABA) neurons (Sesack and Pickel, 1995, Garzon and Pickel, 2002), which 
are hyperpolarized in response to MOR stimulation, and disinhibit local dopamine (DA) 
transmission to facilitate response to drugs of abuse (Johnson and North, 1992, Bergevin et al., 
2002, Dacher and Nugent, 2011). However it was recently shown that MORs can have either 
inhibitory or excitatory functions in both VTA GABA and DA neurons (Margolis et al., 2014). 
Despite this, rats exposed to repeated social defeat stress and then challenged with an intra-VTA 
infusion of a MOR-specific agonist, exhibit sensitized locomotor activity (Nikulina et al., 2005, 
Nikulina et al., 2008), which is typically thought to reflect increased VTA DA transmission. This 
suggests that net effect of social stress-induced MOR upregulation is to enhance VTA DA 
transmission, and given that only a small proportion of MORs are excitatory on VTA DA neurons 
(Sesack and Pickel, 1995, Garzon and Pickel, 2002, Margolis et al., 2014), implies that the VTA 
MORs upregulated after stress are predominantly inhibitory on GABA interneurons. 
Delta FosB is a nuclear transcription factor that gradually accumulates with repeated 
exposure to stimuli, such as stress or drugs of abuse (Nestler et al., 2001, Nestler, 2008, 2014).  
Generally speaking, delta FosB is thought to act as either a transcriptional activator or repressor, 
depending on the nature of the target gene, and an accumulation of delta FosB in the nucleus 
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accumbens (NAc) is one of the most common responses to drugs that effect VTA DA 
transmission (Nestler et al., 2001, Nestler, 2008). In particular, NAc delta FosB expression is 
increased following acute cocaine treatment (Larson et al., 2010), as well as during withdrawal 
from chronic psychostimulant administration (Murphy et al., 2003, Larson et al., 2010). Similar to 
drugs of abuse, social stress also significantly increases the expression of delta FosB in the NAc 
(Nikulina et al., 2008, Nikulina et al., 2012), and the expression of this protein seems to be related 
to mesolimbic brain-derived neurotrophic factor (BDNF) – tropomyosin-related kinase B (TrkB) 
receptor signaling. In fact, viral-mediated overexpression of VTA BDNF exacerbates social 
stress-induced NAc delta FosB expression (Wang et al., 2013), while viral-mediated depletion of 
NAC TrkB, the BDNF receptor, prevents delta FosB induction (Wang et al., 2014). 
Consistent with its effects on NAc delta FosB expression, social stress-induced cross-
sensitization to psychomotor stimulants has also been shown to involve increased mesolimbic 
BDNF – TrkB receptor signaling (Wang et al., 2013, Wang et al., 2014). Specifically, viral-
mediated overexpression of VTA BDNF exacerbated (Wang et al., 2013), while knockdown of 
TrkB receptor in the NAc prevented stress-induced amphetamine cross-sensitization (Wang et 
al., 2014). In addition to increasing VTA BDNF, social stress also rapidly induces BDNF 
expression in the prefrontal cortex (PFC; Fanous et al., 2010), however it is unknown whether 
PFC BDNF expression is effected by manipulations of the mesolimbic circuit. Increased VTA 
BDNF expression has been implicated as a long-term mediator of social stress-induced cross-
sensitization (Nikulina et al., 2012), and in the VTA this increase persists for at least 2 weeks after 
the last social stress exposure (Berton et al., 2006, Fanous et al., 2010, Nikulina et al., 2012).  
Although VTA MOR mRNA expression rapidly increases following social stress exposure, 
VTA BDNF expression is affected more slowly and its expression persists beyond that of VTA 
MORs (Nikulina et al., 2005, Nikulina et al., 2008, Fanous et al., 2010). Since both VTA BDNF 
and MOR expression have been implicated in social stress-induced cross-sensitization to 
amphetamine (Wang et al., 2013, Wang et al., 2014, Johnston et al., 2015), and since increases 
in VTA MOR expression occur prior to increases in VTA BDNF expression, it is possible that 
knockdown of VTA MORs may respectively prevent social stress-induced increases in VTA 
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BDNF and NAc TrkB receptor expression. Given that increased mesolimbic BDNF – TrkB 
signaling is associated with the induction of delta FosB expression in the NAc after stress, it is 
possible that VTA MORs may also mediate this effect, either through indirect augmentation of 
mesolimbic BDNF – TrkB signaling, or through direct mediation of GABA and DA projections to 
the NAc. In addition to sending direct GABA projections to the NAc, the VTA also innervates the 
PFC (Sesack and Grace, 2010, Morales and Pickel, 2012, Walsh and Han, 2014), thus it is 
possible that knockdown of VTA MORs may also have reciprocal effects in the PFC.  
While it has been established that social stress-induced increases in VTA MORs are 
critical for the behavioral consequences of social defeat stress (Johnston et al., 2015), it unknown 
whether upregulation of VTA MORs mediates the effects of social stress on the mesocorticolimbic 
circuit. To address this question, the present study used lentivirus-mediated gene transfer and 
RNA interference to knockdown MORs in the VTA, and then at the time point that stress-induced 
cross-sensitization to amphetamine is known to be present, assessed for social stress-induced 
expression of BDNF in the VTA and PFC, as well as for its TrkB receptor and delta FosB in the 
NAc.  
 
METHODS 
3.1 Subjects 
Subjects were male Sprague-Dawley rats (N = 21; Charles River Laboratories, Hollister, 
CA) weighing 200-250 g on arrival. Three days before social stress exposure, subjects were 
individually housed in standard plastic cages (25x50x20 cm3). Male Long-Evans rats (weighing 
550-700 g), termed ‘residents’, were pair-housed with a tubal-ligated female in large plastic cages 
(37x50x20 cm3). All rats were maintained on a 12-12 reverse light-dark cycle (lights out at 0900 
h) with free access to food (Purina Rodent Diet, Brentwood, MO) and water. Residents had 
previously been screened for aggressive behavior and were used to induce social defeat stress in 
experimental subjects. All experimental procedures were approved by the Institutional Animal 
Care and Use Committees at the Arizona State University and the University of Arizona. All 
studies were conducted in accordance with the Guide for the Care and Use of Laboratory 
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Animals (National Research Council, 2011),  and every effort was made to minimize pain and 
suffering, as well as the number of animals used. 
 
3.2 Experimental Design 
3.2.1 General Procedure 
Before to surgery to manipulate VTA MOR levels, subjects were habituated to laboratory 
conditions for 7 days and randomly assigned to one of four experimental conditions: Non-
Manipulated MOR+Handled, Non-Manipulated MOR+Stressed, MOR Knockdown+Handled, 
MOR Knockdown+Stressed. All subjects were perfused 10 days after the last episode of 
intermittent social stress (Fig. 3.1) to study the effects of Stress and MOR knockdown on stress-
induced changes in the mesocorticolimbic circuit during the time that cross-sensitization to 
amphetamine is known to be occur. 
 
3.2.2 Bilateral VTA Infusion of Lentiviral Constructs 
Rats assigned to control viral groups received infusions of lentivirus that expresses green 
fluorescent protein (GFP) and a short hairpin RNA (shRNA) that does not target any known rat 
gene, while rats assigned to VTA MOR knockdown groups received a lentivirus that expresses 
GFP and a shRNA that targets MOR (shMOR) for RNA interference. The spread and efficacy of 
these lentivirus constructs was  previously established in the rat VTA (Johnston et al., 2015) and 
were prepared as described in (Lasek et al., 2007). After random assignment to GFP or shMOR 
knockdown conditions, rats were anesthetized using isoflurane and positioned in a stereotaxic 
frame (Leica Angle Two; Richmond, IL). The appropriate lentiviral construct (1.0 µl each) was 
infused bilaterally into the VTA (AP -5.15, ML ±2.15, DV -8.7, Tilt 10°; Paxinos and Watson, 2007) 
at a flow rate of 0.1 µl/min (Hamilton syringe; Model 7105 KH; 24 gauge tip; Reno, NV), and 
allowed to diffuse for 10 min. The accuracy of each infusion was later verified using localization of 
GFP expression (data not shown). Subjects were given 7 days to recover before the start of 
intermittent social stress or handling procedures (Fig. 3.1). 
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Figure 3.1. Timeline of Experimental Events. Rats were given 7 days to recover from surgery, 
and then were exposed to intermittent (4x in 10 days) social defeat stress or handling procedures. 
Ten days after the last episode of defeat, subjects were perfused to for immunohistochemical 
analyses of the effect of VTA MOR knockdown on stress-induced changes throughout the 
mesocorticolimbic circuit. 
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3.2.3 Intermittent Social Defeat Stress and Handling Procedures 
Social defeat stress was induced by a short confrontation between an aggressive 
resident and an experimental intruder rat, every third day for 10 days (Fig. 3.1), as previously 
described (Tidey and Miczek, 1996, Nikulina et al., 2004, Nikulina et al., 2012, Johnston et al., 
2015; see also Chapter 1, Fig. 1.1). Briefly, females were removed and an experimental rat was 
placed inside the resident’s home cage for 5 min within the confines of a protective metal cage 
(15x25x15 cm3). Then the protective cage was removed, allowing the resident to attack until the 
subject displayed supine posture for a minimum of 4 sec. After which, the experimental rat was 
placed back in the protective cage and exposed to threat from the resident for an additional 20 
min. During this time, rats in the control groups were handled (~2.5 min), at the end of defeat or 
handling procedures, all subjects were returned to their home cages. 
  
3.3 Perfusion for Immunohistochemistry 
As previously described (Fanous et al., 2010), rats were anesthetized with sodium 
pentobarbital (100 mg/kg, i.p.; Euthasol, Virbac Co., St. Louis, MO) and perfused transcardially 
with 4% paraformaldehyde 10 days after the last episode of stress or handling (Fig. 3.1). Brains 
were then removed, post-fixed for 1.5 hours at 4°C, and placed in graded sucrose solutions. 
Frozen brain tissue was sectioned on a sliding microtome (20 μm) and serial VTA sections were 
mounted onto slides from 0.05 M phosphate buffer (pH = 7.4). Adjacent slides from each brain 
were processed for chromogen immunohistochemistry. 
 
3.4 Immunohistochemistry and Quantification 
3.4.1 Chromogen Immunohistochemistry 
Immunohistochemistry was performed using polyclonal BDNF, FosB, and TrkB receptor 
antisera as described previously (Fanous et al., 2010, Wang et al., 2013, Wang et al., 2014). 
Briefly, blocking solution (10% normal goat serum/0.5M KPBS/0.4% Triton X-100) was applied to 
sections for 1 h at room temperature, then the respective primary antibody diluted in blocking 
solution was applied for 48 hr at 4°C (BDNF 1:1000 dilution, SP1779, Millipore/Chemicon, 
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Temecula, CA; FosB 1:7000 dilution, SC-48, Santa Cruz Biotechnology Inc., Santa Cruz, CA; 
TrkB receptor 1:7000 dilution, Biosensis, 23-36, Thebarton, S. Australia). Sections were then 
incubated for 1 h with a biotinylated rabbit secondary antibody, treated with avidin/biotin complex 
solution for 45 min (Vectastain Elite ABC Kit; Vector Laboratories; Burlingame, CA), and 
developed using a diaminobenzidine (DAB) peroxidase substrate kit with nickel intensification 
(Vector Laboratories). Tissue sections cover slipped and imaged using a Zeiss Axioskop 
microscope with a 20x objective, and digitalized using a color digital camera. It should be noted 
that the FosB antibody used here targets both FosB and delta FosB proteins, due to the similarity 
in their N-terminal. However given the transient nature of FosB vs. delta FosB’s propensity to 
accumulate (Perrotti et al., 2004), and the timeline of prolonged absence from stress used in the 
current study (Fig. 3.1), the FosB labeling seen in this study predominantly reflects delta FosB 
expression and will be discussed as throughout. 
 
3.4.2 Modified Stereological Cell Counts 
Immunolabeled cells were quantified using Stereo Investigator software (MBF 
Biosciences; Williston, VT) and ImageJ (National Institutes of Health, USA, 
http://imagej.nih.gov/ij), and the analysis was conducted using the modified stereology counting 
procedure described in Nikulina et al. (2012). Briefly, a grid of squares (0.0075 mm2) was overlaid 
on each of 2-3 sections from each subject. Immunolabelled cells were counted in half the grid 
squares, the precise squares being randomly determined. Immunolabelled cells had a blue-black 
reaction product and were counted such that cells crossing the bottom or right lines of each 
square were included, while cells crossing the top or left lines of the square were excluded from 
analysis. For each subject, estimates of total labeling density (mm2) were calculated by averaging 
the bilateral counts of labeled cell profiles across sections, and then dividing the total number of 
cell profiles by the total area assessed.  
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3.5 Statistical Analyses 
The results of each measure are expressed as mean ± standard error (SEM) and a p 
value ≤ 0.05 was considered to be significant. All statistical analyses were run using SPSS 
software, version 18 (SPSS Inc., Chicago, IL). No statistical outliers were excluded, sample sizes 
were only reduced when the site of interest was damaged during the course of processing. Since 
a previous study reported no significant differences between GFP-Handled and shMOR-Handled 
rats (Johnston et al., 2015), a t-test was run for each data set and confirmed that there were no 
significant differences between groups (p > 0.05). Based on this, GFP-Handled and shMOR-
Handled groups were combined into one Control Handled group for subsequent statistical 
analyses of immunohistochemical data. Immunohistochemistical cell counts were analyzed using 
separate univariate ANOVA’s, and where necessary, significant main effects were followed by 
post hoc comparisons with Tukey’s test.  
Due to tissue damage during mounting and processing for immunohistochemical 
processing, sample sizes were reduced by 2-3 subjects in the VTA and NAc. Specifically, in the 
case of TrkB staining in the NAc, tissue resulted in the analysis of data from 18 subjects in both 
the NAc core and shell. For FosB staining in the NAc shell, data were analyzed from 19 subjects, 
while additional damage in the NAc core limited analysis to 18 subjects. In the VTA, BDNF 
expression was analyzed in 19 subjects, while PFC cortex sections did not have significant 
damage and consequently data were analyzed from all subjects (N = 21). In the analysis of FosB 
in the NAc core, a violation of homogeneity required a correction, and so Welch’s test was 
employed to adjust the degrees of freedom and F-value.  
  
RESULTS 
Effect of VTA MOR Knockdown on BDNF Expression After Intermittent Social Stress Exposure 
There was a significant main effect of stress on VTA BDNF expression (n = 19, F2,16 = 
33.87, p < 0.0001). Specifically, the GFP-Stressed group had significantly greater VTA BDNF  
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expression compared to Control Handled and shMOR-Stressed groups (p < 0.0001, Fig. 3.2), 
while there were no differences between the shMOR-Stressed and the Control Handled groups (p 
> 0.74). In contrast, there was no significant main effect on BDNF expression in either the 
prelimibic (PL; n = 21, F2,18 = 1.12, p = 0.348) or infralimbic (IL; n = 21, F2,18 = 0.235, p = 0.793) 
areas of the PFC (Fig. 3.3). Taken together, VTA MORs are necessary for the social stress-
induced increases in VTA, but not PFC BDNF expression 10 days after the last episode of stress 
or handling.  
 
Effect of VTA MOR Knockdown on NAc TrkB Receptor and Delta FosB Expression After 
Intermittent Social Stress Exposure 
There was a significant main effect of stress on TrkB receptor expression in both the NAc 
core (n = 18, F2,15 = 9.95, p = 0.002) and shell (n = 18, F2,15 = 9.95, p < 0.0001, Fig. 3.4). 
Specifically, in both the NAc core and shell, GFP-Stressed rats had significantly higher levels of 
TrkB receptor (p < 0.003) than either Control Handled, or shMOR-Stressed rats. By contrast, 
TrkB receptor expression in shMOR-Stressed rats did not significantly differ from Control Handled 
subjects (p > 0.23). Taken together, this is evidence that VTA MORs are necessary for the social 
stress-induced increase of TrkB receptor expression in the NAc.  
 There was also a significant main effect of stress on delta FosB expression in the NAc 
core (corrected with Welch’s test; n = 18, F2,8.98 = 22.64, p < 0.001), but not the NAc shell (n = 19, 
F2,16 = .77, p > 0.47). In the NAc core, GFP-Stressed rats expressed significantly more delta FosB 
than Control Handled subjects (p = 0.01; Fig. 3.5). By contrast, although the difference between 
shMOR-Stressed rats and GFP-Stressed rats approached significance (p = 0.071), the difference 
between the shMOR-Stressed and Control Handled groups was highly non-significant (p > 0.58). 
These data show that VTA MORs attenuate, but do not significantly prevent the effect of social 
stress on delta FosB expression in the NAc core.  
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Figure 3.2. Knockdown of VTA MORs Blocks Social Stress-Induced Increase of VTA BDNF 
Expression. (A) The GFP-Stressed group (n = 5) exhibited significantly (*** - p < 0.0001) more 
VTA BDNF immunolabeling than either Control Handled (n = 8) or shMOR-Stressed (n = 6) 
groups. Numbers of labeled cells did not significantly differ between Control Handled and 
shMOR-Stressed rats (p > 0.74). (B) Representative images of BDNF labeling in the anterior 
VTA. More BDNF labeled cells (identified by arrows) are visible in the GFP-Stressed group than 
in any others. (Scale bar = 100 μm). 
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Figure 3.3. There Was No Effect on BDNF Expression in the PFC Ten Days After the Last 
Episode of Stress. (A) Neither social stress nor VTA MOR knockdown (N = 21) had an effect on 
BDNF expression in the prelimbic or infralimbic areas of PFC (p > 0.34). (B) Representative 
images of BDNF labeling in prelimbic and infralimbic regions, labeled cells are indicated by 
arrows (Scale bar = 100 μm). 
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Figure 3.4. Knockdown of VTA MORs Blocks Social Stress-Induced Increase of TrkB 
Receptor in the NAc. (A) In both the NAc core and shell, the GFP-Stressed group (n = 5) 
exhibited significantly (* - p < 0.003) more immunolabeling for TrkB receptor than either Control 
Handled (n = 8) or shMOR-Stressed (n = 5) groups. Numbers of labeled cells did not significantly 
differ between Control Handled and shMOR-Stressed rats (p > 0.23). (B) Representative images 
of TrkB receptor labeling in the NAc core and shell. More TrkB receptor labeled cells (identified by 
arrows) are visible in the GFP-Stressed group than in any other (Scale bar = 50 μm). 
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Figure 3.5. Knockdown of VTA MORs Attenuated the Stress-Induced Increase of Delta 
FosB in the NAc Core. (A) The GFP-Stressed group (n = 4) exhibited significantly more delta 
FosB labeling than Control Handled rats (n = 9) in the NAc core (* - p < 0.04). Although shMOR-
Stressed rats (n = 6) did not differ from the Control Handled group (p > 0.58), they did tend to 
have lower levels of delta FosB compared to the GFP-Stressed group, however this effect was 
not significant (p > 0.06). In contrast, there was no effect of either stress of VTA MOR knockdown 
on delta FosB expression in the NAc shell (p > 0.47). (B) Representative images of delta FosB 
labeling in the NAc core and shell. In the NAc core, more delta FosB labeled cells (identified by 
arrows) are visible in the GFP-Stressed group than in any others (Scale bar = 100 μm). 
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DISCUSSION 
These data show that induction of VTA MORs by intermittent social defeat stress is 
necessary for social stress-induced increases in mesolimbic BDNF and TrkB receptor, but not for 
social stress-induced increases in delta FosB in the NAc. In particular, lentivirus-mediated 
knockdown of VTA MORs blocked the stress-induced induction of VTA BDNF and NAc TrkB 
receptor expression, but only attenuated the stress-induced increase of NAc delta FosB. There 
was no effect of either stress or VTA MOR knockdown on BDNF expression in the PFC. 
 
Knockdown of VTA MORs Attenuates Intermittent Social Stress-Induced Delta FosB Expression 
in the NAc 
 Social stress-induced increases in NAc delta FosB expression have been well 
documented (Nikulina et al., 2008, Nikulina et al., 2012), consistent with these reports, the current 
study found social stress significantly increased the expression of delta FosB in the NAc core. By 
contrast, the present finding that social stress did not significantly increase delta FosB expression 
in the NAc shell is inconsistent with the significant increase reported in Nikulina et al. (2012). In 
the context of drugs of abuse, such increases in NAc delta FosB are thought to reflect changes in 
VTA DA transmission, as they are associated with enhanced locomotor activity (see reviews of 
Nestler et al., 2001, Nestler, 2008). The social stress-induced increase of NAc delta FosB was 
attenuated, but not prevent by knockdown of VTA MORs. More specifically, shMOR-Stressed rats 
did not significantly differ from rats in either the Control Handled or GFP-Stressed groups. Thus 
VTA MOR only attenuated stress-induced delta FosB expression in the NAc core, which is 
interesting, since knockdown significantly prevented stress-induced changes in mesolimbic BDNF 
– TrkB receptor expression. Moreover, previous studies have shown that expression of VTA 
BDNF and NAc TrkB receptor mediate delta FosB expression in the NAc (Wang et al., 2013, 
Wang et al., 2014). Since VTA MOR knockdown blocked stress-induced increases in mesolimbic 
BDNF – TrkB receptor expression, which are associated with delta FosB expression in the NAc 
(Wang et al., 2013, Wang et al., 2014), it is surprising that knockdown of VTA MORs did not 
produce a statistically significant effect on NAc delta FosB expression. The VTA contains both 
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local GABA interneurons, as well as primary GABA neurons that innervate medium spiny neurons 
in the NAc (Sesack and Grace, 2010), and while MORs are largely localized to VTA GABA 
neurons (Sesack and Pickel, 1995, Garzon and Pickel, 2002), a subpopulation of VTA MORs 
have been localized to DA neurons (Margolis et al., 2014). Thus it is possible that the MORs 
upregulated by stress are localized to both GABA inter- and primary neurons, as well as 
potentially some DA neurons. Based on this, VTA MORs may have differential effects in the NAc, 
depending on whether they indirectly or directly mediate DA transmission, and whether they are 
on primary GABA neurons that directly project to and influence neuronal activity in the NAc. Thus 
VTA MOR knockdown may have had differential effects on NAc delta FosB expression, partially 
cancelling one another out, such that net effect was attenuation, rather than prevention.  
 Of particular interest, when mice were classified as “susceptible” or “resilient” according 
to their post-social stress behavioral phenotypes, resilient mice exhibited increased delta FosB 
labeling in only D1 receptor-containing medium spiny neurons, while susceptible mice showed 
increased delta FosB labeling in only D2 receptor-containing medium spiny neurons (Lobo et al., 
2013). Such differential induction of delta FosB in subtypes of medium spiny neurons in 
susceptible and resilient rodents may help to explain conflicting reports of stress-induced delta 
FosB expression in the NAc. When VTA neurons were phasically stimulated, delta FosB was 
increased in both types of medium spiny neurons in the NAc core, but only increased the 
expression of delta FosB in D1 receptor-containing neurons of the NAc shell (Lobo et al., 2013). 
Moreover, stimulation of D2 receptor-containing medium spiny neurons promotes susceptibility to 
subthreshold social defeat stress in mice, and these neurons show enhanced excitatory inputs 
after stress (Francis et al., 2015). A subset of medium spiny neurons were shown to form 
functions synapses on non-dopamine neurons in the VTA, and the terminals of these medium 
spiny neurons are sensitive to mu-opioids and act via GABAA receptors (Xia et al., 2011) (Xia et 
al., 2011). Taken together, this finding and the finding that activity of D2 receptor-containing 
medium spiny neurons confers susceptibility to social stress (Francis et al., 2015), it is possible 
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the NAc is a potential source of the endogenous mu-opioids that activate, and potentially 
underlie, social stress-induced MOR expression in the VTA. 
 
There Is No Effect of Either Stress or VTA MOR Knockdown on BDNF Expression in the PFC 
 Although a previous study noted a significant increase in PFC BDNF expression that 
persisted for up to 10 days (Nikulina et al., 2012), the present study failed to note a significant 
effect of stress on BDNF in these areas of PFC at the same time point. In addition to being 
transiently expressed in the PFC, BDNF is rapidly upregulated within 2 h of social stress, and 
levels are known to return to normal at most 23 days after the last episode of social stress 
(Fanous et al., 2010). In light of this, the present finding that social stress did not increase BDNF 
expression in the PFC suggests that 10 days may be near the upper limit of this transient stress-
induced increase of PFC BDNF expression. This theory is consistent with reports that intra-BDNF 
infusion to the medial PFC attenuates cocaine seeking (Berglind et al., 2007) and cocaine-
induced neuroadaptations in the NAc (Berglind et al., 2009). Additionally, another study showed 
that chronic unpredictable stress attenuates cocaine-induced increase of PFC BDNF expression, 
and also noted that in repeatedly stressed rats given saline, PFC BDNF levels did not differ from 
saline treated controls (Fumagalli et al., 2009). Taken together, these studies suggest that 
increased BDNF expression in the PFC might not be expected to accompany, and may even 
attenuate, stress-induced cross-sensitization to psychomotor stimulants. In which case, given that 
the present study collected tissue samples at the time that cross-sensitization is known to be 
present (Johnston et al., 2015; see also review of Nikulina et al., 2014), it is not surprising that 
there was no effect of stress on BDNF expression in the PFC.  
The VTA receives dense innervation from PFC glutamate projections, a role for which 
has been well established in behavioral sensitization to drugs of abuse (Vanderschuren and 
Kalivas, 2000), additionally the PFC also receives VTA GABA projections that contain MORs 
(Morales and Pickel, 2012). Taken together, these features of the mesocortical pathway allowed 
for the possibility that VTA MOR knockdown may have altered BDFN expression in the PFC by 
either direct projections or indirect feedback mechanisms, regardless of stress treatment. In 
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contrast, data from this study show that VTA MOR knockdown had no effect on BDNF expression 
in either the infralimbic or prelimbic areas of the PFC. While the VTA receives glutamate 
projections from the PFC, it has efferent DA and GABA projections that innervate the PFC 
(Sesack and Grace, 2010, Morales and Pickel, 2012, Walsh and Han, 2014). The present finding 
that VTA MOR knockdown does not alter PFC BDNF expression suggests that social stress does 
not upregulate MOR expression on VTA neurons that project to the PFC, and that knockdown of 
VTA MORs does not activate a feedback loop to this region. However given the rapid stress-
induced upregulation of BDNF in the PFC (Fanous et al., 2010) and that the present study did not 
note an effect of stress in the PFC at this time point, it is possible that knockdown of VTA MORs 
may have augmented stress-induced changes in PFC BDNF expression at an earlier time point 
than was analyzed in this current study. Namely, it is possible that knockdown of VTA MORs 
augmented DA and/or GABA transmission in the PFC and induced transient changes that were 
not detectable 10 days after the last episode of stress. Thus the possibility that the PFC is 
involved in VTA MOR-mediated effects of stress in the mesocorticolimbic circuit cannot be ruled 
out, and future studies will need to be conducted to determine if the effects VTA MOR knockdown 
vary at different time points after stress.  
 
VTA MORs Are Necessary for Induction of VTA BDNF by Intermittent Social Stress 
The two-fold increase of VTA BDNF expression which was observed in the VTA is 
consistent with previous reports (Berton et al., 2006, Fanous et al., 2010, Nikulina et al., 2012). 
More importantly, these results show that knockdown of VTA MORs prevented social stress-
induced VTA BDNF expression. That knockdown of VTA MORs blocks social stress-induced 
increase of BDNF labeling suggests that VTA BDNF induction after social stress exposure is 
dependent on local MOR upregulation. In fact, increased MOR activity in hippocampus also 
induces local BDNF mRNA (Zhang et al., 2006). While others have suggested that VTA BDNF 
modulates the function of local MORs (Vargas-Perez et al., 2009b, Koo et al., 2012), the current 
study shows that VTA MORs can regulate the local expression of BDNF. These reciprocal 
findings may be attributed to differences between exogenous opiate and endogenous opioid 
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functions, as well by differences in the VTA input systems recruited by exposure to morphine and 
social stress. 
Although VTA BDNF is predominantly thought to be found in DA neurons (Gall et al., 
1992, Seroogy et al., 1994), it is possible that MORs may control the transmission of VTA GABA 
neurons to indirectly produce subsequent changes in local DA neurons. Specifically, if MOR 
activity on GABA neurons increases the excitability of local DA neurons (Mathon et al., 2005), 
then the subsequent reduction in VTA GABAergic tone allows for MORs to affect BDNF 
expression in VTA DA neurons. A recent study showed that a subset of VTA MORs are actually 
excitatory and found on VTA DA neurons (Margolis et al., 2014). Thus it is also possible that 
social stress may upregulate excitatory MORs on VTA DA neurons, to directly increase VTA DA 
transmission and BDNF expression. Additional research using electrophysiology will be needed 
to determine whether social stress differentially increases the expression of excitatory vs. 
inhibitory MORs in the VTA.  
 
VTA MORs Are Necessary for Intermittent Social Stress-Induced Increases in Mesolimbic BDNF-
TrkB Receptor 
Previous studies have indicated that social stress increases the release of VTA BDNF in 
the NAc (Krishnan et al., 2007, Wang et al., 2013, Walsh et al., 2014), and have further 
implicated it’s receptor TrkB in the behavioral consequences of social stress (Wang et al., 2014). 
Taken together, these studies suggest that social stress increases the expression of TrkB 
receptor in the NAc in response to increased release of VTA BDNF. In support of this, the present 
study found that intermittent social stress-significantly increased TrkB receptor expression in both 
the NAc core and shell of subjects that also exhibited stress-induced expression of VTA BDNF. 
Similar to the preventative effect of VTA MOR knockdown on VTA BDNF, the present study also 
found that VTA MOR knockdown blocked social stress-induced TrkB receptor expression in both 
regions of the NAc. Taken together, these data extend on previous findings, suggesting that not 
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only does social stress increase mesolimbic BDNF-TrkB receptor expression, but that this effect 
is mediated by MORs in the VTA. 
 
Implications of VTA-MOR Augmentation of Social Stress-Induced Increases in Mesolimbic BDNF 
– TrkB Receptor Signaling  
 Recently it was reported that social stress-induced upregulation of VTA MORs is critical 
for the behavioral consequences of intermittent social defeat stress (Chapter 2; see also 
Johnston et al., 2015). In particular, knockdown of VTA MORs prevented stress-induced cross-
sensitization to amphetamine (Johnston et al., 2015), a phenomena that has been linked to 
mesolimbic BDNF – TrkB receptor signaling (Wang et al., 2013, Wang et al., 2014). Additionally, 
upregulation of VTA MOR occurs early in the cross-sensitization process (Nikulina et al., 1999, 
Nikulina et al., 2005, Nikulina et al., 2008), prior to a persistent increase of VTA BDNF expression 
(Fanous et al., 2010). In light of these findings, it is not surprising that the present results 
demonstrated that VTA MORs are necessary for social stress-induced increases in VTA BDNF 
and its TrkB receptor in the NAc. Prevention of social stress-induced expression in BDNF by VTA 
MOR knockdown suggests that stress-induced increases in VTA BDNF are a consequence of 
MOR-dependent increases in VTA GABAergic tone. In support of this, and consistent with the 
preventative behavioral effects VTA MOR knockdown (Johnston et al., 2015), is the study by 
Mathon et al. (2005), in which genetic MOR knockout mice showed increased GABAergic input 
onto local VTA DA neurons and decreased cocaine reinforcement. Thus it is likely that social 
stress upregulates MOR expression on VTA GABA neurons to facilitate BDNF expression in local 
DA neurons, while VTA MOR knockdown may increase VTA GABAergic tone, preventing 
alterations in the mesolimbic expression of BDNF and its receptor TrkB.  
 
Concluding Remarks 
 In summary, knockdown of VTA MORs prevented social stress-induced increases in VTA 
BDNF and TrkB receptor in the NAc. By contrast, knockdown of VTA MORs only attenuated the 
effect of stress on NAc delta FosB expression, while there was no effect of either stress or MOR 
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knockdown on BDNF expression in areas of PFC. In rats, continuous social stress suppresses 
cocaine reward and decreases VTA BDNF expression (Miczek et al., 2011a), however it is 
unknown whether continuous social stress alters VTA MOR expression. It is possible that 
continuous social stress reduces cocaine reward and VTA BDNF expression as a function of 
downregulated VTA MOR expression, which would suggest that VTA MORs may mediate a 
switch between the sensitizing effects seen with intermittent social stress and the suppressed 
cocaine reward observed after continuous social stress.  
  In conclusion, the present results indicate that social stress-induced upregulation of VTA 
MORs mediates subsequent increases in mesolimbic BDNF – TrkB receptor signaling, all of 
which have been functionally implicated in stress-induced cross-sensitization to amphetamine 
(Wang et al., 2013, Wang et al., 2014, Johnston et al., 2015). Knockdown of VTA MORs alone 
did not significantly alter the expression of BDNF, TrkB receptor, or delta FosB in the 
mesocorticolimbic circuit, yet significantly prevented stress-induced alterations in their 
expression, and is known to prevent stress-induced cross-sensitization. Taken together, these 
findings suggest that VTA MORs may represent a potentially specific target for the therapeutic 
intervention of stress-related substance abuse. 
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CHAPTER 4: LOCALIZATION OF PHOSPHORYLATED AKT IN VTA GABA NEURONS 
AFTER SOCIAL STRESS EXPOSURE: IMPLICATIONS FOR AMPHETAMINE CROSS-
SENSITIZATION AND WEIGHT REGULATION 3 
 
ABSTRACT 
Intermittent social defeat stress produces long-lasting cross-sensitization to psychomotor 
stimulants, an effect that is known to depend on the expression of mu-opioid receptors (MORs) in 
the ventral tegmental area (VTA). Stimulation of MORs is known to activate a variety of 
intracellular signaling cascades, including phosphorylation of AKT (pAKT) by phosphoinositide 3-
kinase (PI3K). Additionally, AKT phosphorylation is critical for drug-induced sensitization to 
psychomotor stimulants. It is unknown whether social stress increases pAKT downstream of 
MOR upregulation, or whether AKT phosphorylation is related to the behavioral outcomes of 
social stress. To address these questions, two experiments were conducted. In the first, to 
determine whether social stress increases MOR – pAKT signaling, after lentivirus-mediated 
manipulation of VTA MORs and intermittent social defeat stress, fluorescent 
immunohistochemical double labeling of pAKT with markers for DA or GABA neurons was 
conducted in the VTA. The results show that social stress significantly increased pAKT co-
localization with GABA, but not DA neurons in the VTA. Knockdown of VTA MORs prevented this 
effect, suggesting that social stress-induced increases in AKT phosphorylation are dependent 
upregulation of VTA MORs. In experiment 2, intra-VTA inhibition of pAKT during to stress was 
used to assess whether stress-induced AKT phosphorylation mediates the behavioral 
consequences of social defeat stress. When administered an amphetamine challenge (1.0 mg/kg, 
i.p.), rats assigned to Saline-Stressed conditions exhibited significant induction of cross-
sensitization compared to Control Handled subjects, this induction was attenuated in rats who 
received intra-VTA infusions of inhibitor during stress. To determine whether AKT 
                                               
3 None of the data in presented in this chapter have been published, in-text references to 
Johnston et al. (2015) are referring to the behavioral data presented in Chapter 1 or the results of 
VTA BDNF immunohistochemistry presented in Chapter 2 of this dissertation. To see the 
published manuscript in its entirety, please refer to Appendix A. 
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phosphorylation is necessary for the expression of cross-sensitization, a reversal was conducted 
using Saline-Stressed rats that previously exhibited cross-sensitization. Prior to a second 
amphetamine challenge, these rats were given intra-VTA infusions of pAKT inhibitor. Acute 
inhibition of VTA pAKT was sufficient to block the expression of stress-induced cross-
sensitization, without blunting the locomotor-activating effects of amphetamine. Taken together, 
these data suggest that AKT phosphorylation represents a novel target for the treatment of 
substance abuse disorders. 
 
INTRODUCTION 
Stress has been correlated with increased risk of substance abuse and relapse in 
humans (Sinha, 2001, 2008, 2011). In rats, intermittent social defeat stress procedures in rats 
consistently result in enhanced response to psychomotor stimulants, a phenomena known as 
“cross-sensitization” (Covington and Miczek, 2001, Nikulina et al., 2004, Nikulina et al., 2012). 
Additionally, social defeat stress rapidly upregulates mu-opioid receptors (MORs) in the ventral 
tegmental area (VTA), an effect which persists for up to 14 days (Nikulina et al., 2008). Of 
particular importance, a recent study showed that social stress-induced upregulation of VTA 
MORs is necessary for stress-induced weight gain deficits, cross-sensitization to amphetamine, 
and BDNF expression in the VTA (Johnston et al., 2015). Given that increases in VTA MORs are 
necessary for both the behavioral and cellular consequences of social stress, it is important to 
look at activity dependent changes in VTA MOR-mediated intracellular signaling cascades. MORs 
activate numerous intracellular pathways, including the pathway that phosphorylates AKT (pAKT; 
Iglesias et al., 2003, Mazei-Robison et al., 2011).  
Of particular interest, MOR activation has been shown to directly increase 
phosphoinositide 3-kinase (PI3K) – pAKT signaling, an effect that can be disrupted with a 
PI3K/AKT inhibitor, but not an inhibitor of mitogen-activated protein kinase/extracellular signal-
regulated kinase (MAPK/ERK), another MOR-induced intracellular signaling cascade (Iglesias et 
al., 2003). This suggests that MOR-induced AKT phosphorylation is unrelated to MAPK/ERK 
signaling and suggests that it might have distinct functional effects in neurons. In fact, AKT 
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phosphorylation has been implicated in the mediation of GABA transmission through insertion of 
GABAA receptor in the cell membrane (Wang et al., 2003). A functional role for pAKT has also 
been demonstrated in drug-induced sensitization to cocaine, wherein systemic or 
intracerebroventricular inhibition of AKT phosphorylation prevented sensitized responses (Izzo et 
al., 2002, Wu et al., 2011)  
While phosphorylation of AKT is crucial for drug-induced sensitization to cocaine (Izzo et 
al., 2002, Wu et al., 2011), it is unknown whether AKT phosphorylation is important for stress-
induced cross-sensitization to drugs of abuse. Although one study found a regional decrease of 
VTA pAKT after continuous social defeat stress (Krishnan et al., 2008), MORs are only expressed 
in a subpopulation of VTA cells (Sesack and Pickel, 1995, Garzon and Pickel, 2002). Thus if 
stress-induced MOR activity increased pAKT phosphorylation in a subset of VTA cells, it is not 
likely to be detected by the Western blot analyses employed by Krishnan et al. (2008). Moreover, 
in rats continuous and intermittent social defeat stress are known to produce opposite effects on 
response to psychostimulant drugs and VTA BDNF expression (Miczek et al., 2011a), therefore 
while pAKT may be reduced after continuous social stress, it is possible that it increased by 
intermittent social stress. 
Although research has implicated AKT phosphorylation in sensitization to 
psychostimulant drugs (Izzo et al., 2002, Wu et al., 2011), it is unclear whether the VTA is the site 
action and whether AKT phosphorylation is relevant to stress-induced cross-sensitization. To 
address these questions, two separate experiments were conducted. In the first experiment, 
lentivirus constructs were infused to the VTA to manipulate MOR expression, after recovery, 
subjects were put through intermittent social defeat stress procedures. In order to investigate the 
effects of social stress and VTA MOR knockdown on local pAKT expression, subjects were 
sacrificed to quantify pAKT expression in VTA DA and GABA neurons using fluorescent 
immunohistochemical double labeling. The second experiment was conducted to investigate 
whether VTA AKT phosphorylation mediates social stress-induced weight gain deficits and cross-
sensitization. Subjects were bilaterally implanted with intra-VTA cannula and a pAKT inhibitor was 
delivered prior to each episode of stress, 10 days later an amphetamine challenge was 
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administered to assess for the induction of cross-sensitization. To determine whether AKT 
phosphorylation is necessary for the expression of stress-induced cross-sensitization, one week 
later a reversal was conducted wherein intra-VTA infusions of pAKT inhibitor were administered 
prior to a second amphetamine challenge. Finally, the functional role of VTA AKT phosphorylation 
in social stress-induced long-term weight gain deficits was investigated. 
 
METHODS 
4.1 Subjects 
Experimental subjects were male Sprague-Dawley rats (N = 41; Charles River 
Laboratories, Hollister, CA) weighing 200-250 g on arrival. Three days before social stress 
exposure, subjects were individually housed in standard plastic cages (25x50x20 cm3). Male 
Long-Evans rats (weighing 550-700 g), termed ‘residents’, were pair-housed with a tubal-ligated 
female in large plastic cages (37x50x20 cm3). All rats were maintained on a 12-12 reverse light-
dark cycle (lights out at 0900 h) with free access to food (Purina Rodent Diet, Brentwood, MO) 
and water. Residents were retired breeders, previously screened for aggressive behaviors, and 
were used to induce social defeat stress in experimental subjects. All experimental procedures 
were approved by the Institutional Animal Care and Use Committees at the University of Arizona. 
All studies were conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals (National Research Council, 2011), and every effort was made to minimize pain, 
suffering and the number of subjects. 
 
4.2 Experimental Design 
Two experiments were conducted in parallel, the first investigated whether increased 
AKT phosphorylation is a downstream target of social stress-induced MOR upregulation in the 
VTA. Next the second experiment investigated the involvement of AKT phosphorylation in the 
induction and expression of social stress-induced cross-sensitization to amphetamine. In both 
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experiments, after arrival, experimental rats were habituated to laboratory conditions for 7 days 
before surgery to either knockdown VTA MORs or to implant cannulas above the VTA.  
In the first experiment (Fig. 4.1), subjects were randomly assigned to one of four 
conditions: Non-Manipulated MOR+Handled, Non-Manipulated MOR+Stressed, MOR 
Knockdown+Handled, MOR Knockdown+Stressed. At the time that amphetamine cross-
sensitization is known to be present, 10 days after the last episode of stress or handling, all 
subjects (N = 21) were perfused to study the effects of Stress and MOR knockdown on the co-
localization of pAKT with DA and GABA neurons of the VTA. 
In the second experiment (Fig. 4.1), rats (N = 28) were randomly assigned to one of four 
experimental conditions: Saline+Handled, Saline+Stressed, pAKT Inhibitor+Handled, pAKT 
Inhibitor+Stressed. In order to study the effect of VTA AKT phosphorylation on the induction of 
social stress effects, subjects (N = 28) received an amphetamine challenge 10 days after the last 
episode of stress or handling. Additionally, to study the effect of pAKT on the expression of 
amphetamine cross-sensitization, a reversal was conducted 8 days later, wherein 
Handled+Inhibitor and Saline+Stressed rats were given a second amphetamine challenge (N = 
15). All subjects were perfused 23 days after the last episode of defeat or handling for verification 
of infusion sites with Nissl stain. To investigate the influence of VTA pAKT inhibition on social 
stress-induced deficits in weight gain, all subjects were weighed prior to each episode of 
defeat/handling, and again prior to perfusion. 
 
4.3 Surgical Procedures and Infusions 
4.3.1 Bilateral VTA Infusion of Lentiviral Constructs 
The control lentiviral construct induced expression of green fluorescent protein (GFP) and 
a short hairpin RNA (shRNA) that does not target any known rat gene, while the lentiviral 
construct used to induce MOR knockdown expressed GFP and a shRNA that targets MOR 
(shMOR) for RNA interference. Lentiviral constructs were have been previously validated 
(Johnston et al., 2015) and were prepared as previously described (Lasek et al., 2007). After 
random assignment to either GFP or shMOR knockdown conditions, rats were anesthetized with  
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Figure 4.1. Schematic of Experimental Timelines. In experiment 1, rats were given 7 days to 
recover from surgery to manipulate VTA MOR levels, and were then exposed to intermittent (4x in 
10 days) social defeat stress or handling procedures. Ten days after the last episode of stress, at 
a time when stress-induced cross-sensitization is observed (Nikulina et al., 2012, Johnston et al., 
2015), subjects were perfused for fluorescent immunohistochemical double labeling of pAKT 
expression in VTA GABA and DA neurons. In experiment 2, subjects were bilaterally implanted 
with intra-VTA cannula and then a pAKT inhibitor was infused prior to each episode of stress or 
handling. Ten days after the conclusion of stress and handling procedures, subjects were given 
an amphetamine challenge to test for the induction of stress-induced cross-sensitization. To test 
whether acute inhibition of VTA pAKT blocks the expression of stress-induced cross-sensitization, 
eight days later subjects that had previously showed cross-sensitization, intra-VTA infusions of 
pAKT inhibitor were delivered prior to a second amphetamine challenge. Five days later, all 
subjects were perfused to verify locations of cannula. 
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isoflurane and positioned in a stereotaxic frame (Leica Angle Two; Richmond, IL). Bilateral VTA 
(AP -5.15, ML ±2.15, DV -8.7, Tilt 10°; Paxinos and Watson, 2007) infusions of the appropriate 
lentiviral construct (1.0 µl each) were administered at a flow rate of 0.1 µl/min, and allowed to 
diffuse for 10 min before withdrawal of the syringe (Hamilton; Model 7105 KH; 24 gauge tip; 
Reno, NV) . The accuracy of each infusion was later verified using localization of GFP expression 
(data not shown). Subjects were given 7 days to recover before the start of intermittent social 
stress or handling procedures (Fig. 1A). 
 
4.3.2  Bilateral VTA Implantation of Cannulas and Infusions of pAKT Inhibitor 
Rats were anesthetized using isoflurane and positioned in a stereotaxic frame (Leica 
Angle Two; Richmond, IL). Two small stainless steel screws (Tx2-4, Small Parts Inc., Miami 
Lakes, FL) were inserted near bregma to stabilize the skull, and then guide cannulas (24 gauge, 
6 mm long, C316G, Plastics One, Roanoke, VA) were implanted above the VTA (AP -5.15, ML 
+/-2.15, Tilt 10 degrees; Paxinos and Watson, 2007). Everything was cemented into place 
(Duralay, MD-1300, Reliance Dental Mfg. Co., Worth, IL) and then guide cannula were fitted with 
a dummy cannula (6.7 mm long, C316DC, Plastics One) to prevent clogging and contamination. 
During each set of infusions, dummy cannula were removed and infusion cannula (31 gauge, 7.7 
mm long, C316I, Plastics One) were inserted through the guide cannula, directly above the VTA.  
To prevent phosphorylation of AKT, this study utilized a dual AKT/mTORC (mammalian 
target of rapamycin complex) inhibitor (10 µM; NVP-BEZ235, #10565, Cayman Chemicals, Ann 
Arbor, MI). Although this particular AKT inhibitor has not been previously used in the brain, its 
effects have been well validated in other tissue cultures and with systemic administration (Maira 
et al., 2008, Serra et al., 2008, Chapuis et al., 2010, Mukherjee et al., 2012). Additionally, this 
drug is currently undergoing clinical trials at the Novartis Pharmaceutical Corporation. While more 
traditional pAKT inhibitors act to block phosphorylation at Thr308 phosphorylation site, AKT is 
also phosphorylated at Ser473, and it is this site that has been implicated in the full catalytic 
activity of pAKT (Bellacosa et al., 1998, Scheid and Woodgett, 2001, Iwanami et al., 2009). By 
contrast, the inhibitor used in this study blocks the induction of pAKT by preventing both PI3K-
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induced phosphorylation at Thr308, and mTORC2-mediated phosphorylation at Ser473 (Maira et 
al., 2008). Unlike traditional inhibitors, such as LY294002, which interacts with various classes of 
PI3Ks and other unrelated targets (Gharbi et al., 2007), NVP-BEZ235 is specific for Class 1 
PI3Ks and mTOR signaling, but does not does not target other protein kinases (Maira et al., 
2008).  
Using sonification at 4⁰C, the AKT inhibitor (NVP-BEZ235) was dissolved in saline to 
make a 20 µM stock that was aliquoted and stored at -20⁰C. Prior to each set of infusions, a fresh 
solution of 10 µM inhibitor was prepared from stock and kept on ice. Intra-VTA infusions of either 
1µl inhibitor or 0.5 µl saline were administered at a rate of 0.175 µl/min, after which subjects were 
returned to their home cages for 1 h to allow the inhibitor to take full effect (Maira et al., 2008). In 
pilot testing, when given concurrently with systemic amphetamine (2.0 mg/kp, i.p.), chromogen 
immunohistochemistry showed that this intra-VTA dose of inhibitor significantly reduced AKT 
phosphorylation 24 h later (Fig. 4.2B-D). Subjects were given 7 days to recover before the start of 
intermittent social stress or handling procedures (Fig. 4.1B). At the conclusions of the study, 
subjects were perfused and the accuracy of infusions was verified with nissl stain (Fig. 4.2A). 
 
4.4 Behavioral assessments 
4.4.1  Intermittent social defeat stress and handling procedures 
In both experiments, social defeat stress was induced by a short confrontation between 
an aggressive resident and an experimental intruder rat (see Chapter 1, Fig. 1.1), as described 
previously (Tidey and Miczek, 1996, Nikulina et al., 2004, Nikulina et al., 2012). After the female 
was removed, an experimental subject was placed inside the resident’s home cage within the 
confines of a protective metal mesh cage (15x25x15 cm3). After 5 min the protective cage was 
removed, allowing for the resident to attack. Attacks persisted until subjects engaged in 
submissive supine posture for at least 4 sec, after which the experimental rat was placed back in 
the protective cage and exposed to threat from the resident for an additional 20 min. Intermittent 
social stress procedures were administered every third day for 10 days (Fig. 4.1). At each  
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Figure 4.2. Cannula Infusions Were Accurate to the VTA and NVP-BEZ235 Effectively 
Inhibited Local AKT Phosphorylation. (A) Representative black and white image of nissl 
stained tissue showing cannula placement above the left VTA (fr: fasciculus retroflexus; scale bar 
= 500 µm). (B) Compared to saline infusions, a lower intra-VTA dose of 1,000 nM of NVP-
BEZ235, a dual PI3K/mTORC inhibitor of pAKT, produced a small but significant decrease in 
pAKT expression (* indicates p < 0.04). By contrast a higher dose of 10,000 nM was far more 
effective, significantly reducing the number of pAKT labeled cells compared to both saline (p < 
0.001) and 1,000 nM of inhibitor conditions (* indicates p < 0.03). (C and D) Representative 
images of pAKT expression in the VTA 24 h after either infusion of saline (C) or 10,000 nM of 
NVP-BEZ235 pAKT inhibitor (D), arrows indicated labeled cells (Scale bar = 100 µm). Given how 
effectively intra-VTA infusion of 10,000 nM of NVP-BEZ235 inhibited local pAKT expression, this 
dose was used throughout subsequent studies. 
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corresponding time point, rats in the control groups were handled for approximately 2.5 min. 
Defeat or handling procedures were carried out 4x in 10 days (every 3rd day), and at the end of 
each episode of defeat or handling, all rats were returned to their home cages. 
 
4.4.2 Amphetamine challenge 
Using a low dose of d-amphetamine, two separate challenges were administered as 
described in (Nikulina et al., 2004, Nikulina et al., 2012) to respectively test for the induction and 
expression of social stress-induced cross-sensitization to amphetamine (Fig. 4.1B). To test 
whether inhibition of pAKT during social stress prevented the induction of cross-sensitization to 
amphetamine, the first challenge was conducted without intra-VTA infusions of pAKT inhibitor. To 
determine whether inhibition of pAKT is sufficient to prevent the expression of social stress-
induced cross-sensitization to amphetamine, before the start of the second challenge, stressed 
subjects that previously showed cross-sensitization were given intra-VTA infusions of pAKT 
inhibitor. 
For two days prior to the first amphetamine challenge, rats were injected with vehicle 
(0.9% sterile saline; 1.0 ml/kg, i.p.), and were acclimated to the procedure room for 1 h in their 
home cages. On the day of the challenge locomotor activity was recorded at 10 min intervals 
using video tracking software (Videotrack, Viewpoint Life Sciences; Montreal, Canada). 
Locomotor activity was detected as the number of and distance travelled during locomotion (>10 
cm) across 170 min consisting of 3 phases: Baseline, Saline, and Amphetamine. Baseline data 
were recorded for 30 min, after which a saline injection (1.0 ml/kg, i.p.) was given and locomotor 
activity was recorded for 60 min. Finally, rats received an injection of d-amphetamine sulfate (1.0 
mg/kg, i.p.; Sigma-Aldrich; St. Louis, MO), and locomotor data were recorded for 80 min. Video 
tracking and data collection were paused during the administration of saline and amphetamine 
injections. Rather than stereotypical behaviors, this dose of amphetamine has been shown to 
primarily induce large ambulatory movements (Geyer et al., 1987). In order to quantify 
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amphetamine sensitization, ambulatory movements (> 10 cm) were measured in terms of the 
number of movements initiated and the distance travelled (cm) during such movements. 
 
4.5  Tissue Preparation and Immunohistochemistry 
4.5.1 Perfusion 
Rats from both experiments were anesthetized with sodium pentobarbital (100 mg/kg, 
i.p.; Euthasol, Virbac Co., St. Louis, MO) and perfused transcardially with 4% paraformaldehyde 
as described in (Fanous et al., 2010, Johnston et al., 2015). Brains were then removed, post-fixed 
for 1.5 hours at 4°C, and then placed in graded sucrose solutions. Frozen brain tissue was 
sectioned (20 μm) and serial VTA sections were mounted onto slides. 
  
4.5.2 Verification of Infusion Sites 
In experiment 1, one analogous set of slides were used to verify the infusions of lentiviral 
constructs according to viral expression of GFP (data not shown). This efficacy of these lentiviral 
constructs has been previously validated and are known to produce a persistent depletion of 
MORs that is specific to the VTA (Johnston et al., 2015). In experiment 2, slides were processed 
for histology using Nissl stain, and then cannula placement was verified with light microscopy 
(Fig. 4.2A). In general, both lentiviral infusions and cannula placement were accurate and limited 
to the VTA. 
 
4.5.3  Fluorescent Immunohistochemistry 
Fluorescent immunohistochemistry was performed to quantify pAKT double labeling with 
either glutamic acid decarboxylase 65/67 (GAD 65/67) or tyrosine hydroxylase (TH) monoclonal 
antisera. Immunohistochemistry for pAKT and GAD 65/67 were done in the absence of detergent 
to prevent GAD 65/67 from leaving cells. Briefly, blocking solution (10% normal goat serum/0.5M 
KPBS, with 0.4% Triton X-100 for pAKT/TH labeling) was applied to sections for 1 h at room 
temperature, then the respective pair of primary antibodies were diluted in appropriate blocking 
solution and simultaneously applied for 48 h at 4°C (pAKT Ser473 1:500 dilution, #4060, Cell 
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Signaling Technology, Beverly, MA; GAD 65/67 1:250 dilution, M018-3, MBL International 
Corporation, Woburn, MA; TH 1:500 dilution, SC-7837, Santa Cruz). Sections were then 
incubated at room temperature for 2.5 h with fluorescent labelled secondary antibodies diluted to 
1:1000. Specifically, pAKT was labeled with an Alexa 350 secondary rabbit antibody, while GAD 
65/67 and TH were respectively labeled with an Alexa 660 secondary mouse antibody (Alexa 
350-R, A-21068; Alexa 660-M, A-21055; Life Technologies, Grand Island, NY). To prolong 
fluorescent labeling, slides were cover slipped with Prolong® Gold Antifade Mountant (#P36934, 
Life Technologies). 
Tissue sections were imaged using a Zeiss Axiophot microscope and digitalized using a 
black and white digital camera. Black and white images of each channel were then re-colored and 
merged together using ImageJ (National Institutes of Health, USA, http://imagej.nih.gov/ij). 
Although pAKT was labeled with a fluorescent Alexa 350 secondary (blue), it was pseudo-colored 
green in order to better visualize cases of double labeling with cells also stained with Alexa 660 
secondary (pseudo-colored red). In order to maintain high resolution while conducting modified 
stereological counts of single and double labeled cells, 4 separate images of each coronal VTA 
section were taken at 40x magnification and then merged into one image showing 
immunolabeling throughout that entire section. 
 
4.6  Modified Stereological Cell Counts 
Immunolabeled cells were quantified using ImageJ (National Institutes of Health, USA, 
http://imagej.nih.gov/ij) and analyses were conducted using the modified stereology counting 
procedure described in Nikulina et al. (2012), and Johnston et al. (2015). Briefly, a grid of squares 
(0.0075 mm2) was overlaid on both hemispheres of 2 sections from each subject. Immunolabelled 
cells were counted in half the grid squares, the precise squares being randomly determined. Cells 
positive for immunolabeling were counted such that cells crossing the bottom or right lines of 
each square were included, while cells crossing the top or left lines of the square were excluded 
from analysis. For each subject, estimates of total labeling density (mm2) were calculated by 
averaging the bilateral counts of labeled cell profiles across sections, and then dividing the total 
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number of cell profiles by the total area assessed. In pilot analyses of chromogen staining, 
immunolabeling was performed as described in Johnston et al. (2015). For fluorescent analyses, 
both single and double labelled cells were counted. Single labeled labelled cells were indicated 
by either a green (pAKT) or red (GAD 65/67 or TH) color, while double labelled cells (green + red) 
were indicated by an orange/yellow color product. 
 
4.7  Statistical Analyses 
The results of each measure are expressed as mean ± standard error (SEM) and a p 
value ≤ 0.05 was considered to be significant. All statistical analyses were run using SPSS 
software, version 18 (SPSS Inc., Chicago, IL), and Tukey’s HSD was used for all post hoc 
comparison. Data from subjects were excluded only in the case of error during video tracking: no 
statistical outliers were excluded. Due to issues with cannula integrity over time, some additional 
subjects were excluded from the amphetamine challenge(s) and maintained under normal 
housing conditions to collect long-term weight data and for verification of cannula sites. 
 
4.7.1  Immunohistochemical Analyses 
In experiment 1, the results of immunohistochemical cell counts were analyzed using 
separate Oneway ANOVAs of single and double labeled cells, significant main effects were 
followed by post hoc comparisons. No subjects were excluded and both pAKT/TH and 
pAKT/GAD 65/67 data were analyzed from 21 subjects. A violation of homogeneity was corrected 
for with Welch’s test in both analyses of single labeled pAKT expression. In order to compare the 
results of pAKT co-localization with GAD 65/67 and TH, the total number of pAKT double labeled 
cells was calculated (Total = # of pAKT/GAD 65/67 + # of pAKT/TH cells) and then the proportion 
of pAKT in GAD 65/67 and TH cells were respectively calculated (proportion pAKT in TH or GAD 
65/67 = # double labeled cells / Total), the resulting estimates of co-localization.  
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4.7.2  Weight Gain Data 
In experiment 2, the initial weight obtained at the start of social stress procedures was 
used to normalize all subsequent data (n = 28) to weight gained from that time onward; no 
subjects were excluded from this analysis. Oneway ANOVA were run to assess for differences in 
weight at each time point, and significant main effects were analyzed for post hoc comparisons.  
 
4.7.3  Locomotor Activity  
   In the second experiment, two amphetamine challenges were administered and 
amphetamine-induced changes in locomotor activity were analyzed using separate multivariate 
analysis of variance (MANOVA) for the mean number and distance (cm) travelled during 
ambulatory movements. In order to overcome violations of sphericity in the output of repeated 
measures ANOVA, MANOVA was used to analyze the number and distance of ambulatory 
movements exhibited throughout the amphetamine challenge. Significant multivariate effects 
were followed by univariate analyses to determine which time points produced significant group 
differences, significant univariate effects were further analyzed for post hoc comparisons. Given 
that immunohistochemical analyses of social stress-induced AKT phosphorylation in the VTA 
demonstrated that AKT is only phosphorylated after stress (Fig. 4.3 and 4.6), and because there 
were no differences in weight gain of Saline-Handled and Inhibitor-Handled rats (Fig. 4.7), these 
groups were pooled into one Control Handled group. In the first challenge to test for the induction 
of stress-induced amphetamine sensitization, data were analyzed from 23 subjects for both 
dependent measures: Control Handled = 10, Saline-Stressed = 5, Inhibitor-Stressed = 8. Since 
the second challenge was administered to investigate whether intra-VTA inhibition of AKT 
phosphorylation is sufficient to block the expression of stress-induced cross-sensitization, the 
Inhibitor-Stressed group was excluded (n = 8).  
  
  
101 
RESULTS 
Experiment 1: Effects of Social Stress and MOR Knockdown on pAKT Expression in the VTA 
There was a significant main effect of experimental group on the number of VTA cells in 
which pAKT co-localization with GAD 65/67 (n = 21, F3,17 = 44.02, p < 0.001). Specifically, GFP-
Stressed rats had significantly more VTA cells double labeled with both pAKT and GAD 65/67 
than either GFP-Handled, shMOR-Handled, or shMOR-Stressed rats (p < 0.001, Fig. 4.3A and 
4.4). Co-localization of pAKT with GAD 65/67 did not significantly differ between GFP-Handled, 
shMOR-Handled or shMOR-Stressed groups (p > 0.98). In terms of single labeling, there was no 
significant main effect was detected for the number of cells positive for only pAKT (corrected with 
Welch’s test; n = 21, F3,8.69 = 2.57, p > 0.12). By contrast, there was a significant main effect for 
the numbers of single labeled GAD 65/67 cells (n = 21, F3,17 = 23.13, p < 0.001). While this main 
effect was significant, post hoc tests revealed that it was limited to the GFP-Stressed group, 
which had significantly fewer single labeled GAD 65/67 cells (p < 0.001). Although GFP-Stressed 
rats had fewer single labeled GABA neurons, this difference is consistent with and proportional to 
the increased number of double labeled GAD 65/67 cells. Therefore while statistically significant, 
this decrease in single labeled GAD 65/67 cells does not reflect any methodological or functional 
significance and will not be discussed further. 
The results of pAKT double labeling with TH were opposite to that observed with GAD 
65/67. Specifically, sections processed for pAKT and TH labeling showed a significant main effect 
in the number of cells single labeled pAKT (corrected with Welch’s test; n = 21, F3,9.29 = 30.08, p < 
0.001, Fig. 4.3B and 4.5), and pAKT double labeled with TH (n = 21, F3,17 = 7.097, p = 0.003). 
There were no differences in the number of single labeled TH detected in the VTA (n = 21, F3,17 = 
0.97, p > 0.42). In terms of pAKT that did not double label with TH, the GFP-Stressed group had 
significantly higher levels of single labeled pAKT compared to all other experimental groups (p < 
0.001). There was also a tendency for GFP-Stressed rats to have lower levels of pAKT that co-
localized with TH, with this effect being significant compared to shMOR-Stressed rats (p = 0.001).  
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Figure 4.3. 
Intermittent Social 
Stress Significantly 
Increased AKT 
Phosphorylation 
Downstream of 
MOR Expression in 
VTA GABA, but Not 
DA Neurons. (A) 
Compared to all 
other groups, GFP-
Stressed rats 
exhibited 
significantly more co-
localization of pAKT 
in GAD 65/67 
positive cells (* 
indicates p < 0.001). 
Co-localization of 
pAKT with GAD 
65/67 did not 
significantly differ 
between GFP-
Handled, shMOR-
Handled or shMOR-
Stressed groups (p > 0.98), and there was no effect of single labeled pAKT (p > 0.12). (B) 
Compared to all other groups, GFP-Stressed rats had significantly more VTA cells that were 
single labeled for pAKT (* indicates p < 0.001). GFP-Stressed rats also tended to have fewer 
cells double labeled for pAKT and TH, with this effect being significant compared to shMOR-
Stressed rats (* indicates p = 0.001), but not GFP-Handled (p = 0.09) or shMOR-Handled 
subjects (p = 0.144). The shMOR-Stressed group did not significantly differ from either Handled 
groups in terms of either single labeled pAKT (p > 0.87) or pAKT co-localized with TH cells (p > 
0.19).  
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Figure 4.4. VTA MOR Knockdown Prevented the Induction of pAKT Labeling in VTA GABA 
Cells by Social Stress. (A) Representative images of pAKT (green) and GAD 65/67 (red) 
labeling in anterior VTA sections. Single labeled cells are indicated by white arrows, while yellow 
arrows indicate double labelled cells colored with an orange-yellow color product (Scale bar = 
100 µm). (B) Colored single channel images of the immuno-labeling seen in the above 
representative GFP-Stressed image (close up of bottom center of image). 
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Figure 4.5. Social stress did not increase co-localization of pAKT with DA neurons in the 
VTA. (A) Representative images of pAKT (green) and TH (red) labeling in the anterior VTA. 
Single labeled cells are indicated by white arrows, while yellow arrows indicate double labelled 
cells colored with an orange-yellow color product (Scale bar = 100 µm). (B) Colored single 
channel images of the immuno-labeling seen in the above representative GFP-Stressed image 
(close up of center of image). 
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GFP-Handled, shMOR-Handled and shMOR-Stressed rats had no significant differences in either 
single labeled pAKT (p > 0.87) or pAKT co-localization with TH cells (p > 0.19).  
When the proportion of double labeled pAKT that co-localized with either TH or GAD 
65/67 are compared side by side (Fig. 4.6), it is clear that these analyses show that social stress 
increases the proportion of VTA AKT phosphorylation that occurs in GABA cells, but not DA cells, 
and that this change in expression is mediated by VTA MORs.  
 
Experiment 2: Effect of Intra-VTA Inhibition of pAKT on Intermittent Social Stress-Induced Deficit 
of Weight gain 
Weight gain data (n = 28) revealed a significant main effect both during social stress 
exposure (F3,27 = 3.73, p < 0.03), and 23 days after the last episode of stress (F3,27 = 7.87, p = 
0.001). Post hoc comparisons from weight data collected during stress and handling procedures 
showed that the Saline-Stressed group had a tendency to gain less weight than Saline-Handled 
(p = 0.048) or Inhibitor-Handled (p = 0.053; Fig. 4.7). By contrast, rats in the Inhibitor-Stressed 
group did not significantly differ from Saline-Handled, Saline-Stressed, or Inhibitor-Handled rats 
(p > 0.20). Twenty-three days after the final episode of stress or handling, the Saline-Stressed 
group had significantly lower weights than both Saline- and Inhibitor-Handled groups, but also 
rats in the Inhibitor-Stressed group (p < 0.03). Conversely, no significant differences existed 
between the Inhibitor-Stressed group and either Saline- or Inhibitor-Handled groups (p > 0.60). 
These data show that the long-term social stress-induced weight gain deficits are mediated by 
AKT phosphorylation in the VTA, and that inhibition of AKT phosphorylation is not sufficient to 
alter weight gain in the absence of stress. 
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Figure 4.6. Knockdown of VTA MORs Prevented the Proportional Increase of pAKT 
Expression in VTA GABA Neurons That Was Observed After Social Stress. While in control 
conditions pAKT co-localization was generally evenly distributed between VTA GAD 65/67 and 
TH positive cells in the VTA, much more double labeled pAKT was found in VTA GAD 65/67 
neurons after stress (88% in GFP-Stressed rats). Knockdown of VTA MORs prevent this shift in 
the expression of double labeled pAKT, maintain a roughly even distribution of double labeled 
pAKT cells. 
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Figure 4.7. Inhibition of VTA AKT Phosphorylation During Stress Prevented the 
Development of Long-Term Weight Gain Deficits. During stress and handling procedures, 
Saline-Stressed rats (n = 9) began to exhibit a weight gain deficit, showing significantly less 
weight gain than Saline-Handled rats (n = 4; * indicates p < 0.05), however this effect was not 
significant compared to Inhibitor-Handled (n = 7, p = 0.053) or Inhibitor-Stressed groups (n = 8, p 
> .20). Twenty-three days after the last infusion of inhibitor and episode of stress, Saline-Stressed 
rats exhibited a significant reduction in weight gain compared to all other groups (* indicates p < 
0.03). Neither Inhibitor-Handled or Inhibitor-Stressed rats differed from Saline-Handled rats at 
either time point (p > 0.60). 
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Effect of Intra-VTA pAKT Inhibition on the Induction of Intermittent Social Stress-Induced Cross-
Sensitization 
 There were significant main effects of experimental group on the number of ambulatory 
movements (n = 23, Wilks’ λ = 0.196, F16,26 = 2.05, p = 0.05, η2 = 0.56, observed power = 0.85) 
and distance travelled during ambulatory movements(n = 23, Wilks’ λ = 0.114, F16,26 = 3.20, p = 
0.004, η2 = 0.663, observed power = 0.98) across all time points. After amphetamine injection, 
both the number and distance of movements significantly differed at all but the last time point (p ≤ 
0.05, see Table 1 for details). Post hoc tests showed that compared to Control Handled rats, the 
Saline-Stressed group made significantly more movements from 100 – 160 min (p < 0.04; Fig. 
4.8A), and also significantly differed from Inhibitor-Stressed rats at 160 min (p < 0.005). Inhibitor-
Stressed rats did not significantly differ from Handled Controls at any time point (p > 0.05). 
Additionally, immediately after amphetamine injection, subjects in the Saline-Stressed group 
travelled significantly farther than either Handled Controls (p < 0.001) or Inhibitor-Stressed rats (p 
< 0.005) at 100 min. during 100 – 150 min (Fig. 4.8B). In contrast, from 110 – 150 min, the 
Saline-Stressed group only traveled significantly further than Handled Controls (p < 0.05), the 
Inhibitor-Stressed group did not differ from Control Handled or Saline-Stressed rats during this 
time period (p > 0.05). Combined, these data suggest that inhibition of VTA AKT phosphorylation 
during intermittent social stress is not sufficient to prevent the induction of social stress-induced 
cross-sensitization to amphetamine. 
 
Effect of acute intra-VTA pAKT inhibition on the expression of intermittent social stress-induced 
cross-sensitization 
 To test whether inhibition of VTA AKT phosphorylation is sufficient to block the 
expression of stress-induced amphetamine sensitization. One week later Saline-Stressed rats 
that had previously exhibited cross-sensitization (Fig. 4.8) were given intra-VTA infusions of 
inhibitor (Saline-Stressed+Inhibitor), and then a second amphetamine challenge was  
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Figure 4.8. Inhibition of 
pAKT in the VTA During 
Stress Attenuated the 
Induction of Cross-
Sensitization to 
Amphetamine. Vertical 
arrows denote when saline 
or amphetamine injections 
were administered, during 
which data collection and 
video tracking were paused. 
(A) After amphetamine 
injection, Saline-Stressed 
rats (n = 5) made 
significantly more locomotor 
movements from 100 – 150 
min (p < 03) than subjects in 
the Control Handled (n = 10) 
but not Inhibitor-Stressed (n 
= 8) group. At 160 min, the 
Saline-Stressed group 
exhibited significantly more 
locomotor activity than either 
Control Handled or Inhibitor-Stressed groups (* indicates p < 0.04). Inhibitor-Stressed rats did not 
significantly differ from Saline-Stressed rats at any time point (p > 0.05). (B) Immediately after 
amphetamine injection, at 100 min, Saline-Stressed rats traveled significantly further than 
subjects in either Control Handled or Inhibitor-Stressed groups (** indicates p < 0.005). From 110 
– 150 min, Saline-Stressed rats traveled significantly farther than Control Handled rats (* 
indicates p < 0.05), but not Inhibitor-Stressed rats (p > 0.05). Inhibitor-Stressed rats did not 
significantly differ from Control Handled rats at any time point (p > 0.05). 
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Figure 4.9. Acute 
Intra-VTA 
Inhibition of AKT 
Phosphorylation 
Blocked the 
Expression of 
Social Stress-
Induced Cross-
Sensitization to 
Amphetamine. 
(A) Number of 
locomotor 
movements made 
throughout the 
amphetamine 
challenge. (B) 
Average number 
of movements 
made during each 
phase of the 
amphetamine 
challenge. Vertical 
arrows indicate 
infusion of 
inhibitor, as well 
as injections of 
saline and 
amphetamine. Compared to Control Handled rats (n = 8), an effect of stress was no longer 
observed on amphetamine-induced locomotion in Saline-Stressed rats that received intra-VTA 
infusions of pAKT inhibitor (Saline-Stressed+Inhibitor; n = 7, p > 0.10). 
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administered to these and Control Handled rats. In general, there was no overall effect of group 
on either number of (n = 15, Wilks’ λ = 0.203, F13,1 = 2.94, p > 0.10; Fig 4.9) or distance travelled 
during (data not shown; n = 15, Wilks’ λ = 0.223, F13,1 = 2.62, p > 0.12) amphetamine-induced 
ambulatory movements. Given that rats in the Saline-Stressed+Inhibitor group had previously 
exhibited significant stress-induced cross-sensitization (Fig. 4.8), these data suggest that acute 
intra-VTA inhibition of AKT phosphorylation is sufficient to block the expression of amphetamine 
cross-sensitization.  
 
DISCUSSION 
Taken together, experiments 1 and 2 show that intermittent social defeat stress increases 
AKT phosphorylation in VTA GABA cells, and that this increase in pAKT is involved in the 
expression of stress-induced cross-sensitization to amphetamine and long-term weight gain 
deficits. Specifically, in experiment 1, VTA pAKT double labeled significantly more with GAD 
65/67 than TH positive cells after social stress, and this effect was dependent on the expression 
of VTA MORs. In experiment 2, inhibition of VTA AKT phosphorylation during stress was 
sufficient to prevent the development of a long-term social stress-induced weight gain deficit, as 
well as the expression of amphetamine cross-sensitization. 
 
Intermittent Social Stress Increases AKT Phosphorylation in VTA GABA Cells, but Not DA 
While previous studies have reported a regional decrease in VTA expression of pAKT 
after continuous social stress (Krishnan et al., 2008), the present study found that intermittent 
social stress significantly increased AKT phosphorylation in a subset of VTA neurons. 
Specifically, analysis of pAKT expression revealed a three-fold stress-induced increase of AKT 
phosphorylation in cells that also expressed GAD 65/67, an immunohistochemical marker for 
GABA neurons. Correspondingly, social stress significantly reduced the co-expression of pAKT in 
DA, or TH positive cells, and increased the expression of single labeled pAKT. Although Krishnan 
et al. (2008) previously used Western blots to show that pAKT expression is reduced in the VTA 
after social continuous stress, by using homogenates, this finding is heavily biased towards DA 
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neurons, which make up the majority of cells in the VTA (see review of Nikulina et al., 2014). 
Thus the significant decrease in pAKT co-localization with TH that was observed in this study is 
consistent with the Western blot findings of Krishnan et al. (2008), which showed that continuous 
social stress reduced the expression of pAKT in the VTA. While at face value the current finding 
of increased expression of pAKT in VTA GABA neurons appears inconsistent with the results of 
(Krishnan et al., 2008), it important to note that GABA neurons comprise a small percentage of 
VTA cells, therefore it is unlikely that the regional Western blots used in their study were capable 
of detecting changes in this subset of neurons. However by using a fluorescent 
immunohistochemistry, a more sensitive technique to determine cell-type specific effects, the 
present study was able to detect a significant increase of pAKT in VTA GABA cells.  
Taken together, these data suggest that intermittent social stress-induced increases in 
AKT phosphorylation do not occur in DA, and are instead limited to VTA GABA neurons. 
Moreover, while Western blots are an accurate measure of degree of protein expression at a 
regional level, it is important to remember that they are not capable of detecting cell-type specific 
changes. In the case of intracellular signaling cascades that are activity-dependent, such as 
phosphorylation of AKT, and also likely dependent on cell type, Western blots may not be the 
best measure of changes at the cellular level, due to their regional limitations. Thus the present 
finding that social stress increased AKT phosphorylation in VTA GABA cells, is not likely to be 
detected by a Western blot. Moreover, given that the current study did not detect an increase in 
pAKT expression in DA neurons, the present findings do not directly conflict with the results of 
Western blot analyses showing decreased pAKT in the VTA after stress. 
 
Knockdown of VTA MORs Prevents Social Stress-Induced Increases in AKT Phosphorylation in 
VTA GABA Cells 
In addition to finding that intermittent social stress increases the co-localization of pAKT 
with GAD 65/67, this study also determined that this effect is dependent on the expression of 
MORs in the VTA. Specifically, lentiviral-mediated knockdown of VTA MORs prevented increases 
in AKT phosphorylation in GABA cells, without altering pAKT co-expression in TH-positive cells. 
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That phosphorylation of AKT in the VTA is dependent on the local expression of MORs is 
consistent with a study showing that delta-opioid receptors activate pAKT (Margolis et al., 2011), 
which given the high degree of homology among opioid receptor types (Waldhoer et al., 2004, 
Zollner and Stein, 2007, Pradhan et al., 2012), suggests that pAKT may be a common 
downstream target of all opioid receptors. Stress significantly increased the proportion of pAKT 
found in GABA cells, such that 88% of double labeled pAKT was found in GABA cells, while only 
22% of double labeled pAKT co-localized with DA. By contrast subjects in either GFP-Handled, 
shMOR-Handled, and shMOR-Stressed groups exhibited similar levels of pAKT co-localization in 
cells positive for markers of either GABA (53-57%) or DA (43-47%). There was no effect of 
shMOR lentivirus alone on pAKT expression in the VTA, shMOR-Handled rats did not 
significantly differ from GFP-Handled controls. Taken together, these data suggest that 
intermittent social stress increases AKT phosphorylation in VTA GABA cells downstream of 
stress-induced upregulation of VTA MORs. However, it is important to note that AKT 
phosphorylation can be induced by receptors other than MORs, in particular pAKT is a 
downstream target of BDNF’s receptor, tropomyosin-related kinase B (TrkB) (TrkB; see reviews 
of Park and Poo, 2013, Nikulina et al., 2014). Although it is possible that for AKT to be 
phosphorylated independent of MOR activity, and while it was recently reported that a small 
percentage of VTA MORs are also found on VTA DA neurons (Margolis et al., 2014), the current 
study demonstrated that the effect of stress on pAKT expression is limited to GABA neurons and 
preventable by knockdown of MORs. Taken together, these results provide evidence that social 
stress predominantly acts to increase MOR expression in VTA GABA cells, the upregulation of 
which mediates increased phosphorylation of AKT.  
 
Intra-VTA Inhibition of AKT Phosphorylation Prevents Social Stress-Induced Weight Gain Deficits 
Consistent with previous reports (Meerlo et al., 1996, Pulliam et al., 2010, Fanous et al., 
2011, Venzala et al., 2012, Johnston et al., 2015), intermittent social stress reduced weight gain 
both during and 23 days after social stress exposure. Intra-VTA inhibition of pAKT during stress 
attenuated this stress-induced weight gain deficit during stress, and fully rescued the long-term 
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deficit observed 23 days later. This finding is particularly interesting, as the effect of VTA 
inhibition of pAKT was greatest 23 days after stress and infusions of inhibitor, suggesting that 
inhibition of pAKT alone does not acutely alter weight gain. However it was previously shown that 
knockdown of VTA MORs also rescues this stress-induced weight gain deficit (Johnston et al., 
2015), so is possible that AKT phosphorylation converges with other MOR-activated intracellular 
signaling cascades, such as MAPK/ERK, to help mediate stress-induced weight gain deficits. 
Given that stress-induced increase of pAKT is limited to GABA neurons and dependent on local 
MOR expression, the present finding that inhibition of VTA AKT phosphorylation during stress 
attenuated and promoted recovery from the social stress-induced deficit in weight gain is 
consistent with the crucial function of VTA MOR activity in this deficit (Johnston et al., 2015). 
Taken together, these studies suggest that social stress-induced decreases in weight gain are 
mediated by MOR – pAKT signaling in VTA GABA neurons. 
 
The Induction of Stress-Induced Amphetamine Cross-Sensitization is Attenuated by Intra-VTA 
Inhibition of pAKT 
 Compared to the Control Handled group, subjects that received infusions of saline during 
stress exhibited significantly more locomotor activity in a low dose amphetamine challenge, 
confirming prior reports that intermittent social stress induces amphetamine cross-sensitization 10 
days after the last stress episode (Covington and Miczek, 2001, Nikulina et al., 2012, Johnston et 
al., 2015). In contrast, compared to Control Handled and Saline-Stressed groups, subjects that 
had received intra-VTA infusions of pAKT inhibitor during stress did not significantly differ in their 
response to amphetamine. Thus, while inhibition of pAKT in the VTA during stress is not sufficient 
to prevent the induction of social stress-induced cross-sensitization, it did attenuate this effect. 
That inhibition of pAKT did not fully prevent the induction of stress-induced cross-sensitization to 
amphetamine is consistent with a previous study in which intracerebroventricular inhibition of 
pAKT, via its activator PI3K, blocked the expression, but not the induction of sensitization to 
cocaine (Izzo et al., 2002). Despite this, it was previously reported that lentivirus-mediated 
knockdown of VTA MORs is sufficient to prevent cross-sensitization to amphetamine (Johnston et 
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al., 2015). Since AKT phosphorylation occurs in VTA GABA neurons downstream of MOR 
upregulation (Fig. 4.3 – 4.6), intra-VTA inhibition of pAKT was expected to mirror the effect of 
VTA MOR knockdown and prevent the induction of cross-sensitization. It is surprising that 
inhibition of VTA AKT phosphorylation replicated the rescue of VTA MOR knockdown on weight 
gain, but not the induction of the induction of cross-sensitization.  
This discrepancy may be attributed to differences in the methods employed in this study 
and that of Johnston et al. (2015). Specifically, Johnston et al. (2015) used a lentiviral construct to 
induced persistent depletion of VTA MORs, meaning that this viral effect was continuous 
throughout the experiment. By contrast, in the current study, AKT phosphorylation was only 
inhibited on days where subjects were stressed or handled, and since this happened every third 
day and the inhibitor is metabolized within 24 h, this means that AKT phosphorylation may have 
increased in-between episodes of social stress. Although this could not be verified, due to having 
conducted a reversal that altered pAKT expression in previously Saline-Stressed rats, this theory 
fits with the attenuation of cross-sensitization observed in Inhibitor-Stressed rats. Thus, it is 
possible that intra-VTA inhibition of pAKT would have significantly prevented stress-induced 
cross-sensitization if the drug had been administered daily, rather than intermittently, during 
social stress or handling procedures.  
 
The Expression of Social Stress-Induced Cross-Sensitization to Amphetamine is Prevented by 
Co-Administration of Intra-VTA pAKT Inhibitor 
 After the first amphetamine challenge verified the induction of social stress-induced 
cross-sensitization in previously Saline-Stressed rats, these rats were given infusions of pAKT 
inhibitor (Saline-Stressed+Inhibitor) and put through a second amphetamine challenge to access 
for the expression of cross-sensitization. The results showed that intra-VTA inhibition of AKT 
phosphorylation was sufficient to block the expression of social stress-induced cross-
sensitization. Specifically, after intra-VTA infusion of pAKT inhibitor, and compared to Control 
Handled subjects, rats that had previously showed cross-sensitization no longer displayed 
significant differences in amphetamine-induced locomotor activity. This finding is consistent with 
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previous reports that inhibition of pAKT signaling, either systemic or intracerebroventricular, is 
sufficient to block the expression of cocaine sensitization (Izzo et al., 2002, Wu et al., 2011), and 
extends upon them in suggesting that the VTA is a crucial site of action for pAKT-mediated 
expression of psychostimulant sensitization.  
 
Concluding Remarks 
  In summary, experiment 1 found that intermittent social stress significantly increased the 
expression of pAKT in VTA GABA, but not DA neurons. Experiment 2 demonstrated that 
inhibition of VTA AKT phosphorylation is sufficient to prevent social stress-induced deficits in 
weight gain, as well as the expression of amphetamine cross-sensitization. That intra-VTA 
inhibition of pAKT failed to prevent the induction of amphetamine cross-sensitization may reflect 
specificity in the functional role of VTA AKT phosphorylation, or may have been due to the 
temporal pattern of inhibitor administration. Thus while VTA pAKT is crucial for vulnerability to 
psychomotor stimulant drugs, future studies will be necessary to clarify the role of VTA pAKT in 
the induction of stress-induced cross-sensitization.  
In conclusion, social stress increased MOR – pAKT signaling in VTA GABA cells, and 
this increase of pAKT is necessary for the expression of stress-induced cross-sensitization to 
amphetamine and weight gain deficits. Given that inhibition of VTA AKT phosphorylation alone 
did not affect normal amphetamine-induced locomotor activity and that the effect on weight gain 
persisted in the absence of inhibitor, VTA pAKT may represent a novel target for the therapeutic 
intervention of substance abuse and stress disorders. 
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CHAPTER 5: GENERAL DISCUSSION 
Summary of Major Results 
The aim of the current study was to investigate whether VTA MOR signaling serves a 
functional role in social stress-induced vulnerability to psychomotor stimulant drugs. These 
experiments utilized the intermittent model of social defeat stress, which is well known to induce 
cross-sensitization to psychostimulant and opioid drugs (see reviews of Miczek et al., 2008, 
Miczek et al., 2011l, Nikulina et al., 2014). To investigate the role of social stress-induced MOR 
upregulation in the VTA, lentiviral constructs were used to manipulate local MOR levels, either 
non-manipulated or knocked-down, and then subjects put through social defeat stress 
procedures. The experiment in chapter 1 determined whether VTA MORs are necessary for the 
behavioral consequences of social stress. In chapter 2, immunohistochemical analyses of the 
mesocorticolimbic circuit were conducted at a time when cross-sensitization is known to be 
present. Finally, separate experiments were conducted in chapter 3 to investigate whether social 
stress induces AKT phosphorylation downstream of MOR upregulation in the VTA, and whether 
intra-VTA inhibition of AKT phosphorylation is sufficient to mimic the behavioral effects of VTA 
MOR knockdown.  
In chapter 2, VTA MOR expression was knocked down prior to stress, and after stress or 
control handling procedures, subjects were assessed for social stress-induced cross-sensitization 
to amphetamine, as well as for social avoidance and deficits in weight gain. Knockdown of VTA 
MORs was sufficient to prevent social stress-induced social avoidance and long-term deficits in 
weight gain, without effecting normal weight gain or social interaction. Moreover, knockdown of 
VTA MORs prevented social stress-induced cross-sensitization, without affecting normal 
amphetamine-induced locomotion. Mesolimbic BDNF – TrkB receptor expression is also 
enhanced after social stress and also serves to mediate social stress-induced cross-sensitization 
(Fanous et al., 2010, Nikulina et al., 2012, Wang et al., 2013, Wang et al., 2014). Given that 
social stress-induced upregulation of VTA MORs occurs prior to increases in VTA BDNF 
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expression, it was hypothesized that knockdown of VTA MORs would prevent social stress-
induced changes related to mesolimbic BDNF signaling. 
In chapter 3, at the time that cross-sensitization was studied in chapter 2, knockdown of 
VTA MOR was found to attenuate social stress-induced changes in protein expression in the 
mesolimbic pathway. Specifically, VTA MOR expression was necessary for social stress-induced 
increases of VTA BDNF and its receptor TrkB in the NAc, additionally, expression of delta FosB 
was attenuated in the NAc. Thus, while mesolimbic BDNF – TrkB expression mediates social 
stress-induced cross-sensitization to amphetamine and the expression of delta FosB in the NAc 
(Wang et al., 2013, Wang et al., 2014), these effects are mediated by upstream increases in VTA 
MOR activity. A schematic representation of the mesolimbic and behavioral effects of stress and 
VTA MOR knockdown can be seen in Figure 5.1. Given that in the VTA, MORs predominantly 
have inhibitory effects on GABA neurons, it is possible that social stress-induced MOR 
upregulation increases activity of the receptors intracellular signaling cascades. Specifically, it 
was hypothesized that social stress would increase the phosphorylation of AKT, a downstream 
target of MORs, in VTA GABA neurons, and this increase would have functional implications for 
social stress-induced behaviors. 
In chapter 4, fluorescent immunohistochemical analyses were conducted to examine 
social stress-induced changes in pAKT co-localization with VTA GABA and DA neurons, and 
whether these changes are a result of VTA MOR expression. Although GABA neurons represent 
a minor sub-population of VTA neurons, social stress significantly increased the co-localization of 
pAKT in GABA neurons, an effect which was prevented by knockdown of VTA MORs. 
Correspondingly, social stress significantly reduced the co-localization of pAKT with VTA DA 
neurons. Moreover, in these sections processed for pAKT and a marker of DA, social stress 
increased the expression of single labeled pAKT, which is consistent with its co-expression in 
VTA GABA cells. Taken together, these data are evidence that social stress augments pAKT  
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Figure 5.1. Social Stress-Induced Changes in the Mesolimbic Pathway That Have Been 
Related to Cross-Sensitization are Prevented by VTA MOR Knockdown. (A) Social stress 
increases VTA BDNF expression and signaling with its TrkB receptor and expression of delta 
FosB in the NAc (Fanous et al., 2010, Nikulina et al., 2012, Wang et al., 2013, Wang et al., 2014). 
Additionally, intermittent social stress increases VTA DA activity (Tidey and Miczek, 1996, Miczek 
et al., 2011a) and the expression of VTA MORs (Nikulina et al., 1999, Nikulina et al., 2005, 
Nikulina et al., 2008), which are implicated in the control of VTA DA neurotransmission (Johnson 
and North, 1992). These changes have all been related to social stress-induced weight gain 
deficits, social avoidance, and cross-sensitization to psychostimulants (Fanous et al., 2010, 
Fanous et al., 2011, Wang et al., 2013, Wang et al., 2014, Johnston et al., 2015). (B) Stimulation 
of MORs on a sub-population of VTA GABA neurons results in disinhibition of local DA neurons 
(Johnson and North, 1992). Consistent with this, knockdown of VTA MORs prevents social 
stress-induced increase of mesolimbic BDNF – TrkB receptor expression, and attenuates the 
expression of NAc delta FosB (see Chapter 3). Similar to the role of mesolimbic BDNF – TrkB 
receptor expression, VTA MOR expression is also necessary for the behavioral consequences of 
social stress (Chapter 2; see also Johnston et al., 2015). Red circle: GABA neurotransmitter; 
green circle: DA neurotransmitter; yellow circle: BDNF; blue circle: MOR; number of red or green 
circles indicate degree of neurotransmission. 
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Figure 5.2. Schematic Illustration of the Effects of Local MOR Knockdown or Inhibition of 
AKT Phosphorylation on Social Stress-Induced Changes in the VTA. While the effects of 
MOR knockdown on the mesolimbic pathway have been largely confirmed (Chapters 2-4; see 
also Johnston et al., 2015), the mediation by AKT phosphorylation is theoretical and based on 
pAKT’s being a downstream target of MORs and its involvement in the behavioral outcomes of 
stress. Large green circle: DA neuron; large red circle GABA neuron; size of projecting arrows 
indicate respective degrees of DA and GABA neurotransmission; small yellow circles: BDNF; 
small blue circles: MORs; purple circles: AKT; pairs of smallest orange circles: phospho-groups 
on AKT (pAKT). Manipulations of the VTA (bottom row) are indicated by red text. 
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expression in the VTA, such that AKT phosphorylation is increased downstream of VTA MOR 
upregulation (Fig. 5.2).  
Given that AKT phosphorylation is limited to GABA neurons and requires the expression 
of VTA MORs, it was investigated whether inhibition of AKT phosphorylation during stress is 
sufficient to the induction of amphetamine cross-sensitization and weight gain deficits. In fact, 
intra-VTA inhibition of pAKT during stress, prevented the development a long-term weight gain 
deficit, well after the last episode of stress or inhibitor infusion. In contrast, inhibition of AKT 
phosphorylation during stress only attenuated the induction of cross-sensitization to 
amphetamine. Since a previous study had indicated that inhibition of pAKT is sufficient to block 
the expression, but not the induction of drug-induced psychostimulant sensitization (Izzo et al., 
2002), a reversal was conducted to determine whether acute intra-VTA inhibition of pAKT was 
sufficient to block the expression of stress-induced cross-sensitization. In rats that had previously 
showed a sensitized response to amphetamine, acute inhibition of VTA AKT phosphorylation 
blocked the expression of cross-sensitization. Although intra-VTA inhibition of pAKT rescued the 
stress-induced vulnerability to amphetamine, it did not augment the normal locomotor-activating 
effect of amphetamine, suggesting that inhibition of VTA AKT phosphorylation does not produce 
unnatural augmentation of VTA DA transmission. Taken together, these results suggest that 
inhibition of AKT phosphorylation may represent a novel therapeutic target for the intervention 
stress-induced disorders and the treatment of substance abuse.  
 
Expression of Excitatory and Inhibitory MORs in the VTA: Implications for Stress-Iinduced 
Increase of VTA MOR Activity 
While stimulation of MORs is generally thought to have an inhibitory effect, a recent study 
illustrated that MORs can be either inhibitory or excitatory, and that either receptor sub-type can 
be found on both VTA GABA and DA neurons (Margolis et al., 2014). Given that the current 
experiments were conducted prior to this report, the overlying assumption throughout these 
studies was that social stress upregulates VTA MORs on GABA neurons. Although VTA MOR 
activation can have a variety of effects, depending on inhibitory vs. excitatory function and 
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neuronal type, it is possible to parse out the net effect of social stress-induced increases in MOR 
expression. While some VTA MORs are excitatory, the majority are inhibitory, thus at any time 
there is a greater likelihood that MOR stimulation will produce an inhibitory effect, regardless of 
neuronal type (Margolis et al., 2014). Social defeat stress is known to increase mesolimbic DA 
transmission (Tidey and Miczek, 1996, Miczek et al., 2011a) and produce cross-sensitization to 
both opioid and psychostimulant drugs that affect mesolimbic DA transmission (see reviews of 
Miczek et al., 2008, Miczek et al., 2011l, Nikulina et al., 2014). If the majority of VTA MORs 
upregulated by social stress were either inhibitory on DA neurons, or excitatory on GABA 
interneurons, then the net effect should be decreased VTA DA transmission, which is inconsistent 
with social defeat stress-induced increase of DA transmission. In contrast, the increased net 
effect of increased excitatory MORs on DA neurons, or inhibitory MORs on GABA neurons would 
be consistent with increased VTA DA transmission. While it is possible that social stress 
increases the expression of excitatory MORs on VTA DA neurons, the effect of such upregulation 
is likely to be minimal, as excitatory MORs on DA comprise a very small proportion of VTA MORs 
(Margolis et al., 2014). This is supported by the data in chapter 4, which illustrate that AKT 
phosphorylation is increased in VTA GABA neurons downstream of MOR upregulation. Although 
any MOR is capable of phosphorylating AKT, since there was no effect of VTA MOR knockdown 
on pAKT expression in DA neurons, it is likely that social stress predominantly upregulates 
inhibitory MORs on VTA GABA neurons. 
 
Indirect Mediation of VTA DA Transmission by Local GABA Neurons: A Role for MOR – pAKT 
Signaling 
 The inhibitory effects of VTA MORs are generally associated with increased GIRK 
activity, which functions to increase K+ conductance to reduce neurotransmission (Johnson and 
North, 1992, Bergevin et al., 2002). When MORs are stimulated on a sub-population of VTA 
GABA neurons, they have been shown to inhibit GABA release, thereby disinhibiting local DA 
neurons (Johnson and North, 1992). Given that social defeat stress is associated with increased 
VTA DA release (Tidey and Miczek, 1996, Miczek et al., 2011a), it is likely that social stress 
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decreases local GABA release in the VTA to disinhibit neighboring DA neurons and increase DA 
release in the NAc (Fig. 5.2). While future studies utilizing electrophysiology will be necessary to 
verify this, this theory is supported by a report of increased VTA GABA release onto local DA 
neurons and reduced cocaine self-administration in MOR knockout mice (Mathon et al., 2005). 
Based on this finding, it is likely that knockdown of VTA MORs prevented cross-sensitization to 
amphetamine by either increasing or maintaining tonic levels of local GABA release in the VTA. 
Although GIRKS are one downstream target of MORs that result in inhibition, phosphorylation of 
AKT has been shown to increase the insertion of GABAAR into the cell membrane (Wang et al., 
2003). Given that the data in chapter 4 show that social stress increases pAKT in VTA GABA 
neurons, and that VTA AKT phosphorylation serves a functional role in the behavioral outcomes 
of social stress, it is possible that GABAAR expression is increased in GABA neurons 
downstream social stress-induced increase of MOR – pAKT signaling. If social stress increases 
the expression of GABAARs on VTA GABA neurons, one would expect this to further inhibit 
GABA release and disinhibit local DA neurons.  
 
Methodological Considerations and Future Studies 
 Although knockdown of VTA MORs prevented the social stress-induced cross-
sensitization to amphetamine, intra-VTA inhibition of pAKT during stress did not, even though it 
acutely blocked the expression of cross-sensitization (Table 2). While this effect of pAKT 
inhibition on the expression, but not the induction of cross-sensitization has also been observed 
with drug-induced cocaine-sensitization and may in fact be valid, there are several 
methodological considerations that must be noted. First, knockdown of VTA MORs was 
accomplished using lentivirus-mediated interference, which means that the effect of knockdown 
persisted throughout the entire study. Given that the effect of VTA MOR knockdown persisted 
through testing, it is difficult to say whether knockdown of VTA MORs prevented the induction or 
the expression of cross-sensitization. In contrast to the persistent effect of lentivirus-mediated 
knockdown, inhibition of AKT phosphorylation was accomplished with a drug that was 
administered prior to each episode of stress. As a drug, the pAKT inhibitor is metabolized within                                   
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24 h, meaning that while stress-induced AKT phosphorylation was inhibited each day that stress 
procedures were administered, VTA AKT phosphorylation may have increased on subsequent 
days. Based on these considerations, it is possible that if the experiment in chapter 2 were 
repeated using intra-VTA infusions of a MOR antagonist, it would mimic the differential effect of 
intra-VTA inhibition of pAKT on the induction, versus the expression of cross-sensitization. 
Conversely, it is also possible that if VTA pAKT inhibition were accomplished using a viral 
construct, it would replicated the effect of VTA MOR knockdown on the expression of cross-
sensitization. While both VTA MOR expression and AKT phosphorylation are critical for the 
behavioral effects of social defeat stress, additional studies will be needed to determine whether 
MOR – pAKT signaling plays a differential role in the induction, rather than the expression, of 
stress-induced cross-sensitization to psychomotor stimulant drugs.  
 The finding that inhibition of AKT phosphorylation in the VTA during stress is sufficient to 
prevent stress-induced weight gain deficits 23 days after the last infusion of inhibitor, suggests 
that VTA AKT phosphorylation confers susceptibility to intermittent social defeat stress in rats. By 
contrast, a previous study showed there is a regional decrease of VTA pAKT after continuous 
social defeat stress in mice (Krishnan et al., 2008). Additionally, when mice were classified as 
susceptible or resilient after defeat, they found that resilient mice exhibited greater regional levels 
of pAKT in the VTA. Although this seems to contradict the current findings regarding stress and 
VTA AKT phosphorylation, it important to note several distinctions between these studies. The 
study by Krishnan et al. (2008) used regional Western blot analyses which are not sensitive to 
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changes in specific sub-populations of cells, such as MOR containing GABA neurons. Thus it is 
possible that despite their finding of a regional decrease of VTA pAKT after continuous social 
stress, that the mice in the study of Krishnan et al. (2008) may have also exhibited an increase of 
pAKT in a sub-population of VTA GABA neurons. In support of this, the current fluorescent 
immunohistochemical results showed that intermittent social stress tended to decrease pAKT 
expression in VTA DA neurons, and given that DA makes up the majority of VTA neurons, it is 
possible that Western blot analyses of the VTA after intermittent social defeat stress would also 
show a regional decrease of pAKT.  
It is also important to note that the study of Krishnan et al. (2008) utilized mice, while the 
present studies utilized rats. In rats, continuous and intermittent social defeat stress produce 
opposite effects on responses to psychomotor stimulants and DA release in the NAc (Miczek et 
al., 2011a). Moreover, in mice continuous social defeat stress produces an increase in VTA 
BDNF (Berton et al., 2006, Krishnan et al., 2008), while in rats, VTA BDNF is increased after 
intermittent, but decreased after continuous social defeat stress (Miczek et al., 2011a). Given that 
social stress has different effects on VTA BDNF expression in rats and mice, it also possible that 
the continuous social stress-induced decrease in VTA pAKT is specific to mouse models of social 
stress. Future studies will be needed to directly compare whether intermittent social stress-
induced increase of VTA MOR – pAKT signaling also mediates the effects of continuous social 
defeat stress in rats.   
 
Concluding Remarks 
 The studies described in chapters 2-4 show that intermittent social stress increases MOR 
– pAKT signaling in the VTA, and that the expression of VTA MORs and pAKT are crucial for 
stress-induced cross-sensitization to psychostimulant drugs of abuse. In addition to mediating the 
behavioral consequences of social stress, knockdown of VTA MORs prevented social stress-
induced increases in mesolimbic BDNF – TrkB signaling, as well as attenuating the expression of 
delta FosB in the NAc. While the behavioral effects of intra-VTA inhibition of pAKT were similar to 
the preventative effects of MOR knockdown, future studies will be necessary to determine 
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whether inhibition of VTA pAKT also mediates social stress-induced changes in the mesolimbic 
pathway. Taken together, these studies suggest that increased MOR – pAKT signaling in the VTA 
may underlie susceptibility to psychomotor stimulants, and that interruption of this signaling may 
have beneficial effects for the therapeutic intervention of stress-induced disorders and substance 
abuse. 
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Abstract: 
Social defeat stress causes social avoidance and long-lasting cross-sensitization to 
psychostimulants, both of which are associated with increased brain-derived neurotrophic factor 
(BDNF) expression in the ventral tegmental area (VTA). Moreover, social stress upregulates VTA 
mu-opioid receptor (MOR) mRNA. In the VTA, MOR activation inhibits GABA neurons to disinhibit 
VTA dopamine neurons, thus providing a role for VTA MORs in the regulation of psychostimulant 
sensitization. The present study determined the effect of lentivirus-mediated MOR knockdown in 
the VTA on the consequences of intermittent social defeat stress, a salient and profound stressor 
in humans and rodents. Social stress exposure induced social avoidance and attenuated weight 
gain in animals with non-manipulated VTA MORs, but both these effects were prevented by VTA 
MOR knockdown. Rats with non-manipulated VTA MOR expression exhibited cross-sensitization 
to amphetamine challenge (1.0 mg/kg, i.p.), evidenced by a significant augmentation of 
locomotion. By contrast, knockdown of VTA MORs prevented stress-induced cross-sensitization 
without blunting the locomotor-activating effects of amphetamine. At the time point corresponding 
to amphetamine challenge, immunohistochemical analysis was performed to examine the effect 
of stress on VTA BDNF expression. Prior stress exposure increased VTA BDNF expression in 
rats with non-manipulated VTA MOR expression, while VTA MOR knockdown prevented stress-
induced expression of VTA BDNF. Taken together, these results suggest that upregulation of 
VTA MOR is necessary for the behavioral and biochemical changes induced by social defeat 
stress. Elucidating VTA MOR regulation of stress effects on the mesolimbic system may provide 
new therapeutic targets for treating stress-induced vulnerability to substance abuse. 
 
Key Words: 
mu-opioid receptor, social defeat stress, ventral tegmental area, cross-sensitization, brain-derived 
neurotrophic factor, amphetamine 
 
 
 
147 
Highlights: 
• VTA MORs are necessary for social stress-induced weight gain and behavior deficits 
• VTA MOR knockdown prevented cross-sensitization to amphetamine after social defeat 
• VTA MOR knockdown prevented social stress-induced increase of VTA BDNF 
 
Abbreviations: 
• [3H]DAMGO - tritiated [D-Ala2,N-MePhe4,Gly-ol5] enkephalin 
• BDNF – brain-derived neurotrophic factor 
• CREB – cAMP responsive binding element protein 
• DA – dopamine 
• fr – fasciculus retroflexus 
• GABA – gamma-aminobutyric acid 
• GFP – green fluorescent protein 
• MOR – mu-opioid receptor 
• ml – medial lemniscus 
• MT – medial terminal nucleus of the accessory optic system 
• pCREB – phosphorylated cAMP responsive binding element protein 
• shMOR – short hairpin mu-opioid receptor lentiviral construct 
• SNc – substantia nigra pars compacta 
• SNr – substantia nigra pars reticulata  
• VTA – ventral tegmental area  
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1. Introduction 
In humans, stress is one variable that influences the transition from recreational drug use 
to abuse, and it has been correlated with increased risk of substance abuse and relapse (Sinha, 
2001, 2008, 2011). Rodent studies have shown that repeated social defeat stress exposure 
consistently produces social avoidance (Berton et al., 2006, Krishnan et al., 2007, Razzoli et al., 
2009, Fanous et al., 2011b, Komatsu et al., 2011) and augments the effect of psychomotor 
stimulants, a phenomena known as ‘cross-sensitization’ (Covington and Miczek, 2001, Nikulina et 
al., 2004, Nikulina et al., 2012). Genetic mu-opioid receptor (MOR) knockout mice do not exhibit 
social avoidance following continuous social defeat (Komatsu et al., 2011), suggesting that MORs 
play a critical role in stress-induced changes in long-term neuroplasticity. In fact, even acute 
social defeat stress has been shown to rapidly upregulate MOR mRNA expression in the ventral 
tegmental area (VTA; Nikulina et al., 1999), while repeated social stress exposure increases VTA 
MOR mRNA expression for up to 14 days after the last episode (Nikulina et al., 2008). In the VTA 
MORs are expressed by gamma-aminobutyric acid (GABA) neurons (Sesack and Pickel, 1995, 
Garzon and Pickel, 2002), which are hyperpolarized in response to MOR stimulation, thus 
disinhibiting local dopamine (DA) transmission and facilitating response to drugs of abuse 
(Johnson and North, 1992, Bergevin et al., 2002, Vargas-Perez et al., 2009b, Dacher and 
Nugent, 2011). Rats exposed to repeated social defeat stress, then challenged with an intra-VTA 
infusion of a MOR-specific agonist exhibited sensitized locomotor activity (Nikulina et al., 2005, 
Nikulina et al., 2008). This VTA opiate-induced sensitized locomotor activity was present at the 
same time point that social stress-induced cross-sensitization to psychomotor stimulants was 
observed (Covington and Miczek, 2001, Nikulina et al., 2004, Nikulina et al., 2012). Taken 
together, these findings indicate that increased VTA MOR expression might play a role in social 
stress-induced psychostimulant sensitization. Consistent with this view, MOR knockout mice 
exhibit reduced cocaine self-administration and increased VTA GABA transmission (Mathon et 
al., 2005). Furthermore, the expression of amphetamine sensitization is associated with 
persistent VTA MOR upregulation, and can be blocked by a treatment with MOR antagonist 
(Magendzo and Bustos, 2003, Trigo et al., 2010). 
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Increased expression of brain-derived neurotrophic factor (BDNF) in the VTA  is 
frequently observed as a consequence of psychostimulant administration (Horger et al., 1999, 
Grimm et al., 2003, Bolanos and Nestler, 2004, Corominas et al., 2007, Thomas et al., 2008). 
Studies with morphine have shown that an interaction exists between VTA BDNF and MORs 
(Chu et al., 2007, Vargas-Perez et al., 2009b, Koo et al., 2012). Additionally, increased VTA 
BDNF expression has been implicated as a long-term mediator of social stress-induced cross-
sensitization (Nikulina et al., 2012), and in the VTA this increase persists for at least 2 weeks after 
the last social stress exposure (Berton et al., 2006, Fanous et al., 2010, Nikulina et al., 2012). In 
particular, overexpression of VTA BDNF was observed to exacerbate social stress-induced cross-
sensitization to amphetamine (Wang et al., 2013), while viral deletion of VTA BDNF prevented 
social stress-induced social avoidance (Berton et al., 2006, Krishnan et al., 2007, Fanous et al., 
2011b). Although VTA MOR mRNA expression rapidly increases following social stress exposure 
(Nikulina et al., 2005, Nikulina et al., 2008), VTA BDNF expression is affected more slowly 
(Fanous et al., 2010). Based on the modulatory relationship that exists between VTA MORs and 
BDNF (Chu et al., 2007, Vargas-Perez et al., 2009b, Koo et al., 2012), it is possible that 
intermittent social defeat stress-induced increases of VTA BDNF are related to MOR upregulation 
in this brain region.  
Although research has implicated VTA MORs in drug sensitization and social behaviors 
(Van Ree et al., 2000, Miczek et al., 2011b, Lutz and Kieffer, 2013a, b, Pitchers et al., 2014), it is 
unknown whether upregulation of VTA MORs causes the behavioral and biological effects of 
social defeat stress exposure. To address this question, the present study used lentivirus-
mediated gene transfer and RNA interference to knockdown MORs in the VTA, and then 
assessed social stress-induced cross-sensitization to amphetamine and BDNF expression in the 
VTA. Given that social avoidance is altered in MOR knockout mice after continuous social stress 
(Komatsu et al., 2011), we also examined the effect of VTA MOR knockdown on social avoidance 
after stress exposure. Finally, the effect of VTA MOR knockdown on stress-induced deficits of 
weight gain was examined.  
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2. Experimental Methods 
2.1 Subjects 
Experimental animals were male Sprague-Dawley rats (N = 71; Charles River 
Laboratories, Hollister, CA) weighing 200-250 g on arrival. Three days before social stress 
exposure, subjects were individually housed in standard plastic cages (25x50x20 cm3). Twelve 
additional age-matched Sprague Dawley rats were group-housed 3 per cage and served solely 
as novel stimulus subjects during the social approach and avoidance test. Male Long-Evans rats 
(weighing 550-700 g), termed ‘residents’, were pair-housed with a tubal-ligated female in large 
plastic cages (37x50x20 cm3). All rats were maintained on a 12-12 reverse light-dark cycle (lights 
out at 0900 h) with free access to food (Purina Rodent Diet, Brentwood, MO) and water. 
Residents were previously screened for aggressive behavior and were used to induce social 
defeat stress in experimental “intruder” rats. All experimental procedures were approved by the 
Institutional Animal Care and Use Committees at the Arizona State University and the University 
of Arizona. All studies were conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (National Research Council, 2011),  and every effort was made to minimize 
pain and suffering, as well as the number of animals used. 
 
2.2 Experimental Design 
2.2.1 General Procedure 
 Upon arrival, experimental rats were habituated to laboratory conditions for 7 days before 
surgery to manipulate regional MOR level. Rats were randomly assigned to one of four 
experimental conditions: Non-Manipulated MOR+Handled, Non-Manipulated MOR+Stressed, 
MOR Knockdown+Handled, MOR Knockdown+Stressed. Three experiments were conducted in 
parallel (Fig 1A); one group of subjects (n = 25) received an amphetamine challenge 10 days 
after the last episode of intermittent social stress or handling to study the effects of VTA MOR 
knockdown on social stress-induced cross-sensitization. Seven days later, VTA tissue from this 
group of subjects was flash frozen for radioligand binding to verify the efficacy of MOR 
knockdown. A second group of drug-naïve subjects (n = 21) were perfused at the same time point 
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after stress or handling to quantify VTA BDNF expression. Social approach and avoidance testing 
was performed two days after termination of social stress or handling procedures in both these 
groups. The third group of rats (n = 25) were weighed prior to each episode of intermittent social 
stress and handling, and again 10 days later to investigate the influence of VTA MOR knockdown 
on social stress-induced deficits in weight gain. 
 
2.2.2 Bilateral VTA infusion of lentiviral constructs 
Rats assigned to control viral groups received infusions of lentivirus that expresses green 
fluorescent protein (GFP) and a short hairpin RNA (shRNA) that does not target any known rat 
gene, while rats assigned to VTA MOR knockdown groups received a lentivirus that expresses 
GFP and a shRNA that targets MOR (shMOR) for RNA interference. Lentiviral constructs were 
prepared as previously described (Lasek et al., 2007). The shMOR lentivirus reduces VTA MOR 
expression by 88-97% (Lasek et al., 2007). Therefore, the viral titre was diluted by 50% with cold 
sterile saline to reduce the efficacy. After random assignment to GFP or shMOR knockdown 
conditions, rats were anesthetized using isoflurane and positioned in a stereotaxic frame (Leica 
Angle Two; Richmond, IL). The appropriate lentiviral construct (1.0 µl each) was infused 
bilaterally into the VTA (AP -5.15, ML ±2.15, DV -8.7, Tilt 10°; Paxinos and Watson, 2007) at a 
flow rate of 0.1 µl/min, and allowed to diffuse for 10 min before withdrawal of the syringe 
(Hamilton; Model 7105 KH; 24 gauge tip; Reno, NV) . The accuracy of each infusion was later 
verified using localization of GFP expression. Subjects were given 7 days to recover before the 
start of intermittent social stress or handling procedures (Fig. 1A). 
 
2.2.3 Intermittent social defeat stress and handling procedures 
Social defeat stress was induced by a short confrontation between an aggressive 
resident and an experimental intruder rat, as previously described (Tidey and Miczek, 1996, 
Nikulina et al., 2004, Nikulina et al., 2012). After removing the female from the resident’s home 
cage, an experimental rat was placed inside the resident’s home cage for 5 min within the 
confines of a protective metal cage (15x25x15 cm3). The protective cage was then removed, 
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allowing the resident to attack the experimental intruder rat until it displayed supine posture for at 
least 4 sec. Once submissive posture was exhibited, the experimental rat was placed back in the 
protective cage and exposed to threat from the resident for an additional 20 min before being 
returned to its own home cage. Intermittent social stress procedures were administered every 
third day for 10 days (Fig. 1A). At each corresponding time point, rats in the control groups were 
handled for approximately 2.5 min and then returned to their home cages.  
 
2.3 Behavioral assessments 
2.3.1 Social interaction 
The social approach and avoidance test was conducted in a large plastic container 
(58x38x41 cm3) equipped with a lightweight containment cage. Experimental rats were habituated 
to the empty test chamber for 5 min, then reintroduced when a novel stimulus rat was within the 
containment cage (Fig. 1B). The behavior of experimental rat was recorded for 5 min using 
TopScan (Clever Systems Inc.; Reston, VA). The software divided the chamber into virtual zones: 
Interaction, which comprised the area surrounding the containment cage, and Avoidance, which 
comprised the two corners opposite the containment cage (Fig. 1B; arena adapted from Berton et 
al., 2006). The number of respective entries into the avoidance and interaction zones was 
recorded, as was the distance (cm) moved in each zone. 
 
2.3.2 Amphetamine challenge 
A low dose d-amphetamine challenge was administered to test for social stress-induced 
cross-sensitization (Nikulina et al., 2004, Nikulina et al., 2012). For two days prior to the 
challenge, rats were injected with vehicle (0.9% sterile saline; 1.0 ml/kg, i.p.), and were 
acclimated in their home cage to the procedure room for 1 h. On the day of the challenge, rats 
were moved in their home cage to the procedure room, and locomotor activity was recorded at 10 
min intervals using video tracking software (Videotrack, Viewpoint Life Sciences; Montreal, 
Canada). Locomotor activity was detected as the number of and distance travelled during 
movements (>10 cm) across 170 min consisting of 3 phases: Baseline, Saline, and 
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Amphetamine. Baseline data were recorded for 30 min, after which a saline injection (1.0 ml/kg, 
i.p.) was given and locomotor activity was recorded for 60 min. Finally, rats received an injection 
of d-amphetamine sulfate (1.0 mg/kg, i.p.; Sigma-Aldrich; St. Louis, MO), and locomotor data 
were recorded for 80 min. Video tracking and data collection were paused during the 
administration of saline and amphetamine injections. Rather than stereotypical behaviors, this 
dose of amphetamine has been shown to primarily induce large ambulatory movements (Geyer et 
al., 1987). In order to quantify amphetamine sensitization, ambulatory movements (> 10 cm) were 
measured in terms of the number of movements initiated and the distance travelled (cm) during 
such movements. 
 
2.4 Tissue harvesting 
2.4.1 Fresh frozen VTA tissue for radioligand binding 
Rats were anesthetized with isoflurane, and their brains were rapidly removed and frozen 
in -35°C 2-methylbutane for 15 sec, then stored at -80°C prior to sectioning. On a cryostat, serial 
20 μm sections through the VTA were collected (from AP -4.8 to -5.5; Paxinos and Watson, 2007) 
for radioligand binding and localization of GFP expression. Sections were thaw-mounted onto 
glass microslides (Superfrost Plus; Fisher Scientific; Waltham, MA), dried in a vacuum chamber 
at 4°C, and stored at -80°C prior to processing. Separate slides were used to verify the accuracy 
and distribution of lentiviral infusions based on fluorescent detection of GFP expression. 
 
2.4.2 Perfused VTA tissue for BDNF immunohistochemistry  
As previously described (Fanous et al., 2010, Fanous et al., 2011a, Fanous et al., 
2011b), rats were anesthetized with sodium pentobarbital (100 mg/kg, i.p.; Euthasol, Virbac Co., 
St. Louis, MO) and perfused transcardially with 4% paraformaldehyde. Brains were then 
removed, post-fixed for 1.5 hours at 4°C, and placed in graded sucrose solutions. Frozen brain 
tissue was sectioned on a sliding microtome (20 μm) and serial VTA sections were mounted onto 
slides from 0.05 M phosphate buffer (pH = 7.4). Adjacent slides from each brain were processed 
for either BDNF immunohistochemistry or fluorescent localization of GFP expression. 
154 
2.5 [3H]DAMGO autoradiography 
2.5.1 Radioligand binding 
Fresh frozen brain sections were used to verify shMOR knockdown in the VTA using 
tritiated [D-Ala2,N-MePhe4,Gly-ol5] enkephalin ([3H]DAMGO; NIDA Drug Supply Program; 
Bethesda, MD), as described by Zhou and Hammer (1995). Briefly, slides were placed in pre-
incubation solution (15 mM Tris HCl, 150 mM NaCl, 1.0 mg/ml BSA) for 30 min at 4°C, then were 
incubated in 10 nM [3H]DAMGO solution (50 mM Tris buffer, 3.0 mM Mn acetate, 1.0 mg/ml BSA) 
with or without the addition of naloxone (10 μM; NIDA Drug Supply Program) for 60 min at 22°C. 
Slides were washed with a 50 mM Tris buffer at 4°C, then dried and exposed on Kodak BIO Max 
MR X-ray film (Carestream; Sigma-Aldrich; St. Louis, MO) for 10 weeks at room temperature. 
Sections incubated in 1000-fold excess unlabeled naloxone were utilized to determine non-
specific binding in subsequent autoradiography.  
 
2.5.2 Autoradiography analysis 
Autoradiograpy film was developed and scanned at high resolution. In order to determine 
whether the shMOR viral construct infected regions outside of the VTA, the substantia nigra pars 
compacta (SNc) was chosen as a control region due to its close proximity to the VTA, and 
because social stress does not affect MOR expression in substantia nigra regions (Nikulina et al., 
1999, Nikulina et al., 2005). The SNc, not to be confused with the medial terminal nucleus 
accessory optic tract (MT),  contains a higher density of MOR labeling than either the substantia 
nigra pars reticulata (SNr) or VTA (Herkenham and Pert, 1982). Using this difference in 
expression, the SNc could be clearly demarcated on scans of autoradiographs by measuring the 
area directly above the SNr, lateral to the MT, and ventrolateral to the medial lemniscus. Optical 
densities for these regions were measured bilaterally in 2-3 sections using ImageJ (National 
Institutes of Health, USA, http://imagej.nih.gov/ij), and then converted to μCi/g using calibrated 
[3H] radiostandards (ART-123, ARC Inc.; St. Louis, MO) co-exposed with sections. For each 
subject, bilateral measurements were averaged across sections to yield total ligand binding in the 
VTA and SNc, respectively. 
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2.6 BDNF immunohistochemistry and quantification 
2.6.1 Immunohistochemistry 
Immunohistochemistry was performed using BDNF polyclonal antisera as described 
previously (Fanous et al., 2010). Briefly, blocking solution (10% normal goat serum/0.5M 
KPBS/0.4% Triton X-100) was applied to sections for 1 h at room temperature, then the primary 
antibody diluted in blocking solution (1:1000 dilution; SP1779, Millipore/Chemicon; Temecula, 
CA) was applied for 48 hr at 4°C. Sections were then incubated for 1 h with a biotinylated rabbit 
secondary antibody, treated with avidin/biotin complex solution for 45 min (Vectastain Elite ABC 
Kit; Vector Laboratories; Burlingame, CA), and developed using a diaminobenzidine (DAB) 
peroxidase substrate kit with nickel intensification (Vector Laboratories). 
 
2.6.2 Modified stereological cell counts 
Tissue sections were imaged using a Zeiss Axioskop with a 20x objective, and digitalized 
using a color digital camera. Immunolabeled cells were quantified using Stereo Investigator 
software (MBF Biosciences; Williston, VT), and the analysis was conducted using the modified 
stereology counting procedure described in Fanous et al. (2011a) and Nikulina et al. (2012). 
Briefly, a grid of 48 squares (0.0075 mm2) was overlaid on each of 2-3 VTA sections from each 
subject. Immunolabeled cells were counted in half the grid squares, the precise squares being 
randomly determined. Cells exhibiting a black-blue reaction product indicative of immunolabeling 
were counted such that cells crossing the bottom or right lines of each square were included, 
while cells crossing the top or left lines of the square were excluded from analysis. For each 
subject, estimates of total labeling density (mm2) were calculated by averaging the bilateral 
counts of labeled cell profiles across sections, and then dividing the total number of cell profiles 
by the total area assessed (0.18 mm2). 
 
2.7 Statistical analyses 
The results of each measure are expressed as mean ± standard error (SEM) and a p 
value ≤ 0.05 was considered to be significant. All statistical analyses were run using SPSS 
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software, version 18 (SPSS Inc., Chicago, IL), and Tukey’s HSD was considered the preferred 
post hoc test across experiments. An exception was made in the case of the amphetamine 
challenge, where Fisher’s LSD was used because violations of sphericity necessitated our use of 
a more conservative test of the main effects. Data from subjects were excluded only in the case 
of error during video tracking or loss of data due to damaged tissue sections: no statistical outliers 
were excluded. The locomotor and social approach and avoidance assays relied on automated 
video tracking systems, requiring that the animals be housed in black bedding to block light from 
reflecting off the cage bottom. However in some instances, rats exposed the cage floor while 
moving, causing illumination artifacts that necessitated the removal of individual bin data due to 
inaccurate tracking. In addition, damage to tissue sections during processing sometimes 
precluded data collection from brain regions. More specifically in the locomotor and social 
approach and avoidance assays, which relied on automated video tracking systems, individual 
bin data were removed in those instances where reflection artifacts prevented accurate tracking. 
For analyses of mounted tissue sections, the sample size of each group was also reduced in 
cases where tissue was damaged in the course of processing.  
 
2.7.1 Weight gain data 
The initial weight obtained at the start of social stress procedures was used to normalize 
all subsequent data (n = 25) to weight gained from that time onward; no subjects were excluded 
from the analysis. A one-way analysis of variance (ANOVA) was performed to assess differences 
in weight at each time point, and all significant main effects were analyzed using Tukey’s test for 
post hoc comparisons among the means.  
 
2.7.2 Social interaction 
Social approach and avoidance data were analyzed in terms of the number of entries to, 
and the distance travelled (cm) within the interaction and avoidance zones (Fig. 1B). Where 
illumination artifacts interfered with tracking, data were lost in a zone-specific manner. For 
example, avoidance zone entry data were analyzed from 40 subjects because illumination 
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artifacts resulted in the exclusion of subjects from the following groups: GFP-Handled: 1; GFP-
Stressed: 3; shMOR-Handled: 2. For distance travelled in the avoidance zone, an additional 
tracking error which occurred after a subject entered the zone further reduced the number of 
analyzed subjects to 35; subjects were excluded from the following groups: GFP-Handled: 2; 
GFP-Stressed: 1; shMOR-Handled: 5; shMOR-Stressed: 3. Illumination artifacts and tracking 
error reduced the number of subjects in the interaction zone to 37;  subjects were excluded from 
the following groups: GFP-Stressed: 3; shMOR-Handled: 4; shMOR-Stressed: 2. A one-way 
ANOVA was run on data pertaining to each zone and any significant main effects were followed 
by an analysis of post hoc comparisons with Tukey’s test.  
 
2.7.3 Locomotor activity 
 Locomotor data were analyzed using separate multivariate analysis of variance (MANOVA) 
for the mean number and distance (cm) travelled during ambulatory movements. In order to 
overcome violations of sphericity in the output of repeated measures ANOVA, MANOVA was 
used to analyze the number and distance of ambulatory movements exhibited throughout the 
amphetamine challenge. Significant multivariate effects were followed by univariate analyses to 
determine which time points produced significant group differences. Significant univariate effects 
were further analyzed for post hoc comparisons using Fisher’s Least Significant Difference (LSD) 
test. Data were analyzed from 21 subjects for both dependent measures of ambulatory 
movements. Some subjects’ data were excluded from analysis due to the presence of illumination 
artifacts that interfered with tracking: GFP-Stressed: 2; shMOR-Handled: 1; shMOR-Stressed: 1. 
 
2.7.4 MOR binding and BDNF expression 
The results of radioligand binding with [3H]DAMGO in the VTA and SNc, as well as the 
results of BDNF immunohistochemistry in the VTA were analyzed using separate one-way 
ANOVAs, and where necessary, significant main effects were followed by post hoc comparisons 
with Tukey’s test. In the case of VTA [3H]DAMGO results, a violation of homogeneity was 
corrected for with Welch’s F test.  Sample sizes were reduced after the target region was 
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damaged during processing for BDNF immunohistochemistry in 2 subjects from the shMOR-
Handled group, and during [3H]DAMGO binding for 1 shMOR treated subject. Consequently, 
BDNF data were analyzed from 19 subjects, while receptor autoradiography was analyzed from 
25 subjects in the VTA and 24 subjects in the SNc.  
 
3. Results 
3.1 Verification of MOR Knockdown Using [3H]DAMGO Autoradiography 
Fluorescent detection of virally expressed GFP revealed that lentiviral infusions were 
specific to the VTA (Fig. 2A), and GFP was not detected in either SN region (data not shown). 
While lentiviral constructs were infused at AP -5.15, GFP expression indicated infusions to the 
target site varied by ±0.1 mm, and that the average spread of GFP was within AP -4.8 to -5.5 and 
Lateral 0.4 mm to 1.4 mm (Fig. 2B). Quantitative in vitro autoradiography with [3H]DAMGO was 
used to determine the functionality of VTA MORs after lentivirus-mediated knockdown. Compared 
to the control GFP lentiviral construct, the subjects infused with the shMOR construct showed 
reduced [3H]DAMGO binding (Fig. 2C). One-way ANOVA revealed that this effect was significant 
in the VTA (n = 25, F1,20.13 = 102.46, p < 0.0001), but not the SNc  (n = 24, F1,22 = 1.63, p > 0.22; 
Fig. 2D). Thus, our surgeries were accurate and bilateral shMOR knockdown selectively reduced 
VTA MOR binding density. 
 
3.2 Effect of VTA MOR knockdown on intermittent social stress-induced deficit of weight gain 
Weight gain data (n = 25) revealed a significant main effect during social stress exposure 
(F3,21 = 10.15, p < 0.0003; Fig. 3), and 10 days after the last stress episode (F3,21 = 9.46, p < 
0.0004). Post hoc comparisons at this time point show that the GFP-Stressed group experienced 
less weight gain than either the GFP-Handled or shMOR-Handled groups (p < 0.006), while the 
shMOR-Stressed group only differed from the shMOR-Handled group (p < 0.02). Ten days after 
the final episode of social stress, the GFP-Stressed group showed significantly lower body 
weights compared not only to GFP-Handled and shMOR-Handled groups (p ≤ 0.006), but also 
the shMOR-Stressed group (p < 0.05). These data suggest that social stress significantly reduces 
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body weight, and that while VTA MOR knockdown attenuated this effect during social stress 
exposure, it rescued this effect 10 days after termination of stress. 
 
3.3 Effect of VTA MOR knockdown on intermittent social stress-induced social avoidance 
The social approach and avoidance test revealed a main effect of experimental group on 
number of entries to the avoidance zone (n = 40, F3,36 = 5.89, p = 0.002), with significantly more 
entries by GFP-Stressed rats compared to both GFP-Handled (p < 0.005) and shMOR-Stressed 
(p < 0.004) groups (Fig. 4A). Similarly, there was a significant main effect of experimental group 
on the distance traveled in the avoidance zone (n = 35, F3,31 = 4.77, p = 0.008), with significantly 
more activity in the GFP-Stressed group than the GFP-Handled (p = 0.011), shMOR-Handled (p 
< 0.05), or shMOR-Stressed (p < 0.05) groups. There was no main effect of experimental group 
on the number of entries to the interaction zone (n = 37, F3,26 = 1.14, p = 0.351; Fig. 4C). These 
data suggest that prior social stress exposure significantly increases social avoidance, and local 
VTA depletion of MOR prevents social stress-induced social avoidance without significantly 
altering social interaction.  
 
3.4 Effect of VTA MOR knockdown on intermittent social stress-induced cross-sensitization 
There were significant main effects of experimental group on the number of ambulatory 
movements (n = 21, Wilks’ λ = 3.78x10-7, F51.0,17 = 10.57, p = 0.019, η2 = 0.993, observed power = 
0.87) and distance travelled during ambulatory movements(n = 21, Wilks’ λ = 1.26x10-6, F51.0,17 = 
7.03, p = 0.039, η2 = 0.989, observed power = 0.87) across all time points. The number of 
movements differed significantly only, at 30 (F 3,17 = 3.66, p = 0.034), 40 (F3,17 = 3.36, p = 0.043), 
and 50 (F3,17 = 4.46, p = 0.017) min after amphetamine injection, but there were no differences 
across groups before or after saline injection (p > 0.05 at all other time points). Post hoc testing 
(Fig. 5A) showed that the GFP-Stressed group exhibited significantly greater number of 
movements compared to GFP-Handled (p < 0.005) and both shMOR-Handled and -Stressed 
groups (p < 0.05) at 30 min after amphetamine injection, compared to GFP-Handled (p < 0.01) 40 
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min post-amphetamine, and compared to GFP-Handled (p < 0.002) and both shMOR-Handled 
and -Stressed groups (p < 0.03) 50 min after amphetamine.  
Similarly, distance travelled exhibited significant main effects only 20 (F3,17 = 3.51, p = 
0.038), 30 (F3,17 = 6.83, p = 0.003), and 40 (F3,17 = 4.86, p = 0.013) min after amphetamine 
injection. Post hoc analyses (Fig. 5B) showed that the GFP-Stressed group moved a significantly 
greater distance compared to the GFP-Handled, shMOR-Handled, and shMOR-Stressed groups 
(p < 0.02)  20 min after amphetamine injection, compared to GFP-Handled and both shMOR 
groups (p < 0.002) 30 min post-injection, and compared to the GFP-Handled and both shMOR 
groups (p < 0.03) groups 40 min post-amphetamine. Thus, the GFP-Stressed group showed 
social stress-induced cross-sensitization following amphetamine challenge, but the shMOR-
Stressed group did not. 
 
3.5 Effect of VTA MOR knockdown on VTA BDNF after intermittent social stress exposure 
There was a significant main effect of experimental group on VTA BDNF expression (n = 
19, F3,15 = 30.17, p < 0.0001), such that the GFP-Stressed group had significantly greater VTA 
BDNF expression compared to GFP-Handled, shMOR-Handled, and shMOR-Stressed groups (p 
< 0.0001, Fig. 6). There were no significant differences between GFP-Handled and either of the 
shMOR groups, regardless of stress treatment (p > 0.15). Thus, social stress-induced increase of 
VTA BDNF expression is blocked by knockdown of MORs in the VTA.  
 
4. Discussion 
Our data show that lentivirus-mediated overexpression of shMOR successfully reduced 
MOR binding activity in the VTA, and that the affected region was limited to the VTA. 
Furthermore, we show that intermittent social stress induction of VTA MORs is required for 
various behavioral and biological changes. For example, we observed that lentivirus-mediated 
knockdown of VTA MORs blocks intermittent social stress-induced social avoidance, cross-
sensitization to amphetamine, and deficit of weight gain, as well as the augmented VTA BDNF 
expression which normally persists 1-4 weeks after stress exposure.  
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4.1 VTA MOR upregulation is necessary for intermittent social stress-induced weight gain deficits  
Exposure to social stress attenuated weight gain both during and 10 days after social 
stress exposure, which is consistent with previous findings (Meerlo et al., 1996, Pulliam et al., 
2010, Fanous et al., 2011b, Venzala et al., 2012). VTA MOR knockdown rescued the deficit of 
weight gain 10 days after the last episode of stress, but not during stress exposure. That 
knockdown of VTA MORs attenuated and promoted recovery from social stress-induced weight 
gain deficit is consistent with a report of increased body weight in MOR knockout mice (Han et al., 
2006). Another study using the same lentiviral construct in the VTA (Lasek et al., 2007) also 
showed no significant effect on weight, indicating that VTA MOR knockdown is not sufficient to 
alter weight gain in the absence of social stress. 
The role of MORs in the regulation of food intake and weight gain is complex, making it 
difficult to separate MOR effects on food palatability, food intake, and a more general increase of 
hedonic value. Pharmacological stimulation of MORs has frequently been associated with 
increased hedonic value of food and drug stimuli (Badiani et al., 1995, Nathan and Bullmore, 
2009), while MOR antagonism has been associated with decreased consumption of highly 
palatable food (Segall and Margules, 1989), as well as decreased sensitivity to natural reward 
(Pitchers et al., 2014). Stimulation of VTA MORs has been found to facilitate food consumption in 
a dopamine D1 receptor-dependent manner (Badiani et al., 1995, MacDonald et al., 2004), while 
antagonism reduced consumption of palatable foods (Segall and Margules, 1989). Based on this, 
one might expect that VTA MOR knockdown would further reduce weight gain by altering feeding 
behaviors. By contrast, our data show that VTA MOR knockdown rescues the stress-induced 
deficit in weight gain without affecting normal weight gain.  
If knockdown of VTA MORs rescued the stress-induced reduction of weight gain by 
attenuating the psychological effects of stress, one might expect to see signs of increased reward 
or hedonic value in the amphetamine challenge or social approach and avoidance test. However, 
compared to GFP-Handled rats, subjects in the shMOR-Handled group did not show increased, 
or impaired response to amphetamine, or differ in social interaction. That subjects with VTA MOR 
knockdown, regardless of stress treatment, did not exhibit significant differences in weight gain 
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compared to control GFP-Handled subjects, suggests that the rescue of weight gain is likely due 
to the prevention of downstream stress-induced changes in the mesolimbic circuit. In support of 
this idea, stress-induced increase of VTA BDNF expression was prevented by VTA MOR 
knockdown, and BDNF expression in the VTA is necessary for the stress-induced deficit of weight 
gain (Fanous et al., 2011b).  
The current study did not measure food consumption, so we cannot ascertain whether 
altered food intake contributed to the weight gained after stress with or without VTA MOR 
knockdown. However, if the stress-induced deficit of weight gain were related to VTA MOR-
mediated changes in food intake, one would expect both Handled- and Stressed-shMOR 
knockdown groups to show significant differences in weight gain compared to GFP-Handled rats, 
which was not the case. There is some evidence to suggest that that MOR activity can alter 
weight gain without producing deficits in food consumption. In particular, daily morphine injection 
for 8 days had no effect on weight gain or food intake, while a parallel group of subjects that 
received escalating doses of morphine exhibited reduced weight gain without significant any 
significant effect on food consumption (Ren et al., 2013). In the same study, injections of 
escalating doses of morphine led to activation of cAMP responsive binding element protein 
(pCREB) in the VTA, implicating this region in MOR-mediated reduction of weight gain, but not 
food intake. Based on this, it is possible that escalating endogenous mu-opioid activity in the VTA 
underlies the weight gain deficit seen after social stress. 
 
4.2 Upregulation of VTA MORs is necessary for intermittent social stress-induced social 
avoidance 
Rodents with non-manipulated VTA MORs and a history of social stress engaged in 
significantly more social avoidance (Berton et al., 2006, Fanous et al., 2010, Komatsu et al., 
2011). However, MOR knockout mice do not show social avoidance after continuous social stress 
(Komatsu et al., 2011), just as our knockdown of VTA MORs prevented intermittent social stress-
induced social avoidance. MORs have been implicated in the rewarding components of social 
behavior, while MOR antagonists are associated with reduced social play (Vanderschuren et al., 
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1997) and experience-induced facilitation of sexual behavior (Pitchers et al., 2014), allowing for 
the possibility that VTA MOR knockdown might alter normal social interaction. However, our data 
reveal that VTA MOR knockdown in handled rats did not alter any measures of social interaction, 
suggesting that VTA MORs affect social behavior only upon the impact of stress exposure. 
Previous research has also indicated that social history alone (isolation vs. social 
housing) or in conjunction with a social interaction test has a profound effect on MOR expression 
(Vanderschuren et al., 1995). Specifically, long-term social isolation increased MOR binding 
density in the VTA, while an acute social interaction reduced VTA MOR binding. Taken together, 
it is possible that positive and negative social situations alter VTA MOR expression, respectively 
decreasing or increasing VTA MOR activity.  
 
4.3 Knockdown of VTA MORs prevents intermittent social stress-induced cross-sensitization 
Stressed rats with non-manipulated VTA MORs exhibited significantly greater locomotor 
activity after a low dose amphetamine challenge, confirming prior reports that intermittent social 
stress induces amphetamine cross-sensitization 10 days after the last stress episode (Covington 
and Miczek, 2001, Nikulina et al., 2012). By contrast, knockdown of VTA MORs prevented social 
stress-induced cross-sensitization without blocking amphetamine-induced locomotion. VTA 
MORs are presynaptically expressed by GABA neurons (Sesack and Pickel, 1995, Garzon and 
Pickel, 2002), and when activated, reduce GABAergic inhibition of VTA DA neurons (Johnson 
and North, 1992, Bergevin et al., 2002, Vargas-Perez et al., 2009b, Trigo et al., 2010, Dacher and 
Nugent, 2011) and facilitate response to psychomotor stimulants . Thus, if stimulation of MORs in 
the VTA indirectly increases VTA DA activity by reducing GABA transmission, then it is likely that 
knockdown of VTA MORs increases GABA release. In fact, MOR knockout mice showed 
enhanced VTA GABA release onto local DA neurons, resulting in reduced cocaine self-
administration (Mathon et al., 2005). 
We observed that knockdown of VTA MORs did not block psychomotor activation 
following amphetamine challenge, even though treatment with a MOR antagonist has been 
shown to abolish amphetamine responses (Magendzo and Bustos, 2003). This suggests that 
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knockdown of VTA MORs does not produce unnatural alterations of mesolimbic tone. Our results 
reveal that VTA MOR upregulation is necessary for intermittent social stress-induced cross-
sensitization to amphetamine. As such, in the VTA social stressors may function to increase 
endogenous MOR activity on GABA neurons, thus reducing the GABAergic inhibition of local DA 
neurons and facilitating behavioral sensitization to psychostimulant drugs. 
 
4.4 VTA MORs are necessary for induction of VTA BDNF by intermittent social stress 
The two-fold increase of VTA BDNF expression which we observed in the VTA is 
consistent with previous reports (Berton et al., 2006, Fanous et al., 2010, Nikulina et al., 2012). 
More importantly, we found that knockdown of VTA MORs prevents induction of VTA BDNF by 
social stress exposure. That knockdown of VTA MORs blocks social stress-induced increase of 
BDNF labeling suggests that VTA BDNF induction after social stress exposure is dependent on 
local MOR upregulation. In fact, increased MOR activity in hippocampus also induces local BDNF 
mRNA (Zhang et al., 2006). While others have suggested that VTA BDNF modulates the function 
of local MORs (Vargas-Perez et al., 2009b, Koo et al., 2012), we show herein that VTA MORs 
can regulate the local expression of BDNF. These reciprocal findings may be attributed to 
differences between exogenous opiate and endogenous opioid functions, as well by differences 
in the VTA input systems recruited by exposure to morphine and social stress. 
Although VTA BDNF is predominantly thought to be found in DA neurons (Gall et al., 
1992, Seroogy et al., 1994), it is possible that MORs may control the transmission of VTA GABA 
neurons to indirectly produce subsequent changes in local DA neurons. Specifically, if MOR 
activity on GABA neurons increases the excitability of local DA neurons (Mathon et al., 2005), 
then the subsequent reduction in VTA GABAergic tone allows for MORs to affect BDNF 
expression in VTA DA neurons, potentially by altering the intracellular signaling that regulates 
BDNF expression in DA, for example mitogen-activated protein kinase/extracellular regulated 
kinase (MAPK/ERK) or cAMP responsive binding element protein (CREB; Shieh and Ghosh, 
1999, Lu et al., 2006, Covington et al., 2011, Russo and Nestler, 2013).  
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Previous studies have indicated that VTA BDNF is crucial for social stress-induced social 
avoidance (Berton et al., 2006, Fanous et al., 2011b) and cross-sensitization to amphetamine 
(Wang et al., 2013), and have shown that VTA MOR upregulation occurs early in the cross-
sensitization process (Nikulina et al., 1999, Nikulina et al., 2005, Nikulina et al., 2008), prior to a 
persistent increase of VTA BDNF expression (Fanous et al., 2010). Thus it is likely that our VTA 
MOR knockdown prevented social stress-induced alterations of behavior by preventing increased 
BDNF expression as a consequence of MOR-dependent increases in VTA GABAergic tone. In 
support of this, and consistent with the preventative behavioral effects of our VTA MOR 
knockdown, is the study by Mathon et al. (2005), in which genetic MOR knockout mice showed 
increased GABAergic input onto local VTA DA neurons and decreased cocaine reinforcement. 
Thus it is likely that social stress upregulates MOR expression on VTA GABA neurons to facilitate 
BDNF expression in local DA neurons, while VTA MOR knockdown may increase VTA 
GABAergic tone, preventing subsequent social stressor-induced changes in the region. 
 
4.5 Concluding remarks 
  In summary, knockdown of MORs in the VTA prevents intermittent social stress-induced 
cross-sensitization to amphetamine, social avoidance, deficit of weight gain, and increase of VTA 
BDNF expression. In rats, continuous social stress suppresses cocaine reward and decreases 
VTA BDNF expression (Miczek et al., 2011a), however it is unknown whether continuous social 
stress alters VTA MOR expression. It is possible that continuous social stress reduces cocaine 
reward and VTA BDNF expression as a function of downregulated VTA MOR expression, which 
would suggest that VTA MORs may mediate a switch between the sensitizing effects seen with 
intermittent social stress and the suppressed cocaine reward observed after continuous social 
stress. 
  The nucleus accumbens (NAc), with reciprocal projections to the VTA, has also been 
identified as a brain region crucial for the effects of stress, drugs of abuse, and food 
intake/palatability. Since VTA MOR knockdown likely functioned in the present study to block 
stress-induced increase of dopaminergic tone, this manipulation also might prevent stress-
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induced changes in the NAc. Future studies are needed to determine whether VTA MOR 
knockdown alters stress-induced changes in the NAc, and the importance of NAc 
neurotransmission for stress-induced effects associated with the VTA.  
  In conclusion, our results indicate that social stress exposure increases VTA MOR 
activity, potentially disinhibiting VTA dopaminergic tone to facilitate response to drugs of abuse. 
The present data suggest that upregulation of VTA MORs following social stress exposure may 
underlie vulnerability to psychostimulant drugs in some individuals, thereby providing a potential 
target for therapeutic intervention during abuse of these drugs. 
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Figure Captions 
Figure 1. Timeline of experimental events and schematic of social approach and avoidance test 
procedure. (A) Rats were given 7 days to recover from surgery, and were then exposed to 
intermittent (4x in 10 days) social defeat or handling procedures. Two days after the last episode 
of defeat, all rats were given the social approach and avoidance test. Ten days after the last 
episode of defeat, one group received amphetamine challenge while a separate group was 
perfused to examine immunohistochemical changes at the time cross-sensitization is observed. 
Five days after receiving the amphetamine challenge, brains from the remaining rats were 
removed and processed for in vitro [3H]DAMGO autoradiography to verify the location and 
efficacy of MOR knockdown. (B) All experimental subjects were assessed for social approach 
and avoidance using a procedure adapted from Berton et al. (2006). Left: Virtual arena dividing 
the chamber into 2 virtual zones: Interaction Zone (IZ), comprising of the 1019.35 cm2 area 
immediately surrounding the containment cage, and Avoidance Zone (AZ), which comprised the 
two corners, combined 52.2 cm2, opposite the containment cage. Right: Schematic of the timeline 
for the social approach and avoidance procedure. 
 
Figure 2. [3H]DAMGO autoradiography revealed that the shMOR construct, but not the 
scrambled GFP construct, significantly reduced MOR binding in the VTA, but not the SNc. (A) 
Left: Representative image of reporter GFP expression in infected VTA cells (fr: fasciculus 
retroflexus; scale bar = 100 µm). Right: Plate 37, modified from Paxinos and Watson (2007). (B) 
Parasagittal illustrations showing the extent of GFP expression across the VTA, drawn in green 
(lateral plates 0.40 - 1.4, modified from Paxinos and Watson, 2007). (C) Representative 
autoradiographs of [3H]DAMGO binding in the VTA after infusion of either scrambled-GFP or 
shMOR lentiviral constructs (MT: medial terminal nucleus of the accessory optic system; scale 
bar = 500 µm). (D) shMOR lentiviral construct (n = 14) significantly (* - p < 0.0001) reduced MOR 
binding in the VTA compared to the scrambled-GFP construct (n = 11), without affecting MOR 
binding of either the GFP (n = 11) or shMOR (n = 14) groups in the adjacent SNc (p > 0.22). 
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Figure 3. Knockdown of VTA MORs prevents social stress-induced deficit of weight gain. While 
undergoing social stress or handling, GFP-Stressed rats (n = 5) exhibited significantly (** - p < 
0.05) less weight gain than did GFP-Handled (n = 6) or shMOR-Handled (n = 7) rats. By contrast, 
shMOR-Stressed rats (n = 7) did not differ from GFP-Handled or -Stressed rats, showing 
significantly (α - p < 0.05) less weight gain than shMOR-Handled rats. Ten days after the last 
episode of exposure, GFP-Stressed rats had gained significantly (* - p < 0.05) less weight than all 
other groups. 
 
Figure 4. Knockdown of VTA MORs prevents social stress-induced social avoidance. (A) GFP-
Stressed rats (n = 7) made significantly (* - p < 0.005) more entries to the avoidance zones than 
did GFP-Handled (n = 7) or shMOR-Stressed rats (n = 14). (B) GFP-Stressed rats (n = 9) were 
significantly (*** - p < 0.05) more active in the avoidance zones than GFP-Handled (n = 7), 
shMOR-Handled (n = 8), or shMOR-Stressed (n = 11) rats. (C) GFP-Stressed rats (n = 7) showed 
a slight tendency to spend less time in the interaction zone, but there was no significant (p > 0.3) 
main effect compared to GFP-Handled (n = 9), shMOR-Handled (n = 9), or shMOR-Stressed (n = 
12) groups. 
 
Figure 5. Knockdown of VTA MORs prevents social stress-induced amphetamine cross-
sensitization without affecting baseline activity. Multivariate analyses revealed that the only 
significant main effects occurred during the amphetamine phase of the assay. Data collection and 
video tracking were paused to administer saline and amphetamine, vertical arrows denote the 
time point when injection occurred. (A) GFP-Stressed rats (n = 4) exhibited significantly (*** - p < 
0.05) more movements at 120 and 140 min compared to GFP-Handled (n = 5), shMOR-Handled 
(n = 6), and shMOR-Stressed (n = 6) rats, and differed significantly (* - p < 0.02) from GFP-
Handled rats at 130 min. (B) GFP-Stressed rats travelled a significantly (*** - p < 0.03) greater 
distance at 110, 120, and 130 min compared to all other groups. 
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Figure 6. Knockdown of VTA MORs blocks social stress-induced increase of VTA BDNF 
expression. (A) Representative images of BDNF labeling in the VTA approximately AP -5.1 from 
bregma. More BDNF labeled cells (identified by arrows) are visible in the GFP-Stressed group 
than in any others. (Scale bar = 100 μm) (B) The GFP-Stressed group (n = 5) exhibited 
significantly (* - p < 0.0001) more VTA BDNF immunolabeling than GFP-Handled (n = 4), 
shMOR-Handled (n = 4), or shMOR-Stressed (n = 6) groups. Numbers of labelled cells did not 
significantly differ between GFP-Handled rats and either shMOR group (p > 0.15). 
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